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Sum m ary
Prior to the start of this project, several recombinants had been selected from a 
library of human genomic DNA cloned in XCharon 4A using a mixed tRNA probe 
(Goddard et a l ., 1983). One such clone was termed XHt363. Restriction digests of 
DNA from this recombinant were transferred to nitrocellulose membranes and 
hybridised to the mixed tRNA probe used in the original cloning. Several fragments 
from each digest hybridised to the probe, indicating the possible presence of a tRNA 
gene cluster. The cluster was partially characterised (McLaren and Goddard, 1986) 
and found to contain a 4.2 kb Bam HI fragment carrying three tRNA genes, coding 
for tRNALys, tRNA^ln tRNA^eu. The partial sequence of a fourth gene, 
coding for tRNA^ly, was found at one end of an 800 bp Eco RI fragment, thought 
to originate from close to the right hand arm of the X recombinant.
The restriction map of XHt363 was determined, and the positions of the genes 
ascertained by correlating the restriction map with the restriction fragments which 
hybridised to the mixed tRNA probe. The genes and their immediate flanking 
regions were sequenced, confirming the presence of a tRNA^ly gene. A previously 
undetected fifth tRNA gene from the recombinant was detected by its transcription in 
vitro and sequenced. This tRNA gene codes for a tRNA^rg with an intron. The 
presence of an intervening sequence in the tRNA-^g gene possibly explains its poor 
hybridisation to the mixed tR N A  probe. The genes for tR N A L y s ,  tRNA^ln and 
tRNA^eu have identical coding and almost identical flanking sequences to a cluster 
previously published (Roy et a l ., 1982). The gene coding for t R N A ^ l y  has an 
identical coding and flanking sequence to one published during the course of this 
study (Doran e ta l . ,  1988). The restriction map of AJit363 differs from those of the 
other published recombinants, suggesting that XHt363 contains a different fragment 
of genomic DNA. The insert of ^Ht363 contains a large number of sites for 
restriction endonucleases with G+C rich recognition sequences. The distribution of 
these recognition sites, together with sequence data, suggests that the insert contains 
regions significantly richer in G+C than the norm for human genomic DNA.
Restriction fragments containing tRNA genes, or individual tRNA gene probes, 
(generated by amplification using the polymerase chain reaction) were employed in 
Southern hybridisations to human genomic DNA. Such experiments were used to 
give an estimate of the copy number of the tRNA gene cluster, calculated as 2.7 
copies per haploid genome. Probes from the insert of XHt363 hybridised to
xiv
genomic restriction fragments which corresponded in size to fragments predicted on 
the basis of the restriction map of AHt363, suggesting that the insert of the 
recombinant had not undergone any rearrangements relative to genomic DNA.
Polymerase chain reaction experiments were also used to investigate whether the 
cloned tRNA gene cluster had undergone any rearrangements, by comparing the 
sizes of the fragments amplified when using genomic or XHt363 DNA as the target 
for primers which recognised different sequences within the cluster. A fragment of 
unexpected size (623 bp) was amplified when using primers specific for the 
tRNA^ln gene from the tRNA gene cluster on a human genomic DNA target. This 
fragment was cloned and sequenced and found to contain two human tRNA^ln 
genes, arranged as a direct repeat. Finally, polymerase chain reaction amplification 
and direct sequencing of genomic copies of the tRNA-^rg gene facilitated the 
determination of the nature of the intervening sequence in this tRNA gene family.
In vitro transcription assays were used to establish the maximum transcription 
rate for each of the five tRNA genes from A.Ht363. The ranking of transcriptional 
efficiency in this system, from most active to least active gene, was tRNA^ly, 
tR N A ^g, tR N A ^ 11, tRNA^ln and tRNA^ys. The last four of these tRNA genes 
were found to have the same relative transcriptional activities when transcribed as a 
cluster. An investigation into the processing of tRNA precursors in the in vitro 
transcription system, particularly using the tRNA^rg gene, suggested that this 
system does not efficiently produce mature tRNA species. For the final group of in 
vitro transcription assays, a series of recombinants were constructed with differing 
amounts of the 5’ flank of the tRNA^ty gene deleted. Transcription and competition 
assays using these recombinants indicated that the 5’ flank of this gene may contain 
an element or elements that affect transcription. Preliminary gel shift and footprinting 
assays were undertaken to investigate the possibility of any protein or proteins 
associating with this region of DNA.
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INTRODUCTION.
1.1. General introduction.
The major role of transfer RNAs (tRNAs) is to act as adaptor molecules in protein 
synthesis, although some specific tRNAs have additional functions. They can act as 
donors of their charged amino acids in the formation of some cell walls and as 
primers for reverse transcriptase in the synthesis of some retrovirus DNAs. Some 
tRNAs also have a role in amino acid biosynthesis. The existence of adaptor 
molecules, needed for the translation of information carried by nucleic acids, was 
predicted by Crick in 1955. Transfer RNAs were shown to be these adaptors by 
Hoagland et al..> (1958). Recent advances in the techniques of molecular biology 
have led to a very rapid accumulation of data on the sequences, organisation and 
expression of tRNA genes. Up to the end of 1988 almost 1000 tRNA genes had 
been cloned and sequenced (Sprinzl et a l ., 1989). Results from recent experimental 
work indicate a high degree of complexity in the fine control of expression and the 
genomic organisation of these genes. Since tRNAs play a central role in protein 
synthesis, a better picture of the way in which tRNA gene expression is controlled 
might be useful in increasing understanding of how organisms meet the demand for 
the production of proteins, particularly where there are highly tissue- or 
developmental stage-specific patterns of protein synthesis. The organisation of 
eukaryotic genomes is another area attracting considerable interest in current research 
in the field of molecular biology. Studies of the way in which tRNA genes are 
organised in eukaryotes might help insight into the mechanisms of evolution of 
complex genomes, and cloned tRNA genes could also be useful as markers for 
genetic mapping.
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1.2. tRNA structure
The nucleotide sequences of some 400 tRNAs and some 1000 tRNA genes have 
been determined. This primary sequence data provides strong evidence for a 
secondary structure common to almost all tRNAs, the familiar "cloverleaf' 
secondary structure shown in figure 1.1. This structure, proposed by Holley et al.., 
(1965) is maintained by base pairing between short complementary regions. Each 
cloverleaf is made up of a number of domains, consisting of a double helical stem, a 
single-stranded loop or both a stem and a loop, collectively termed an arm. The 
amino acid acceptor stem contains the 5’ and 3’ ends of the tRNA molecule. Usually 
the stem is made up of seven Watson-Crick base pairs, but a "wobble” G-U pair is 
present in a yeast tRNA^he (Clark and Klug, 1975). The 3' terminus consists of 
four unpaired nucleotides, the last three of which, CCA, are added 
post-transcriptionally in eukaryotes (see section 1.5.5.). The cognate amino acid is 
attached to the 3' terminal A. The D arm (see figure 1.1.) is so called because it 
almost always contains the modified nucleoside dihydrouridine (D). This arm 
consists of a three or four base pair stem and a variable sized loop. The anticodon 
arm has a stem of five base pairs and a loop of seven nucleotides. The middle three 
nucleotides of the loop form the anticodon of the tRNA which pairs with the triplet 
codon on mRNA during protein synthesis. The variable arm has between four and 
twenty-one nucleotides, arranged either as a loop of four or five residues or as a 
stem and loop. Finally, the TVFC arm consists of a five base pair stem and a seven 
nucleotide loop. The loop always contains the sequence T'FC OP represents 
pseudouridine). Modified residues are a characteristic feature of tRNAs (Sprinzl et 
al., 1989).
All tRNAs have invariant nucleotides in the positions indicated in figure 1.1. as 
well as semi-invariant nucleotide positions (constant purine, (R), or constant 
pyrimidine, (Y)) (Rich and RajBhandry, 1976). The numbering scheme of the tRNA 
nucleotides shown in figure 1.1. is based on that of a yeast tR N A ^e which has 76 
residues. The total length of tRNAs varies between 74 and 95 nucleotides. 
However, because the variability in size of tRNAs is confined to three regions of the 
sequence (two regions in the D loop and the variable arm) a common numbering 
scheme for all tRNAs is possible.
The three dimensional structure of a yeast tRNA^^e was determined in 1974
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using X-ray diffraction analysis of the crystallised tRNA (Suddath et al., 1974; 
Robertus et a l,  1974). The tertiary structure deduced using this data appears to be 
common to all tRNAs. Figure 1.1 shows the L-shaped configuration of this 
structure, formed by tertiary hydrogen bonding interactions, many of which involve 
invariant or semi-invariant nucleotides. The entire structure is about 2.5 nm thick 
and 9 nm long (Kim, 1979). The cloverleaf secondary structure is folded into the L 
shape by the formation of two double helices, one formed by the acceptor stem with
the T'FC stem and the other by the D stem with the anticodon stem. The region
coaxial stacked
between the \  helices contains the T'FC loop and the D loop. A consequence of 
this conformation is that the amino acid acceptor CCA is located at the far end of the 
L from the anticodon. This may facilitate alignment of charged tRNAs on the 
ribosome, although this has not been proved.
1.3. tRNA identity.
In order for protein synthesis to occur correctly, each tRNA must be aminoacylated 
with the appropriate amino acid through , the action of an aminoacyl-tRNA 
synthetase. Because of degeneracy in the genetic code, most amino acids are 
represented by a group of tRNAs, termed isoacceptors. In general there is a single 
aminoacyl-tRNA synthetase for each amino acid. Each group of isoaccepting tRNAs 
must share a set of features enabling recognition only by the cognate 
aminoacyl-tRNA synthetase. These distinguishing elements comprise the identity of 
the tRNA. Recently, two complementary approaches have been used in determining 
the mechanisms of tRNA identity, one involving the alteration of tRNA suppressor 
identity and the other the production of altered tRNAs in vitro using transcription of 
synthetic tRNA genes (reviewed in Normanly and Abelson, 1989). Such studies 
have produced two main conclusions. Firstly, it appears that tRNA identity is 
determined by a relatively small number of elements, and these can act either 
positively in determining the identity of a tRNA or negatively in preventing 
recognition by an aminoacyl-tRNA synthetase. Secondly, the anticodon appears to 
be an important identity element for a majority of tRNAs. The anticodon would seem 
to be the most logical identity element since it is directly responsible for association 
with the appropriate codon. However, it has long been established that the anticodon 
cannot control the identity for all tRNAs because of the existence of amber
3
Figure 1.1. Secondary and tertiary structure of tRNA.
Figure 1 .1 .A shows the general cloverleaf secondary structure for tRNAs with the 
standard numbering system based on that for yeast tRNAP^e. The positions of 
invariant and semi-invariant bases are shown. Y denotes pyrimidine, R purine, 
pseudouridine and H hypermodified purine. The dotted regions in the D loop and in 
the variable loop contain different numbers of residues in different tRNAs.
(Adapted from Watson et a l ., 1987).
Figure 1.1.B. illustrates the tertiary structure of yeast tRN A ^^e . The 
ribose-phosphate backbone is drawn as a continuous ribbon and internal hydrogen 
bonding is indicated by crossbars. The positions of unpaired bases are indicated by 
unjoined bars. The anticodon arm and the acceptor stem are shaded.
(Adapted from Watson et a l ., (1987), after Kim et a l ., (1974)).
3’
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suppressor tRNAs where the anticodon has been altered with no effect on amino 
acid specificity. Schulman and Pelka (1990) used synthetic tRNA genes to show that 
the anticodon is a major recognition element in E. coli tRN A ^et. The anticodon is 
also an important element for E. coli tRNA^a* identity (Schulman and Pelka, 
1988).
The number of residues responsible for the identity of a tRNA (the "identity set") 
appears to differ for different tRNA species. Hou and Schimmel (1988) showed that 
in E. coli tR N A ^a, mutations in the G-U pair at position 3-70 (found in almost all 
tRNA^te species sequenced) abolished recognition by the alanine aminoacyl-tRNA 
synthetase. Insertion of G3 -U 70 was sufficient to cause a tRNA^ys amber 
suppressor to insert alanine. In contrast, the identity set for E. coli tRNA^er 
appears to involve at least 8  residues (Normanly et a l ., 1986, Normanly and 
Abelson, 1989, Himeno et a l ., 1990) and that for yeast tR N A ^ e at least 5, of 
which three comprise the anticodon (Sampson et a l ., 1989). As yet, no general 
rules have been established for identity determination.
1.4. Eukaryotic tRNA gene organisation.
Eukaryotic transfer RNA genes are members of complex multigene families. The 
tRNA genes are found dispersed throughout the eukaryote genome, either as solitary 
genes or in small clusters. There may be several different isoaccepting tRNAs for 
each amino acid, which implies that there is a similar redundancy in tRNA gene 
species. The gene for any particular tRNA isoacceptor may be present in multiple 
copies in the genome, and these gene copies may be located at more than one 
chromosomal locus. It is uncertain how different gene copies within gene families 
originated or how they are maintained, but it is probable that some new gene copies 
will have been produced by gene duplication. There is some evidence that tRNA 
genes can be inserted at new sites in the genome as a result of retroposition events 
(Reilly et a l ., 1982; McBride et a l ., 1989). Gene copies may be maintained by gene 
conversion since it is difficult to see how selective pressures could act on individual 
members of a gene family containing ten or more genes. Several hundred eukaryotic 
tRNA genes have been cloned, either as dispersed individual genes or in small
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clusters of two or more genes within a few kilobases of each other. The tRNA genes 
within these clusters may code for different tRNAs and can occur on either DNA 
strand. Unlike E. coli tRNA genes, these clustered genes are generally not 
cotranscribed as large multimeric precursors although there arc examples of pairs of 
eukaryotic tRNA genes being transcribed as dimeric precursors (Schmidt et a l ., 
1980; Mao et a l ., 1980; Willis et a l ., 1984; Amsutz et a l ., 1985).
So far, tRNA genes from 17 different eukaryote species have been sequenced. 
Most data is available for the organisms described in the following sections: yeast, 
Drosophila melanogaster, Xenopus laevis, rat, mouse and finally humans.
1.4.1. O rganisation of yeast tRNA genes.
Saturation hybridisation analysis of S. cerevisiae genomic DNA gives an estimate 
of 360 tRNA genes per haploid genome, which corresponds to an average copy 
number of 8  per tRNA species (Schwiezer et a l ., 1969). Members of at least ten 
yeast tRNA gene families contain introns (Ogden et a l ., 1984; Stuka and Feldmann, 
1988). Yeast tRNA genes are frequently associated with transposable elements such 
as sigma, delta, Tyl and tau (Eigel and Feldmann, 1982; Hauber et a l ., 1988).The 
most common of these is the sigma element, which has been found to occur 16 to 
18 bp upstream of several yeast tRNA genes (Sandmeyer and Olsen, 1982; Del Ray 
et a l ., 1982; Brodeur et a l ., 1983; Sandmeyer et a l ., 1988). Sigma is about 340 
bp long, with 8  bp inverted terminal repeats and 5 bp flanking direct repeats. Sigma 
elements have so far only been found in association with tRNA genes, which has led 
rise to speculation that they may play a role in the evolution or the transcriptional 
initiation of yeast tRNA genes.
Most yeast tRNA genes appear to be dispersed randomly through the genome 
although some clusters have been cloned. For example, a tRNASer_tRNA^et gene 
pair has been found at three different loci in S.pom be . The genes are separated by 7 
bp and are transcribed as a dimeric precursor, which is unusual for eukaryotic tRNA 
genes (Mao et a l ., 1980; Amsutz et a l ., 1985). Similarly, four separate clones have 
been characterised in which genes for tRN A ^S and tRNA Asp arc separated by 9 bp 
and are again transcribed as a dimeric precursor (Schmidt et a l ., 1980).
Probably the best characterised dispersed yeast tRNA gene family is that for a S.
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cerevisiae tR N A ^u gene (Hauber et al .,1988). Eight different gene copies have 
been cloned. These copies all have the same coding sequence, contain no introns and 
are flanked by transposable elements. The genes have been assigned to different 
chromosomal loci and show little or no homology in their flanking sequences. The 
eight tRNA^yr genes from S. cerevisiae again have identical coding sequences 
(although there is a C/T polymorphism within the intron) but differ in their flanking 
regions (Johnson and Abelson, 1983).
1.4.2 Organisation of Drosophila melanogaster tRNA genes.
The D. melanogaster genome contains some 750 tRNA genes, (Weber and 
Berger, 1976) with an average copy number of 12 for each of the approximately 60 
isoacceptor species. In situ hybridisation studies using polytene chromosomes (Gall 
and Pardue, 1969; Steffensen and Wimber, 1971) have shown these genes to be 
distributed over at least 50 sites in the genome, with clustering at particular loci. 
Clusters may be of multiple copies of the same gene (homoclusters) or of different 
genes (heteroclusters).
Chromosomal locus 42A of the Drosophila chromosome 2R contains a region 
of 94kb isolated by Yen and Davison (1980). Within this 94 kb area, a central 46kb 
region contains three widely spaced homoclusters of tRNA ^sn, tRNA^ r 8  and 
tRNA^ys genes. Another homocluster characterised consists of five nearly identical 
copies of tRNAG*ucTc (Hosbach et a l ., 1980). These genes are organised as a 
group of three genes spanning approximately 0.55 kb, followed by a 0.45 kb gene 
doublet 3 kb downstream. The flanking regions of certain of the gene copies showed 
strong patterns of sequence homology. The pattern of homology led Hosbach et a l . 
to propose that this tRNA^lu homocluster evolved through two ancestral 
tRNAGliicjc genes each giving rise to gene doublets by gene duplication, and one 
of these gene pairs then forming a trio of genes as the result of an unequal 
crossover. A third homocluster at chromosomal locus 12DE consists of eight 
tRNA^er genes (for tRN A ^er and tRNA7^er) The genes are 96% homologous, 
and all of the gene copies show several blocks of homology in their flanking 
sequences. A ninth tRNA^er gene, separate from the gene cluster has also been 
sequenced (Cribbs et al ., 1987). Of the six D rosophila  tRNA^y1 genes
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characterized, three compose a homocluster and two a second homocluster. The 
sixth gene copy is a solitary gene. All six genes have identical coding sequences but 
contain different sizes of introns, and no apparent homology exists between the 
flanks of the different gene copies (Suter and Kubli, 1988).
In addition to the solitary tRNA^er and tRNA^yr genes mentioned above, 
several other tRNA genes from Drosophila do not appear to be organised in 
clusters. Genes for tRNAjMet at chromosomal locus 61D are separated by at least 17 
kb (Sharp et a l ., 1981a), and solitary tRNA^ly genes have been mapped to 
chromosomal locus 56F (Hershey and Davison, 1980). The irregular dispersed 
arrangement of tRNA genes in Drosophila has turned out to be the general case for 
higher eukaryotes.
1.4.3. Organisation of Xenopus laevis tRNA genes.
Generally, the copy number of tRNA genes varies from organism to organism, 
and is only approximately related to genome size. The Xenopus laevis genome 
contains a yery large population of tRNA genes (6500-7800 genes per haploid 
complement; see Long and Dawid, 1980). The majority of gene copies are located 
within DNA fragments repeated 150 to 300-fold (Clarkson and Kurer, 1976). One 
of these repeated DNA fragments contains a cluster of eight tRNA genes within a 
3.18 kb region of DNA which is tandemly repeated approximately 150 times per 
haploid genome (Clarkson et a l ., 1978; Muller and Clarkson, 1980; Fostel et a l ., 
1984; Muller et a l ., 1987). The tandem repeats probably form a large gene cluster 
on one chromosome. Each repeating unit contains two tRNA ^et genes, the A-copy 
and the B-copy, along with one gene each for tR N A ^ e, tRNA^y1, tRNA^sp, 
tRNA-Ak, tRNA^ 11 and tRNA^Ys. The tRNA coding regions are separated by large 
regions of noncoding, spacer DNA. Both the coding and noncoding regions show 
sequence homology between repeating units. Another highly reiterated gene, for 
tRNA^al^ has been found on two 250-fold repeated fragments, of 892 and 4100 bp 
(Peterson, 1987). However, a dispersed tRNA^yr gene, not highly repeated in the 
Xenopus genome, has also been characterised. The gene differs from the clustered 
tRNA^yr gene mentioned above in both its coding and flanking regions (Gouilloud 
and Clarkson, 1986).
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1.4.4. Organization of the ra t and mouse tRNA genes.
Other than in humans, mammalian tRNA gene organisation has been studied 
mainly in the rat and the mouse. In both species tRNA genes are found as solitary 
gene copies as well as in small clusters. In the rat, the average copy number of 
tRNA genes is 10-20 per haploid genome (Lasser-Wiess et a l ., 1981). In the 
mouse, the average copy number may be as high as 100 (Marzluff et a l ., 1975). 
Most rat tRNA genes characterized so far occur in small clusters, although this may 
be a function of the relative ease of detection of a tRNA gene cluster as opposed to a 
single tRNA gene. One such cluster was isolated on a 3.3 kb Eco RI fragment.The 
cluster contains genes for tRNA^eu^ tRNA^sP, tRNA^ly and tRNA^^u, and 
appears to be part of a larger 13.5 kb repeated unit, with a copy number of 10 per 
haploid genome (Sekiya et a l ., 1981; Shibuya et a l ., 1982 and 1985). When the 
sequences for all 1 0  repeats were compared, seven appeared to be broadly 
homologous, although deletions, insertions or base substitutions were observed at 
several positions (Rosen et al ., 1984). Five of the repeats contain tRNA 
pseudogenes (Shibuya et a l ., 1982). One copy of the cluster (containing a tRNA^ 11 
pseudogene instead of the tRNA^ 11 gene) showed only minimal homology to the 
rest of the repeats. This data led Rosen et a l ., (1984) to suggest that the different 
copies of the cluster were derived by gene duplication, followed by mutations and 
deletions of nonessential sequences. Interestingly, a mouse tRNA gene cluster has 
been characterised which is highly homologous to one of the repeats in the rat. The 
rat and mouse tRNA-Asp and tRNA^ly genes are identical, while the mouse 
tRNA^lu gene differs from that on the rat cluster in only two residues (Sekiya et 
a l ., 1981; Looney and Harding, 1983). A solitary tRNA^sp gene, identical to that 
in the rat cluster, has also been characterised from the mouse (Looney and Harding, 
1983).
Several other small tRNA gene clusters have been found in rat and mouse. One 
cluster in the rat contains three tRNA^ys genes and three tRNA^r0  genes. The 
genes occur on both strands and show no homology in their 5 ' flanking sequences 
(Sekiya et a l ., 1982). In the mouse, a partially characterised cluster has been shown 
to carry a tRNA^ 1"0  and a tRNA^ly gene (Hu et a l ., 1983) and a cluster carrying 
single copies of genes for tR N A ^3, tRNA^e, tRNA^ 1 0  and tRNA^ys has been 
reported (Russo et a l ., 1987a).
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In addition to the solitary m o u s e  tRNA Asp gene mentioned above, scattered 
tRNA genes have been reported for a mouse tRNA^is gene (Han and Harding, 
1982); a mouse tR N A ^et gene (Han et a l ., 1984) and a rat tR N A ^e gene (Rosen 
and Daniel, 1988).
1.4.5. Organisation of human tRNA genes.
The human haploid genome contains in the order of 1000 tRNA genes (Hatlen 
and Attardi, 1971), of some 60 different species (Lin and Agris, 1980). This implies 
an average copy number for each individual gene of 10-20. Copy numbers have 
been determined for several human tRNA gene families using Southern 
hybridisations of the genes to restriction fragments from genomic DNA. Most of the 
published estimates for copy number fall within the predicted range. Among these 
estimates are 13 copies per haploid genome for tRNA^lu (Gonos and Goddard, 
1990a), 12 copies per haploid genome for tRNAjMet (Zasloff and Santos, 1980), 
13-16 copies for tRNA^ys (Doering et a l ., 1982), at least 8 copies for tRNA^er 
(Krupp et a l ., 1988) and at least 13-15 copies for the human tRNA^al gene family 
(Arnold et a l ., 1986; Schmutzler and Gross, 1990). However, the copy number for 
a human tRNA^sn gene family was estimated as 60-70 per haploid genome 
(Buckland, 1989). This level of reiteration has not been found for any other human 
tRNA gene family.
As in other mammalian systems, human tRNA genes have been isolated both 
as dispersed gene copies and as members of small gene clusters of 2-5 genes within 
a few kb of each other. Over 50 human tRNA genes have been cloned (Schmidtke 
and Cooper, 1990), and a number of these have been assigned to their respective 
chromosomes. Assignments have been made either by in situ hybridisations or 
using somatic cell hybrids with differing complements of human chromosomes. 
Transfer RNA genes have been assigned to 8  different chromosomes so far, and 
given the large number of human tRNA genes and the lack of any apparent pattern of 
organisation, it seems likely that most if not all human chromosomes will be found 
to carry tRNA genes. Several tRNA gene clusters have been mapped to single sites 
in the genome (see below). In contrast, two tR N A dyGCC genes with an identical 
coding sequence but different flanks have been assigned to two different
1 0
chromosomes (see below and Chapter four).
The human tRN A j^et gene family has been extensivly studied (Zasloff and 
Santos, 1980; Santos and Zasloff, 1981; Zasloff e ta l ., 1982; Wahab e ta l ., 1989). 
Twelve genes have been found at scattered locations through the genome. Analysis 
of two of these gene copies showed the genes to be identical, with several blocks of 
homology in the flanking regions. Both are located on chromosome 6  (6p23-ql2) 
(Naylor et a l ., 1983).
tRNA^y1  genes have also been detected at at least 1 2  independent loci in the 
human genome (McPherson and Roy, 1986; van Tol et a l ., 1987). All of these 
genes have been shown to contain an intron (van Tol and Beier, 1988). The four 
gene copies characterised have almost identical coding sequences. Two of these 
characterised tRNA^yr gene copies belong to homologous 2 0 0  bp repeat fragments 
(McPherson and Roy, 1986).
Thirteen independent tRNA^al gene loci have been detected in the human 
genome. Studies on three of the members of the tRNA^al gene family have shown 
two to encode the major and minor tRNA^al isoacceptors, while the third does not 
correspond to any known tRNA^al. The flanks of these genes do not show any 
significant homology. Two of the gene copies are associated with Alu type repeats 
(Arnold et a l ., 1986). Six additional human tRNA^al genes have been cloned and 
characterised (Thomann et al .,1989).
Three different human genomic clones have been isolated with dispersed 
tR N A ^yGCC genes (in addition to a fourth human tRNA^lyGC^ gene described in 
Chapter three of this study). All three have the same coding sequence but different 
flanking sequences (Pirtle et a l ., 1986; Doran et a l ., 1988). The tRNAGlyGCC 
gene cloned by Pirtle et a l . is 758 bp away from a tiR-NA^ly^^ pseudogene, and 
the DNA fragment carrying the tRNAGlyGGG gene and pseudogene has been 
mapped to chromosome 16 (McBride e t a l ., 1989). A solitary tRNAGlyCCG Sene 
has also been cloned, (Shortridge et a l ., 1985) and assigned to chromosome 1 
(lp34-pter) (McBride et a l ., 1989).
A solitary human tRNA^lu gene has been cloned and mapped to chromosome 1 
(lp36 and a secondary site at lq21) (Goddard e ta l ., 1983; Boyd e t a l ., 1989). A 
second solitary tRNA^lu gene, with a coding sequence differing in two 
non-conserved residues from the first and similar 5' and 3' flanks has also been 
characterised (Gonos and Goddard, 1990b). Among the other dispersed human 
tRNA genes cloned are two tRNA^sn genes (Ma et a l ., 1984), four tRNA^er genes
(Yoo, 1984; Hong et a l ., 1987; Hoe et a l ., 1987; Krupp et a l ., 1988) and finally 
an opal suppressor phosphoserine tRNA gene. This last gene has been assigned to 
chromosome 19, and its corresponding pseudogene to chromosome 22 (O'Neil et 
a l ., 1985; McBride et a l ., 1987).
A number of small tRNA gene clusters have been cloned from human genomic 
DNA. One such cluster contains three tRNA genes, coding for tRNA^ys, tRNA^ln 
and tR N A ^ u, separated by short (about 500 bp) intergenic regions (Roy et a l ., 
1982; Buckland et a l ., 1983). (See Chapter 3 for a description of an almost identical 
copy of this cluster). A second cluster characterised contains four tRNA genes 
arranged in two pairs, separated by 3 kb. A tRNAP1 0  gene is separated from a 
tRNA^eu gene by 724 bp in the first pair and a second tRNA^ 1 0  is 316 bp away 
from a tRNA^ 11 gene in the second pair (Chang et a l ., 1986). This cluster has been 
mapped to chromosome 14 (Olsen et a l ., 1987). The tRNA^ 1-0 genes have identical 
coding sequences but differ in their flanking regions. Another cluster of four tRNA 
genes contains two genes for tRNA^ys and two for tRNA^he arranged in 
alternating order. The tRNA^ys genes are identical, and the tR N A ^e genes differ 
in only one nucleotide, at residue 57. Again, no apparent homology exists in the 
flanking regions of the genes (Doran et a l ., 1987). Two further clusters containing 
three human tRNA genes have been characterised. One encodes the major and minor 
valine tRNAs and a lysine tRNA. The recombinant carrying these genes also 
contains at least 9 Alu family members (Craig et a l ., 1989). The final cluster 
encodes threonine, proline and valine tRNAs. This cluster is associated with two 
Alu elements, one of which overlaps the tRNA^al gene (Shortridge et a l ., 1989). 
This cluster has been mapped to chromosome 5 (McBride et a l ., 1989).
1.4.6. tRNA pseudogenes.
Given the large number of tRNA genes occurring in eukaryotic genomes, it is 
perhaps not surprising that a considerable number of tRNA pseudogenes have been 
characterised. For a protein-producing gene, a pseudogene can be defined as one 
that gives rise either to no product or to an inactive polypeptide. For tRNA genes, 
the term generally implies a sequence which if transcribed cannot be folded into a 
cloverleaf configuration, and that does not correspond to any known RNA species.
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tRNA pseudogenes may consist either of a partial sequence of a corresponding 
tRNA sequence or of sequences that resemble a tDNA with differences at some 
positions. Transfer RNA genes with mutations in one or more of the promoter 
elements, rendering them transcriptionally inactive, might also be classed as 
pseudogenes. Pseudogenes have been sequenced in several eukaryotes, although so 
far none are known in yeast. The significance, if any, of this finding is uncertain.
In Drosophila melanogaster, several pseudogenes have been characterised. A 
tR N A ^s gene is clustered with a tR N A ^s pseudogene. The pseudogene contains a 
run of 8 nucleotides between residues 38 and 45 that differ from the corresponding 
gene sequence. However, this gene was found to be transcriptionally active in vitro 
when its 5' flanking sequence was replaced with one from an active tR N A ^s gene 
(Cooley et al ., 1984). (Other eukaryotic pseudogenes have been found to be 
transcriptionally inactive in vitro ; Shibuya et a l ., 1982; Sharp et a l ., 1981a).
A dispersed "family" of pseudogenes has been located at about 30 sites in the 
Drosophila genome. These sites all contain short fragments which are homologous 
to parts of the initiator tRNA. The largest of these only spans 34 bp, representing 
approximately half of the intact sequence. The fragments have a genomic distribution 
characteristic of a mobile DNA element, suggesting that this "family" may have 
arisen through the repeated insertion and excision of a transposable element into an 
intact tRNA gene (Sharp etal .,1981a).
A number of pseudogenes have been found within a rat tRNA gene cluster 
(Sekiya et a l ., 1981; Shibuya et a l ., 1982 and 1985; see section 1.4.4.). In the ten 
characterised repeats of the cluster (encoding tR N A ^ 11, tRNA Asp, tRNA^ly and 
tRNA^lu) a total of 9 pseudogenes have been discovered, including incomplete 
tRNA^ly and tRNA^lu genes and a tRNA^eu pseudogene which differs in 15 
residues from the corresponding tR N A ^u gene (Rosen et a l ., 1984; Shibuya et 
a l ., 1982; Makowski et a l ., 1983).
A tRNAPhe pseudogene has been isolated from the mouse (Reilly et a l ., 1982). 
This pseudogene consists of the 38 nucleotides of the 3’ end of the tRNA, including 
the terminal CCA. The terminal CCA is added post-transcriptionally to all eukaryotic 
tRNAs for which the genes have been identified. This suggests that the psuedogene 
may have arisen through a tRNA gene product being partially copied back into the 
genome. A mouse tRNAGhi pseudogene has also been characterised (Smardo and 
Calvert, 1987).
Two human tRNA pseudogenes were mentioned in section 1.4.5. One of these, a
1 3
human opal suppressor phosphoserine tRNA pseudogene differs in 7 nucleotides 
from the corresponding "true" gene (O'Neil et al ., 1985). The other, a 
tRNAGlyGCC pseudogene differs in just 2 nucleotides (including the invariant C at 
position 56) from the corresponding gene (Pirtle et a l ., 1986). The two t R N A ^ l y  
genes share 8  nucleotides of 5' flanking sequence.
1.5. T ranscription of eukaryotic tRNA genes.
Both in vivo and in vitro experimental systems have been developed to study 
tRNA gene transcription. Transcription assays can be performed using 
micro-injection of DNA into Xenopus oocyte nuclei or using cell-free transcription 
systems. Such studies have been used to show that the primary product of tRNA 
gene transcription is not the tRNA itself but a longer precursor molecule. This 
precursor is processed in a stepwise manner to yield the mature tRNA (see section
1.5.5.). Transcriptional studies on truncated or mutated tRNA genes have allowed 
the characterisation of the tRNA gene promoter and the initiation and termination 
sites for transcription. These studies, coupled with experiments involving the use of 
purified transcription factors, have also helped to elucidate the mechanism by which 
the tRNA gene interacts with transcription factors to form the transcription complex.
1.5.1. Genes transcribed by RNA polymerase III.
Eukaryotic RNA polymerase HI is a multi-subunit enzyme of approximately 650 
kd (for review see Ciliberto et a l ., 1983a; Geiduschek and Tocchini-Valentini, 
1988). RNA polymerase HI synthesizes a variety of small nuclear and cytoplasmic 
RNAs. Among these are tRNA, 5S ribosomal RNA, 7S cytoplasmic RNA and U6  
and 4.5S small nuclear RNAs. The enzyme also transcribes a number of genes 
coding for small RNAs in adenoviruses (VAI and VAII), and in Epstein-Barr virus 
(EBER I and EBER II). In addition RNA polymerase HI is responsible for the 
synthesis of small RNAs from some repetitive elements (e.g. the Alu family).
Transcription of the majority of RNA polymerase III genes is controlled by 
intragenic DNA sequences (Sharp e ta l ., 1985; Geiduschek and Toccini-Valentini,
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1988 and references therein). These internal control regions (ICR) are 
discontinuous, with conserved "boxes" separated by spacer regions. RNA 
polymerase HI genes can be divided into two main groups according to the nature of 
these internal promoter sequences. Type 1 genes (5S RNA) have an ICR consisting 
of 2 domains, box A and box C, with an intermediate element associated with box 
C. Type 2 genes (e.g. tRNA genes) again have two domains in their internal 
promoters, box A and box B. The box A sequence is highly conserved in both types 
of promoter, and the box B sequence is highly conserved in type 2 promoters. The 
conservation of promoter sequences between different RNA polymerase III genes 
explains the fact that only three major transcription factors ( IFlJLlA, TFIHB and 
T F in C )  are required for the transcription of all of the genes transcribed by this 
enzyme.The promoters of VA and Alu family small RNA genes belong to type 2, 
and sequence homologies suggest that the EBER genes, human 7SL and mouse 
4.5S genes also belong to this class. The U6  and 7SK genes have promoter 
sequences 5' to the gene, and therefore fall into a separate group (for review see 
Folk, 1988; Sollner-Webb, 1988). The type 2 promoter of tRNA genes will be 
discussed in section 1.5.2.
The intragenic 5S promoter has been extensively studied. Genetic dissection of a 
Xenopus somatic 5S RNA gene established that its promoter extends from residues 
50-97 of the gene, this region containing 3 separate elements that determine 
promoter strength. (Sakonju et a l ., 1980; Bogenhagen et a l ., 1980; Pieler et a l ., 
1985a, 1985b and 1987). At least three transcription factors (TFHIA, iFlilB  and 
TFIIIC; Segall et a l ., 1980; Lassar et a l ., 1983; Bieker et a l ., 1985; Setzer and 
Brown, 1985) are required to bind to the promoter elements prior to the addition of 
RNA polymerase ID. The box A element (residues 50-64) is involved in the binding 
of TFIIIC, while the intermediate element (residues 67-72) and box C (residues 
80-97) have a high affinity for TFIIIA. The binding of TFMA (which contains zinc 
finger motifs) to the gene helps recruit TFMB and TFIIIC to the stable transcription 
complex (Engelke et a l ., 1980; Sakonju et a l ., 1981; Bogenhagen et a l ., 1982; 
Brown, 1984; Schlissel and Brown, 1984). (TFIIIA has no effect on transcription 
of type two genes ; Gottesfeld and Bloomer, 1982). The sequence of the spacer 
regions between the elements is unimportant but alterations in their length can reduce 
or prevent the formation of a stable transcription complex (Pieler et a l ., 1987; 
Bogenhagen, 1985). Figure 1.2. summarises the transcription factor binding sites 
found in 5S RNA genes.
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Figure 1.2. T ranscrip tion factor binding sites on tRNA and 5S RNA 
g en es.
The sites on tRNA and 5S RNA genes that are protected from DNase I digestion by 
the RNA polymerase III transcription factors TFIIIA, T F TTTR and TFIIIC are 
indicated below. Boxes A, B and C and the intermediate element (IE) are shown. 
Dotted lines indicate the possible existence of two different subunits of a single large 
factor. (From Palmer and Folk, 1990).
t R N A A B
-45
M
5 S
-45
IE
120
(flUffi) =  TFIIIA =  TFIIIB =  TFIIIC
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1.5.2. The tRNA gene promoter.
Analyses of the transcription of a number of eukaryotic tRNA genes, including a 
Xenopus tRN A ^et gene (Kressmann et a l ., 1979; Hofstetter et a l ., 1981; Folk 
and Hofstetter, 1983) and tRNA^ 11 gene (Galli et a l ., 1981), a Drosophila 
tRNA^rg gene (Sharp et a l ., 1981b, 1982, 1983a and 1983b) and tRNA^ys gene 
(De Franco et a l ., 1980), a C. elegans tRNA^ 0  gene (Traboni et a l ., 1984) and a 
yeast suppressor tRNA^yr gene (Koski et a l ., 1980 and 1982; Allison et a l ., 
1983), have defined an internal promoter with two domains. Internal deletions and 
substitutions in these genes have located the promoter domains, box A and box B, to 
residues 8-19 and 52-62 respectively (numbered according to the standard system 
described in section 1.2.). The box A sequence in tRNA and other type two gene 
promoters is structurally and functionally homologous with the box A component of 
the 5S gene promoter (Ciliberto et a l ., 1983b; Geiduschek and Tocchini-Valentini, 
1988). Box A is also termed the D control region or 5' ICR, and box B the T control 
region or 3* ICR. The two regions of the ICR coincide with the highly conserved 
nucleotides in the D and W C  arms of the tRNA gene. Genetic manipulations of 
these residues in conjunction with transcription assays have been used to determine 
the consensus sequence of the promoter: TRGCNNAGY-GG for box A and 
GGTTCGANTCC for box B (where N= any nucleotide, R= a purine, Y= a 
pyrimidine and - a nucleotide (residue 17) not present in all tRNAs; Geiduschek and 
Tocchini-Valentini, 1988). The box B sequence is the more highly conserved of the 
two, box A showing some variation both in sequence and in the number of 
nucleotides. This high degree of conservation of box B in all characterised tRNA 
genes may reflect constraints due to the role of these residues in the tertiary structure 
of the tRNA product as well as in interactions with transcription factors.The spacing 
between box A and box B varies in tRNA genes owing to the presence of 
intervening sequences and the varying lengths of the extra arm in some genes. In 
yeast genes the spacing varies between 31 and 93 bp (Raymond and Johnson,
1983).
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1.5.3. T ranscrip tion  complex form ation.
It has been shown that tRNA genes are efficient competitors of adenovirus VAI 
genes as well as of type one genes (5S RNA) which suggests that faithful 
transcription of these genes depends on similar transcription factors (Segall et a l ., 
1980; Burke et a l ., 1980; Wormington et a l ., 1981; Guilfoyle and Wienmann, 
1981). Transcription studies have established that eukaryotic tRNA genes are 
transcribed by RNA polymerase III in the presence of at least two transcription 
factors, TFIIIB and TFIIIC (Stillman and Geiduschek, 1984; Baker and Hall, 1984; 
Baker et a l ., 1986; Huibregtse et al .,1987; Burke and Soli, 1985; Carey et a l ., 
1986). (In yeast, transcription factor x is analogous to the vertebrate factor TFIIIC). 
TFIIIB has been purified from S. cerevisiae as a 60 kd polypeptide (Klekamp and 
Weil, 1986a and 1987). Antibodies to this polypeptide have been shown to inhibit 
transcription. Since TFIIIB alone cannot bind stably or specifically to DNA (Lassar 
et a l ., 1983; Klekamp and Weil, 1986b; Carey et a l ., 1986), its incorporation into 
transcription complexes is dependent on interactions with other proteins.
TFIIIC binds tightly and specifically to DNA, thereby sequestering and directing 
transcription activity (Lasser et al ., 1983). Vertebrate TFIIIC has been only 
partially purified (from HeLa cells, Schneider et a l ., 1989), but the corresponding 
yeast factor x has been extensively characterized (Ruet et a l ., 1984; Camier et a l ., 
1985; Kassevetis et a l ., 1989; Gabrielsen et a l ., 1989a and 1989b; Johnson and 
Wilson, 1989; Bartholemew et a l ., 1990), and shown to be a multisubunit protein 
of about 600 kd. TFIIIC and x have different molecular properties, although they 
seem to perform the same function. TFHIC from HeLa cells can be resolved by 
chromatography into two components, TFIIIC 1 and TFIIIC2 (Yoshinaga et a l ., 
1987; van Dyke and Roeder, 1987; Dean and Berk, 1987). These may represent 
separate factors which copurify. In contrast, yeast factor x cannot be resolved in the 
same way into two active components. It has been suggested that this protein 
contains two domains, x^  and xg (Gabrielsen et a l ., 1989b; Marzouki et a l ., 1986) 
which may be analogous to TFIIIC 1 and TFIIIC2. However, photochemical 
crosslinking experiments (Bartholomew e ta l  ., 1990), have shown that TFHIC 
appears to be made up of subunits of 145,135,95 and 55 kd. The 135 kd subunit is 
thought to play a role in positioning the one of the subunits of TFIIIB on the 
transcription complex.
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The physical interactions of TFUiC/x have'been analysed qualitatively by various 
footprinting methods (Camier et a l ., 1985; Stillman et a l ., 1985; Klemenz et a l ., 
1982; Fuhrman et a l ., 1984; Ruet et a l ., 1984; Stillman and Geiduschek, 1984) and 
quantitatively by gel retardation assays (Baker et al .., 1986 and 1987). DNA 
protection experiments have shown TFIIIC2 to bind to the box B region of the 
tRNA gene promoter. The addition of TFIIIC 1 to the TFIIIC2-DNA complex 
extends DNasel protection to the box A region (Yoshinaga et a l ., 1987), and the 
binding of TFIIIB creates a footprint that includes approximately 40 bp of the 5' 
flanking region of the gene (Kassavetis et a l ., 1989). Mutations introduced at 
conserved positions within the promoter, particularly in box B, dramatically reduce 
the affinity of TFIIIC for DNA (Fabrizio et a l ., 1987; Newman et a l ., 1983). 
Changes in the ionic environment can also affect transcription complex stability 
(Ruet et a l ., 1984; Stillman et a l ., 1984; Gabrielsen and Oyen, 1987).
The nucleotide sequence between the ICR of tRNA genes is generally considered 
to act as a spacer region, maintaining the optimum distance between the two parts of 
the promoter (Hofstetter et a l ., 1981; Ciliberto et a l ., 1982). The effects of varying 
the spacing between box A and box B upon the binding of transcription factors to 
the gene have been measured using mutant tRNA genes in which the spacing varied 
from 12-1530 bp (Ciliberto et a l ., 1982; Dingerman et a l ., 1983; Baker and Hall,
1984). A wide range of box A-B separations has been found to be compatible with 
tRNA gene transcription (Hall et a l ., 1982; Carrara et a l ., 1981; Raymond and 
Johnson, 1983; Dingermann et a l ., 1983) but a distance of 34-53 nucleotides 
between boxes A and B appears to be the optimum for stable binding of TFIIIC. 
This range of distances allows for the efficient transcription of tRNA genes 
containing introns or sequences coding for a long variable arm, either of which 
would increase the spacing between box A and box B.
Recent research on the interactions of eukaryotic tRNA genes with their 
transcription factors has suggested the following model for the formation of the 
transcription complex (Geiduschek and Tocchini-Valentini, 1988; Dean and Berk, 
1988; Schneider e ta l ., 1990; Kassavetis et a l ., 1989 and 1990; Yoshinaga e t a l ., 
1987 and 1989; Camier et al .,1990; Bartholomew et a l ., 1990). Figure 1.2. shows 
a simplified summary of transcription factor binding onto tRNA genes. Firstly, 
TFIIIC/t binds to the ICR, contacting box B first. The multiple subunits of this 
transcription factor allow TFIIIC/t the flexibility needed for association with both 
parts of a split promoter. The binding of TFIIIC/t to the gene allows TFIIIB to
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become associated with the 5' end of the gene, and it is thought that this factor then 
sequesters RNA polymerase El onto the transcription complex. RNA polymerase IE 
then rapidly cycles on and off the complex for multiple rounds of transcription. 
Transcription usually initiates at a specific purine nucleotide located between -20 and 
-3 bp upstream of the tRNA coding sequence (Clarkson, 1983) although some genes 
may have alternative initiation sites for transcription both in vivo and in vitro 
(Dingermann and Nerke, 1987; Thomann et al ., 1989; Schmutzler and Gross,
1990).
Recently it has been shown in yeast that once the transcription complex has been 
formed, TFElC/x can be removed (by high salt or heparin treatment) without 
affecting further rounds of transcription (Kassavetis et a l ., 1990). TFEIB alone 
appears to be responsible for positioning RNA polymerase D3 for repeated cycles of 
transcription. TFEIB is thus the sole transcription initiation factor in yeast, and 
TFE3C/X is purely an assembly factor for the transcription complex.
1.5.4. Term ination of transcrip tion.
The 3’ ends of eukaryotic tRNA genes have a simple consensus sequence of four 
or more T residues that act as the signal to terminate transcription (Garber and Gage, 
1979; Koski et a l ., 1982; Koski and Clarkson, 1982). The run of Ts usually occurs 
within a few bp of the 3' end of the gene, although exceptions to this rule have been 
reported (Garber and Gage, 1979; Clarkson, 1983). Deletion of these residues 
causes read-through transcription (Adeniyi-Jones et a l ., 1984; Allison and Hall, 
1985), and mutations creating stretches of 4, 5, or 6  intragenic T residues cause 
premature termination of transcription (Koski et al ., 1980). In some cases 
shortening the run of T residues can affect termination, as in the case of a yeast 
tRNA^y1 gene where shortening T7 to T4  abolishes termination (Allison and Hall,
1985). A human tRN A ^et gene produces multiple transcripts in vitro as a result of 
a series of inefficient termination sites of less than four T residues (Vnencak-Jones et 
a l ., 1987). Other short sequences have been shown to act as termination signals. 
The sequences ATCTT and CTTCTT were demonstrated to act as termination 
signals for human tR N A ^  genes (Thomann et a l ., 1989).
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1.5.5. Processing of tRNA gene transcripts.
Transcription of tRNA genes yields a precursor tRNA molecule that has to be 
processed to form the mature tRNA (for review see Deutscher, 1984). Processing 
occurs in a stepwise fashion, and involves endonucleolytic removal of the 5' leader 
and the 3' trailer, addition of the 3' terminal CCA, site-specific base modifications 
and if present, excision of the intron (Sharp et a l ., 1985; Dingermann and Nerke, 
1987; Thomann et a l 1989; Marchfelder et a l ., 1990; O’Connor and Peebles, 
1991). The order of the steps involved in maturation does not appear to be the same 
for all tRNAs; different precursor tRNAs have been shown to be processed along 
different pathways (Rooney and Harding, 1986; van Tol et al ., 1987) and 
alternative processing paths for one tRNA may occur in vivo (O'Connor and 
Peebles, 1991). The enzymes involved in processing recognise the universally 
conserved structural features of tRNAs, which allows all tRNA precursors to be 
processed by the same apparatus (Castagnoli et a l ., 1982; Mattocia et a l ., 1983; 
Swerdlow and Guthrie, 1984). It has been shown that chemical modification of 
conserved nucleotides can inhibit the processing of pre-tRNAs (Thurlow et a l .,
1991). After the completion of processing the mature tRNA leaves the nucleus.
It is uncertain why tRNAs are transcribed as precursor molecules. Possibly the 
presence of extra nucleotides in such precursors prevents immature transcripts from 
leaving the nucleus (De Robertis et al ., 1981; Melton and Cortese, 1979). 
Maturation of the 3' end of the precursor is presumably necessary to remove the 
termination signal. The exact role of the specific base modifications characteristic of 
mature tRNAs is also poorly understood, although some individual examples have 
been studied. It is known that all mature eukaryotic tyrosine tRNAs have a 
pseudouridine (¥ 35) in the central position of the anticodon and that modification of 
this residue is important in codon-anticodon interactions (van Tol and Beier, 1988; 
Choffat et a l ., 1988).
It has been shown for a yeast tRNATyr processed in Xenopus oocytes that the 
5' leader is removed in three stages, the last of which is apparently accompanied by 
excision of the 3' trailer and addition of the 3’ CCA (De Robertis and Olsen, 1979; 
Melton et a l ., 1980; De Robertis et a l ., 1981). In in vitro transcription reactions 
this three stage process has not generally been observed. The CCA motif occurs at 
the 3' end of all mature tRNAs, but is not coded for in any eukaryotic tRNA gene.
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The three bases are added post-transcriptionally by the enzyme tRNA nucleotidyl 
transferase.
The tRNA^yr gene family is one of at least ten tRNA gene families in yeast 
which contain intervening sequences (Ogden et a l ., 1984; Stucka and Feldman,
1988). The presence of an intron in tRNA genes does not appear to be related to 
transcriptional activity. However, the intron present in all yeast tRNA^yr genes has 
been shown to be essential for modification of its tRNA product (Johnson and 
Abelson, 1983; Choffat et a l ., 1988). The same requirement for an intron occurs for 
human tRNATyr genes (van Tol and Beier,1988). In higher eukaryotes, only a 
small proportion of the genes described so far contain an intervening sequence. 
Apart from the human tRNA^yr genes mentioned above, introns have only been 
found in members of the human tRNA^ 11 (Green et a l ., 1990) and tR N A ^S (see 
Chapter three and Chapter four) gene families. Where introns are present, neither 
their sequence nor their length appear to be conserved between different tRNA genes 
but the position of the intron is always the same, one nucleotide 3' of the anticodon. 
Within gene families, the sequence and length of introns tends to be conserved 
(Szekely et a l ., 1988). The intron is removed by a two stage process, excision of 
the intron followed by splicing of the two tRNA half molecules (Abelson, 1979; 
O'Farrell et a l ., 1978; Knapp et a l ., 1978; Stanching et a l ., 1981; De Robertis et 
a l ., 1981; Willis et a l ., 1984; Baldi et a l ., 1986). As for the other steps in tRNA 
processing, the mechanism relies on the conformation of the molecule rather than 
any sequence motif: point mutations which affect the secondary stucture of an 
Arabidopsis tR N A ^yr gene cause inefficient splicing of intron-containing 
pre-tRNAs (Szweykowska-Kulinska and Beier, 1991).
1.5.6. The role of flanking sequences in transcrip tion modulation.
As described in sections 1.5.1. and 1.5.2. the transcription of tRNA genes is 
predominantly controlled by an intragenic split promoter. However it has now been 
well established that flanking sequences modulate transcription in B. mori (Sprague 
et a l ., 1980; Larson et a l ., 1983; Morton and Sprague, 1984; Young e ta l ., 1986), 
in S. cerevisiae (Raymond and Johnson, 1983 and 1987; Johnson and Raymond, 
1984; Shaw and Olsen, 1984), in D. melanogaster (Dingermann et a l ., 1982;
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Schaack et a l ., 1984; Sajjadi et a l ., 1987), in Xenopus (Hipskind and Clarkson,
1983) and in humans (Arnold and Gross, 1987; Morry and Harding, 1986). Genes 
with identical coding sequences but different flanking sequences have been found to 
differ in their transcriptional efficiency (Lofquist and Sharp, 1986; Gouilloud and 
Clarkson, 1986; Arnold et al .,1986 and 1988; Doran et a l ., 1987 and 1988). 
Flanking regions are not generally conserved between different tRNA gene copies, 
and so far no definite mechanism for modulation by extragenic sequences has been 
established. It is thought that tissue- or developmental stage-specific factors may 
interact with control elements in the flanking sequences to regulate gene expression. 
There may be several levels of control over gene expression; the methylation status 
of bases flanking tRNA genes can have an effect on transcription (Besser et a l ., 
1990) and recently it has been shown that changes in the levels of selinium in culture 
can affect the levels of expression of selenocysteine tRNA[Ser]Sec genes in 
mammalian cells (Hatfield e ta l ., 1991).
The majority of experiments on the role of flanking sequences have isolated 
elements in the 5' flank of tRNA genes, although changes in the 3' flank have also 
been shown to affect transcription (Wilson et a l ., 1985; Wu et a l ., 1987; Schaack et 
a l ., 1983; Arnold et a l ., 1988). Most such studies have been carried out in vitro 
with some exceptions (Shaw and Olsen, 1984; Schaack and Soli, 1985; Raymond et 
a l ., 1985; Marschalek and Dingermann, 1988). The predominant finding has been 
that deletions of the 5' flank diminish transcription to a greater or lesser extent. 
However, in some cases the replacement of the 5’ flank with unrelated DNA actually 
increases transcription, suggesting that negative as well as positive modulator 
elements exist (Arnold et a l ., 1988). These results also suggest that this effect may 
not be very sequence specific.
Positive modulators have been isolated from the 5' flanks of a number of 
tRNA genes (Sprague et a l ., 1980; Larson et a l ., 1983; Shaw and Olsen, 1984; 
Johnson and Raymond, 1984; Raymond e t a l ., 1985; Mony and Harding, 1986; 
Sajjadi and Spiegelman, 1987; Arnold and Gross, 1987; Arnold et a l ., 1988; 
Lofquist e ta l ., 1988; Horvath and Spiegelman, 1988; Rooney and Harding, 1988). 
These elements are of 5-35 nucleotides in length, and occur within about 50 bases 
upstream of the gene (although a tRNA-like structure extending further upstream of 
a human tRNA^lu gene appears to affect its transcription; Goddard e t a l ., 1983; 
Gonos and Goddard, 1990b). Potential Z-DNA sequences in the 5' flanks of tRNA 
genes appear to inhibit their transcription (Hipskind and Clarkson, 1983; Nordheim
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and Rich, 1983; Santoro et al ., 1984; Glew et al ., 1986), as does an 
undecanucleotide sequence in the 5' flanking region of a Drosophila tRNA^ys gene 
(De Franco et a l ., 1981).Generally when modulatory elements exist, their position 
relative to the coding sequence is of importance in determining their effect
Finally, it has been demonstrated in several cases that 5' flanking sequences 
modulate transcription differently in different transcription assays, and when using 
extracts from different sources (Raymond and Johnson, 1983; Johnson et a l ., 1984; 
Schaack and Soil, 1985; Drabkin and RajBhandry, 1985a and 1985b; Gonos and 
Goddard, 1990c; Schmutzler and Gross, 1990) which supports the idea that their 
role in vivo may be in controlling tissue-specific expression.
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M ATERIALS AND M ETHODS.
2.1* M aterials.
2.1.1. List of suppliers.
Unless otherwise specified all chemicals were Analar grade, supplied by BDH 
Chemicals, Poole, Dorset, or Fisons Scientific, Loughborough, Leics. All 
radiochemicals were provided by Amersham International pic. Growth media were 
supplied by Difco Laboratories, Detroit, USA. Where chemicals or equipment were 
obtained from other sources, this is indicated in the text. A list of suppliers of 
special reagents is given below:
Aldrich Chemicals Co., Gillingham, Dorset 
Amersham International pic., Amersham, Bucks.
Anglian Biotechnology Ltd., Colchester
Boehringer Corporation (London) Ltd., Lewes, E. Sussex
Fuji Photofilm Co., Japan
Gibco/BRL (Bethesda Research Laboratories) Ltd., Paisley
IBI Ltd., Cambridge
Kodak Ltd., Kirby, Liverpool
Northumbria Biologicals Ltd., Cramlington, Northumberland 
Pharmacia Ltd., Milton Keynes 
Promega Ltd., Southampton 
Sigma Chemicals Co., Poole, Dorset
2.2. Media and buffers.
All media and solutions used for the growth of microorganisms or the handling
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of nucleic acids were sterilised as appropriate by autoclaving for 20 minutes at 15 
psi or by filter sterilisation.
2.2.1. Bacterial growth media.
LB medium (per litre) 10 g Bacto tryptone 
5 g Yeast extract 
lOgNaCl
LB plates (per litre) : 1 litre LB 
15 g Bacto agar
LBA plates (per litre) :996 ml LB 
15 g Bacto agar
4 ml Ampicillin (25 mg/ml stock solution)
LB top agar (per litre) : 1 litre LB 
7g Bacto agar
2 x TY (per litre) 16 g Bacto tryptone 
10 g Yeast extract 
5 g NaCl
Minimal glucose plates 
(per litre)
15 g minimal agar in 900 ml H2O 
100 ml 10 x M9 salt 
1 ml 0 .1 M CaCl2 
1 0  ml 2 0 % (w/v) glucose 
1 ml 1M MgS04 
1 ml 1M thiamine HC1
H-plates (per litre) : 10 g Bacto tryptone
8  g NaCl 
8  g agar
2 6
H-top agar (per litre) 10 g Bacto tryptone 
8  g NaCl 
8 g agar
2.2.2. Buffers.
PBS mix 
Solution A
Solution B 
Solution C
lOxTBE
20 x SSC 
20 x SSPE
TE
: 8/1/1 mix of solutions A, B and C 
: 170 mM NaCl 
0.5 mM KC1 
10 mM Na2  HP04 
2  mM KH2 P04 
: 7 mM CaCl2 .2H20  
: 5 mM MgCl2 .6H20
: 0.89 M Tris 
0.89 M boric acid 
0.025 M EDTA 
(this gives pH 8.3)
: 3 M NaCl
0.3 M tri-sodium citrate
: 3.6 M NaCl 
0.2 M sodium phosphate, pH 7.7 
0.02 M EDTA
: 10 mM Tris-HCl 
1 mM EDTA
Adjusted to pH 7.6 with HC1
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STET buffer
Quiagen plasmid DNA 
preparation
Buffer A
Buffer C
Buffer F
Human genomic DNA 
preparation
Blood lysis buffer
: 50 mM Tris-HCl pH 8.0 
50 mM EDTA 
8 % (w/v) sucrose 
5% (v/v)Triton x-100
: 400 mM NaCl 
50 mM MOPS 
15% ethanol 
Adjusted to pH 7.0
: 1 M NaCl 
50 mM MOPS 
15% ethanol 
Adjusted to pH 7.0
: 1.5 M NaCl 
50 mM MOPS 
15% ethanol 
Adjusted to pH 7.5
: 0.32 M Sucrose 
10 mM Tris-HCl pH 7.5 
5 mM MgCl2 
1 % Triton X-100
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Nuclear lysis buffer : 10 mM Tris-HCl pH 8.2
0.4 M NaCl 
2 mM EDTA
2.3. Bacterial strains and storage.
Bacterial strains were stored in the short term (for up to one month) at 4 °C on 
tightly sealed LB, H- or minimal glucose plates. Longer term storage was in 50% 
(v/v) glycerol at -20 °C. The following E. coli strains were used in this study.
A. Strain used as host to plasmid pUC19 and bacteriophage M l3 recombinants:
TGI supE hsd A5 thi A(lac-proAB ) F  [tra D 36proAB + lacl Q lacZ AM 15]
(Gibson, 1984).
B. Strain used for bacteriophage X recombinants:
BHB 2600 r "£ m SupE + SupF +met ~ (Hohn, 1979).
2.4. DNA vectors, recom binants and oligonucleotides used in this 
s tu d y .
DNA vectors, recombinants and oligonucleotides were stored in TE (see section
2.2.2.) at -20 °C. DNA stored in this way remains stable indefinitely.
2.4.1. X H t363.
The recombinant bacteriophage XHt363 is one of several X Charon 4A 
recombinants selected from a human genomic DNA library by Dr. J.P. Goddard 
using a mixed tRNA probe labelled by ligation of [3 2P]pCp (see section 2.5.11.4). 
This recombinant had been partially characterised as described in section 3.1.
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2.4.2. M13 bacteriophage vectors.
The bacteriophage vectors M13mpl0, M 13m pll, M13mpl8 and M13mpl9 
(Norrander et a l ., 1983; Yanisch-Perron et a l ., 1985) were used to subclone DNA 
fragments for sequencing by the chain termination method (Sanger et a l ., 1980). 
M13mpl8 and M13mpl9 vectors are shown in figure 2.1. M13mpl0 and 
M 13mpll differ from M13mpl8 and M13mpl9 only in the smaller number of 
restriction sites in the polylinker multiple cloning site.
2.4.3. pUC19 plasmid vector.
The plasmid vector pUC19 (Yanisch-Perron eta l .,1985) was used for all of the 
subcloning of restriction fragments from ^Ht363 described in this study, other than 
subclones used for sequencing purposes. All of the pUC19 recombinants described 
were constructed by inserting restriction fragments into the multiple cloning site. 
The pUC19 vector is shown in figure 2.2.
2.4.4. Synthetic oligonucleotides.
Synthetic oligonucleotides (for use as primers in the polymerase chain reaction; 
see section 2.5.15. and table 4.1.) were made in the Department of Biochemistiy by 
Dr. V. Math, using an Applied Biosystems 381A DNA synthesiser for the 
phosphite-triester method (Atkinson and Smith, 1984).
2.5. Methods.
2.5.1. Small scale preparation of plasmid DNA.
The method used was an adaptation of that of Holmes and Quigley (1981). A 3 
ml overnight culture was prepared from a single colony of transformed bacteria in 
LB (see section 2.3.) supplemented with the appropriate antibiotic (100 pg/ml 
ampicillin for pUC19 and recombinants derived from pUC19). 1.5 ml of the
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Figure 2.1. Restriction map of bacteriophage M13 vectors M13mpl8
and M13mpl9.
The bacteriophage M13 vectors M13mpl0, M 13mpll, M13mpl8 and M13mpl9 
were used in this study for nucleotide sequence analysis by the Sanger chain 
termination method. The polycloning sites for M13mpl8 and M13mpl9 are shown 
below. M13mpl0 and M13mpll differ from M13mpl8 and M13mpl9 only in the 
lack of the Kpn I and Sph I restriction enzyme sites in the polycloning site.
(From Sambrook et a l ., 1989).
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Figure 2.2. Restriction map of the plasmid vectors pUC18 and
pUC19.
The plasmid vector pUC19 was used for all of the subcloning of DNA fragments 
described in this study, apart from subclones needed for nucleotide sequence 
analysis. This figure also shows the polycloning site of pUC18, which differs from 
that of pUC19 only in its orientation.
(From Sambrook et a l ., 1989).
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overnight culture was transferred to an Eppendorf tube and the bacteria harvested 
by centifugation at 10,000 rpm for 5 min. The remainder of the overnight culture 
was set aside for the preparation of a glycerol stock if necessary (see section
2.4.1.). The bacterial pellet was dried and resuspended in 700 pi of cold STET 
buffer (see sectin 2.2.2.). 50 pi of a solution of fresh cold lysozyme (10 mg/ml) 
was added and the solution was left on ice for 5 min. The samples were then heated 
to 95 °C for one minute and bacterial debris removed by centrifugation at 10,000 
ipm for 15 min. The bacterial lysate was extracted twice with an equal volume of a 
1:1 mixture of TE saturated phenolichloroform (see section 2.5.5.1.). After the 
addition of 50 pi 3M sodium acetate and 400 pi isopropanol, and a period of 20 
min at -20 °C plasmid DNA was precipitated by centrifugation (10,000 rpm for 15 
min at 4 °C). The plasmid DNA was washed once with 70% ethanol and once with 
100% ethanol, dried at room temperature and redissolved in 50 pi TE. A 10 pi 
sample from each preparation was subjected to restriction endonuclease digestion 
and electrophoresed through an agarose gel to check the size and quality of the 
plasmid DNA.
2.5.2. Plasmid DNA preparation using QUIAGEN pack cartridges.
This method was used to prepare up to 100 pg of high purity plasmid DNA. The 
method is that described in "The Ouiagenologist" Application Protocols (Diaeen 
GmbH). Transformed cells from a 50 ml overnight culture prepared from a single 
colony (in LB+ 100 pg/ml ampicillin) were: harvested by centrifugation at 2,500 
rpm for 5 min at 4 °C. The cells were resuspended in 3.6 ml of an ice-cold solution 
of 50 mM Tris-HCl, pH 7.4. To this suspension 0.4 ml of a fresh solution of 20 
mg/ml lysozyme was added and the cells left at 0 °C. After 10 min 1 ml of 0.5 M 
EDTA (pH 8.0) was added, and after a further 10 min at 0 °C 0.2 ml of 2% Triton 
X-100. The mixture was left on ice for 1 h then the cell debris and chromosomal 
DNA removed by centrifugation at 10,000 rpm for 45 min at 4 °C. The cleared 
lysate was treated with RNase A (final concentration 20 pg/ml) for 30 min at 37 °C 
then proteinase K (final concentration 10 pg/ml) again for 30 min at 37 °C. The 
treated lysate was centrifuged at 10,000 rpm for 10 min at 4 °C. 5 ml of the 
supernatant was added to 1.1 ml 5M NaCl and 0.5 ml 1M MOPS, pH 7.0. A
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Quiagen pack cartridge was equilibrated with 2 ml of buffer A (see section 2.2.2.) 
then the DNA adsorbed onto the cartridge by forcing the sample through using a 
sterile 5 ml syringe. Proteins, RNA, phenol and any other contaminants were 
removed by washing the cartridge with 5 ml of buffer C (see section 2.2.2.). The 
plasmid DNA was eluted from the cartridge using 2 ml of buffer F (see section
2.2.2.), and precipitated by the addition of 0.8 vol. of isopropanol. After 30 min on 
ice samples were centrifuged at 10,000 ipm for 15 min at 4 °C. The DNA pellet 
was washed once with 70% ethanol, once with 100% ethanol and then dried at 
room temperature.The concentration of the DNA was determined by measuring the 
A260» using assumption that a 50 |ig/|il solution of DNA has an A2 6 0  of 1.0 
when measured in a spectrophtometer cell with a 1 cm light-path. The A ^o ° f  tf16 
DNA preparation was also determined, since the ratio A2fl):A28o gives an indication 
of the purity of the DNA. Pure double-stranded DNA gives an A26o:A280 1-8:1.
Finally, a sample of each preparation was subjected to restriction endonuclease 
digestion and together with an uncut sample electrophoresed on an agarose gel to 
check the quality of the preparation.
2.5.3. Large scale preparation of bacteriophage X DNA.
A single colony of the bacterial host E. coli BHB 2600 was inoculated into a 10 
ml overnight culture of LB. A suitable dilution of phage, giving 10-100 plaques, 
was adsorbed onto 200 jil of the overnight culture of the bacterial host, mixed with 
3 ml LB top agar (see section 2.2.1.), poured onto a LB plate (see section 2.2.1.) 
and incubated overnight A single plaque was removed from the plate, added to 200 
|il of an overnight culture of bacterial host and left standing for 20 min at room 
temperature. The culture was then transferred to a fresh flask containing 20 ml LB 
supplemented with 10 mM MgSC>4 and 0.2% (w/v) maltose. The flask was shaken 
at 37 °C until lysis occured (usually between 4 to 6  h after inoculation), when 1 ml 
of chloroform was added. After 10 min of shaking, the upper layer was sedimented 
by centrifugation at 2,000 rpm for 20 min and the supernatant stored at 0 °C  in a 
fresh tube. The titre of the supernatant was generally about 1010 pfu/ml. Two 500 
ml batches of LB, supplemented with 10 mM MgSC>4 and 0.2% maltose, were 
inoculated with 2 x 5 ml of an overnight bacterial culture. The culture was grown
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until A5 1 0  reached 0.3 when a total of 5 x 1010  pfu of phage was added. (This 
gives a ratio of pfurhost cells of 1:200). The infected culture was shaken until lysis 
occured (usually between 3 and 4 h) and then 5 ml of chloroform was added to each 
flask and shaking continued for a further 10-15 min.The lysed cultures were 
decanted and bacterial debris was removed by centrifugation at 4,000 rpm for 20 
min. DNasel and pancreatic RNase were added (each to a final concentration of 10 
|ig/ml) to the supernatant which was incubated at room temperature for 30 min. 
Solid NaCl was added to 2%, solid polyethylene glycol (PEG-6000 Serva) was 
added to 8 % and the culture was left standing at 4 °C overnight to precipitate the 
phage particles. The phage was sedimented by centrifugation at 6,000 rpm for 30 
min and carefully resuspended in 20 ml of lambda diluent (100 mM Tris-HCl, pH 
8 ; ImM EDTA ; 10 mM Mg SO4 ) to which 0.71 g of solid CsCl was added per ml 
of sample. After a clarifying centrifugation at 1,500 rpm for 30 min the solution 
was transferred into sealable tubes and centrifuged at 48,000 rpm and 20 °C 
overnight using a VTi50 rotor of a Beckman ultracentrifuge. The white phage band 
was collected after piercing the tube with a 18 g needle just below the band.The 
phage was then dialysed against three changes (1 h each) of 500 ml buffer (10 mM 
Tris-HCl, pH 7.5; ImM EDTA ; 10 mM Mg SO4 ) to remove CsCl. DNA was 
extracted with 1:1 phenol/chloroform (see section 2.5.5.1.) twice, and ether twice. 
After the addition of 2.5 vol. ethanol the DNA was precipitated by centrifugation at
10,000 rpm for 10 min, dried and resuspended in 0.5 ml TE. The DNA 
concentration was determined as described in section 2.5.2.
2.5.4. P reparation  of high m olecular weight hum an genomic DNA 
from  blood.
The method used is that described by Miller et a l ., (1988). 40 ml of blood lysis 
buffer (see section 2 .2 .2 .) was added to 1 0  ml of fresh or frozen whole blood kept 
on ice. The mixture was centrifuged at 2,800 rpm for 10 min at 4 °C. The cell pellet 
was then resuspended in 3 ml of nuclear lysis buffer (see section 2.2.2.). To the 
suspension 0.2 ml 10% SDS and 0.1 ml proteinase K (10 mg/ml in 1% SDS, 2 
mM EDTA) were added and the mixture incubated at 37 °C overnight. After the 
addition of 1 ml of a saturated solution of NaCl (approximately 6  M) the mixture
35
was extracted gently with 1 :1  phenol/chloroform two or three times until the 
interface was clear. Two volumes of ethanol were added to the aqueous phase and 
the precipitated DNA spooled out onto a closed Pasteur pipette. The DNA was 
washed once in 70% ethanol and once in 100% ethanol and redissolved in an 
appropriate volume of TE. The concentration of the DNA was determined as 
described in section 2.5.2. Agarose gel electrophoresis of a sample of the DNA 
confirmed that genomic DNA prepared in this way was over 50 kb in size. 
Genomic DNA was stored at 4 °C.
2.5.5. Extraction and precipitation of DNA.
2.5.5.1. Phenol/chloroform  extraction.
Phenol/chloroform stock was made by mixing equal amounts of phenol and 
chloroform then equilibrating the mixture by extracting several times with TE. The 
equilibrated mixture was stored under TE in the dark. 8 -Hydroxyquinoline was 
added to 0 . 1 % as an antioxidant and to assist in distinguishing the 
phenol/chloroform from the aqueous phase in extractions. Extraction with 
phenol/chloroform was performed as follows: an approximately equal volume of 
phenol was added to the DNA solution to be extracted, mixed and centrifuged for 5 
min; the upper aqueous layer was transferred to a fresh tube and the extraction 
repeated as necessary.
2.5.5.2. Ethanol and isopropanol precipitation.
Ethanol used was of the absolute alcohol 100 grade and was stored at -20 °C. A 
salt solution was added to the DNA solution to the appropriate concentration (0.1 
volume of 5 M ammonium acetate or 0.1 volume of 3 M sodium acetate) and mixed 
with 2.5 volumes of cold ethanol. The samples were placed at -20 °C or in dry ice 
for an appropriate period then centrifuged at 10,000 rpm for 15 min at 4 °C. The
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precipitated DNA was washed successively with 70% ethanol and 100% ethanol 
and dried at room temperature under vacuum. DNA was usually stored at -20 °C in 
TE. When the DNA sample volume was such that addition of 2.5 volumes of 
ethanol was impractical, precipitation was carried out by the addition of an equal 
volume of isopropanol to the DNA + salt solution.
2.5.6. DNA digestion with restriction endonucleases.
Restriction digests were routinely carried out in 1.5 ml Eppendorf tubes in the 
presence of the appropriate buffer. One unit of restriction enzyme activity is defined 
as the amount of enzyme required to digest 1 pg of X DNA to completion in one 
hour at the correct incubation temperature and in the appropriate buffer. In practice a 
several fold excess of enzyme was usually added to digest the DNA. A typical 
reaction mixture contained 1 pg of DNA, the correct restriction enzyme bufferc~ l'
(usually supplied by the manufacturer) and 5 units of the desired restriction enzyme 
in a final volume of 25 pi. The mixture was incubated for at least one h at the 
temperature recommended by the manufacturer, usually 37 °C. The completion of 
the digestion was monitored by electrophoresis of an aliquot through an agarose 
gel. After digests, restriction enzymes were heat inactivated (65 °C for 10 min) or 
removed by phenol/chloroform extraction. Digestions of genomic DNA were 
incubated overnight, using 8  units of enzyme per pg of genomic DNA. For multiple 
digestions where different buffers were required, the digestion which required the 
lower ionic strength was carried out first, then the ionic conditions were adjusted, 
the second enzyme added and the incubation continued.
2.5.7. Separation of DNA fragm ents by electrophoresis.
2.5.7.I. DNA electrophoresis in agarose and polyacrylam ide gels.
Agarose gels were routinely used to separate DNA fragments in the size range
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0.1-20 kb. They were prepared by dissolving agarose (BRL ultra PURE) in 1 x 
TBE (see section 2.2.2.) to the desired concentration (0.5-2%; Sambrook et a l .,
1989). Ethidium bromide was added to 10 |ig/ml and the gel poured onto a 
horizontal tank (BRL model H5 or model 200). Wells with a suitable capacity were 
formed by insertion of a comb into the gelling agarose. After submerging the gel in 
1 x TBE (see section 2.2.2.) one fifth volume of loading buffer (10% glycerol, 
25% ficoll 400,1 mM EDTA and 0.25% bromophenol blue) was added to the DNA 
samples and the mixture loaded into the wells. Electrophoresis time and current 
(20-50 mA) were varied as needed. After electrophoresis gels were destained by 
two x 10 min washes in 1 x TBE or distilled water. DNA fragments were visualised 
by the use of a long wavelength u.v. transilluminator (U.V. Products Inc.) and 
photographed with a Polaroid Cu-5 camera, using type 665 positive/negative film. 
The sizes of the restriction fragments were determined by comparison with DNA 
marker fragments of known size, electrophoresed on the same gel. The distances 
(in mm) travelled by the known marker fragments were plotted on semi-log graph 
paper against log size of DNA (kb). The sizes of unknown fragments could then be 
determined by measuring the distance travelled and referring to the standard curve. 
When 32P or 35S labelled DNA fragments were separated on agarose gels the gels 
were dried under vacuum on a gel drier (model 1125B Bio-Rad, 2 h at 80 °C) prior 
to autoradiography.
Polyacrylamide gels were used to separate DNA fragments of 0.2 kb and below. 
Gels were prepared as follows: a deionised 40% stock solution (38% acrylamide, 
2% N’N'-methylene bisacrylamide) was diluted to the desired concentration 
(usually 10%) in 1 x TBE. After the addition of 300 pi of fresh 10% ammonium 
persulphate and 50 pi TEMED, the mixture was poured between two glass plates 
and a comb placed at the top of the gel. After polymerisation, DNA samples plus 
loading buffer were placed in the wells and electrophoresis carried out at 40 mA 
using a vertical gel kit (BRL model VI61).
2.S.7.2. Recovery of DNA from  low melting point agarose.
Low melting point agarose (BRL ultra PURE) gels were prepared and used in the 
same way as standard agarose gels. The DNA band of interest was visualised and
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the gel containing it excised over u.v. and transferred to an Eppendorf tube. The gel 
sample was placed at 70 °C in a waterbath for 8  min to melt the agarose and three 
volumes of TE were added. The sample was then extracted twice with phenol 
saturated with TE and three times with ether to remove the agarose and the DNA 
was then precipitated with ethanol.
2.5.8. Subcloning DNA fragm ents into pUC19.
Insert DNA and pUC19 vector DNA were digested with the appropriate 
enzyme(s) and the extent of digestion checked by gel electrophoresis. Insert DNAs 
were usually purified from low melting point agarose gels as described in section
2.5.7.2. In some cases, to reduce background due to religation of the vector the 
digested pUC19 DNA was treated with alkaline phosphatase to remove 5' 
phosphates: the reaction mix (50 pi), containing 5 pg digested vector DNA, 1 unit 
of calf intestine alkaline phosphatase (Boehringer grade I), 50 mM Tris-HCl (pH 
9), 1 mM MgCl2 , 0.1 mM ZnCl2  and 1 mM spermidine was incubated at 37 °C for 
1 h. After heat inactivation of the enzyme (65 °C  for 10 min) the digested, 
dephosphorylated vector DNA was purified by phenol/chloroform extraction 
followed by ethanol precipitation and resuspended at 20 ng/pl in TE. Typical 
ligation reactions contained: insert DNA (20-100 ng), vector DNA (20-50 ng), 1 
mM ATP, 10 mM DTT, 50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 2 mM 
spermidine, bovine serum albumin (100 pg/ml) and 2 units of T4 DNA ligase in a 
final volume of 10 pi. The ligation mixture was incubated at 15 °C  for 16 h. 
Greater concentrations of T4 ligase (5-10 units in 10 pi) were used for the ligation 
of DNA molecules with blunt ends.
2.5.9. Transform ation of bacterial cells with plasmid DNA.
Competent E. coli cells were prepared by a modified version of the method of 
Dagert and Erlich (1979). 2 ml of an overnight 10 ml LB culture of E. coli TGI 
was used to inoculate 40 ml of LB. The cells were grown at 37 °C with shaking for
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2-3 h until the A55 0  of the culture exceeded 0.3. The cells were cooled on ice and 
harvested by centrifugation at 2,500 rpm for 10 min at 4 °C. The cells were gently 
resuspended in 20 ml of ice cold sterile 50 mM CaCl2  and left on ice for 20 min. 
The cells were pelleted as before and resuspended in 4 ml sterile 50 mM CaCl2 . 
Competent cells prepared in this way remained usable for up to 5 days if stored on 
ice. Transformations with pUC19 DNA were carried out in Eppendorf tubes. 5 pi 
of ligation mix containing 25-50 ng of DNA was added to 100 pi of competent cells 
and the mixture incubated on ice for at least 40 min, then heat shocked at 42 °C for 
1 min. The cells were placed on ice then spread together with 50 pi of 100 mM 
IPTG and 50 pi of X-gal (2% (w/v) in dimethylformamide) onto LB plates 
containing 100 pg/ml ampicillin. Plates were incubated at 37 °C overnight to allow 
colony formation. Colonies transformed with recombinant pUC19 were colourless 
in the presence of X-gal and IPTG because they lacked a functional 
p-galactosidase. Colonies transformed with pUC19 alone are blue in the presence 
of X-gal and IPTG.
2.5.10. DNA transfer to m em branes (Southern blotting).
2.5.10.1. DNA transfer to nylon m em branes.
This method is basically that of Southern (1975). After electrophoresis (see 
section 2.5.7.1.) the agarose gel was immersed in 0.25 M HC1 for 15 min at room 
temperature with gentle agitation. (This "depurination” step was only necessary to 
increase the efficiency of transfer of DNA fragments of over 10 kb). The gel was 
rinsed in distilled water then immersed in denaturation buffer (1.5 M NaCl, 0.5 M 
NaOH) for 30 min at room temperature. After rinsing the gel was washed in 
neutralising solution (1.5 M NaCl, 0.5 M Tris-HCl pH 7.2, 1 mM EDTA) for 2 x 
15 min at room temperature. Blots were set up as follows: 10 x SSC (see section
2 .2 .2 .) was used to fill two buffer reservoirs connected over a solid support by two 
wicks of Vvhatman 3 MM paper, the gel was placed on the bridge. A cling film 
sheet covered the whole apparatus, leaving a window of the same size and position 
of the gel, to prevent side capillary transfer. A nylon filter (Hybond-N, Amersham
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International pic) cut to the size of the gel was placed on the gel and four sheets of 3 
MM paper cut to the same size placed on top. An excess stack of absorbent paper 
was further placed on top and the whole system compressed using a 1 kg weight on 
top of a glass plate. Transfer of DNA was allowed to proceed for 16-20 h at room 
temperature. After blotting the nylon filter was marked for orientation, rinsed in 2 x 
SSC then baked at 80 °C  for 5 h in a vacuum oven to bind the DNA to the 
membrane. Membranes were stored in sealed plastic bags at room temperature.
2.5.10.2. DNA transfer to nitrocellulose m em branes.
The method used was that described for nylon membranes (section 2.5.10.1.) 
with the following variations. The denaturation buffer used was 0.2 M NaOH, 0.6 
M NaCl and the neutralisation buffer was 1 M Tris-HCl (pH 7.5), 0.6 M NaCl. 
Nitrocellulose membranes (Schleicher and Schuell) were blotted and stored in the 
same way as described in section 2.5.10.1.
2.5.11. Radiolabelling of nucleic acids.
2.5.11.1. R andom  oligonucleotide-prim ed synthesis from  DNA 
fragm ents.
The method used was that described by Feinberg and Vogelstein (1983 and
1984). DNA fragments were separated on a low melting point agarose gel as 
described in section 2.5.12 . Two volumes of distilled water were added to the gel 
slice containing the excised band and the sample was heated to 95 °C  for five 
minutes before being transferred to a 37 °C  waterbath. A volume of diluted gel 
containing approximately 100 ng of DNA was added to the following: 10 pi of 
oligolabelling buffer (see below), 20 pg of bovine serum albumin, 30 pCi of 
a _[32p]_dCTP (Amersham, 3000 Ci/mmol), 2 units of large fragment DNA 
polymerase I (Klenow; BRL) and distilled water to 50 pi. The reaction was carried
41
out at room temperature overnight and stopped by the addition of a solution 
containing 20 mM NaCl; 20 mM Tris-HCl, pH7.5; 2 mM EDTA; 0.25% SDS and 
1 pM dCTP. Purification of the labelled DNA was not performed. Oligolabelling 
buffer was made up from the following three components: (i) two volumes of 
0.018% 2-mercaptoethanol and the remaining unlabelled dNTPs (dATP, dGTP and 
dTTP, each 0.5 mM) in 1.25 M Tris-HCl (pH 8 ) and 0.125 M MgCl2; (ii) five 
volumes of 2 M HEPES (pH 6 .6 ); and (iii) three volumes of random sequence 
hexadeoxyribonucleotides (Pharmacia) at 90 OD units/ml in TE. This mixed buffer 
was stored at -20 °C. The extent of incorporation (typically 70-80%) of the 32P 
labelled dCTP was assayed using Whatman DE81 paper with 0.3 M ammonium 
formate (pH 8 ) as the solvent for paper chromatography. The specific activity of the 
DNA labelled by this method was up to 109 cpm per p.g of DNA when cpm were 
assayed using the Cerenkov channel of a scintillation counter.
2.5.11.2. End-labelling of DNA restriction fragm ents.
The following method was used for end-labelling isolated restriction fragments 
having recessed 3' termini, e.g. in the preparation of radioactive DNA size markers: 
to the restriction fragments were added dTTP, dGTP and dCTP to 100 pM each, 10 
pCi a - [ 3 2 P]-dATP (Amersham, 3000 Ci/mmol) or 10 pCi a - [ 3 5 S]-dATP 
(Amersham, 600 Ci/mmol), 2 units of large fragment DNA polymerase I (Klenow; 
BRL) and distilled water to 50 pi. The reaction was carried out at room temperature 
for 30 min.
2.5.11.3. End-labelling of oligonucleotides.
Single stranded oligonucleotides were end-labelled using polynucleotide kinase 
and y-[32P]-ATP as follows: 0.5 pg of synthetic oligonucleotide was added to 1 pi 
10 x buffer (0.5 M Tris-HCl, pH 8 ; 0.1 M MgCl2, 50mM DTT), 60 pCi 
y-[32P]-ATP (Amersham, 5000 Ci/mmol) and 10 units T4 polynucleotide kinase 
(NBL) in a final volume of 10 pi and the mixture incubated at 37 °C  for 1 h. The
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labelled oligonucleotide DNA was recovered and separated from unincorporated 
radioactivity by two ethanol precipitations as follows: 40 pi of 2.5 M ammonium 
acetate and 160 pi of cold ethanol were added to the incubation mix and the DNA 
was precipitated at -70 °C for 15 min. The DNA was pelleted by centrifugation at
10,000 rpm for 15 min at 4 °C. The pellet was resuspended in 100 pi 0.3 M 
sodium acetate, 300 pi of cold ethanol was added and the DNA precipitated as 
before. The labelled oligonucleotides were washed in 70% ethanol and dried at 
room temperature. An oligonucleotide labelled in this way could be used with an 
appropriate unlabelled oligonucleotide in the polymerase chain reaction (see section
2.5.15.1.) to amplify a specific DNA fragment end-labelled only at the 5' end of 
one strand.
2.5.11.4. Labelling of a mixed population of "p erio d a te  trea ted "  
small RNAs.
"Periodate treated" tRNA (prepared by Dr. J P. Goddard) was a mixed 
preparation of small placental RNAs which had been subjected to periodate 
oxidation and p elimination at alkaline pH after protection of the tRNAs by prior 
aminoacylation with all 20 amino acids as described in Goddard et a l ., (1983) 
using the method of Traboni et a l ., (1980). Only those RNAs in the mixture which 
were aminoacylated will have 3' OH groups capable of accepting pCp after 
periodate treatment. An aliquot of the periodate treated material was labelled by the 
ligation of [32P]pCp as follows: 1 pg of periodate treated material was added to 50 
pCi [32P]pCp (Amersham, 3000 Ci/mmol), together with 1 pi of 10 x buffer (100 
mM Tris-HCl, pH7.5; 2.5 mM DTT; 100 mM MgCl2), 1 pi DMSO, 4 pi of 100 
pM ATP, 10 units ofT4 RNA ligase (Anglian Biotec) and distilled water to 10 pi. 
The reaction was carried out at 4 °C overnight.
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2.5.12. Hybridisation of blotted DNA.
2.5.12.1. H ybridisation using nylon m em branes.
The following conditions were used for the hybridisation of DNA fragments 
(labelled by the random priming method; see section 2.5.11.1.) to denatured DNA 
immobilised on nylon membranes. The nylon membrane with blotted DNA was 
placed in a polythene bag containing 10 ml of hybridisation buffer (5 x SSPE (see 
section 2.2.2.), 0.5% SDS, 100 |xg/ml denatured, sonicated salmon sperm DNA 
and 5 x Denhardt's solution (100 x Denhardt's solution contains 1% (w/v) of each 
of Ficoll (type 400, Pharmacia), polyvinylpyrrolidone and bovine serum albumin 
(Fraction V; Sigma)). The bag was sealed and the membrane pre-hybridised for 
16-24 h at 65 °C  with constant agitation. The appropriate DNA probe was 
denatured by boiling the sample for 8  min and cooling it on ice for 5 min. The 
probe was then added to the membrane plus prehybridisation buffer, the bag 
resealed and hybridisation allowed to take place for 16-24 h at 65 °C with constant 
agitation. The stringency of the washes used after hybridisation to remove 
non-specifically hybridised probe was varied as appropriate. Typically membranes 
were washed successively in 2 x 100 ml of 1 x SSPE for 5 min at room 
temperature; 2 x 100 ml of 1 x SSPE and 0.1% SDS for 30 min at room 
temperature; 2 x 100 ml of 1 x SSPE and 0.1% SDS at 65 °C and 2 x 100 ml of 
0.5 x SSPE and 0.1% SDS at 65 °C. After washing, the membrane was wrapped 
with cling film and exposed to preflashed X-ray film (Fuji) using two intensifying 
screens (Dupont, Cronex-lightning plus) for a suitable period at -70 °C. Nylon 
membranes were stripped for subsequent re-use by two immersions for 1 0  min in 
distilled water plus 0.1 % SDS at 100 °C.
2.5.12.2. H ybridisation using nitrocellulose m em branes.
The following conditions were used for the hybridisation of mixed tRNA probes 
(labelled with [3 2P]pCp; see section 2.5.11.4.) to DNA fixed to nitrocellulose
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membranes. Membranes were placed in polythene bags together with 10 ml of 
hybridisation buffer (5 x SSC, 50% formamide) and the labelled probe added to the 
bag. No prehybridisation step was used, and no heat denaturation of the RNA 
probe is necessary. Hybridisation was allowed to take place for 16-24 h at 42 °C 
with constant agitation. The stringency of the washes used to remove 
non-specifically hybridised probe from nitrocellulose membranes was varied as 
appropriate. Typically membranes were washed briefly in 5 x SSC, 50% 
formamide then successively in 2  x 100 ml of 5 x SSC at room temperature for 30 
min with gentle agitation and 2 x 100 ml of 2 x SSC at room temperature for 30 min 
with gentle agitation. Membranes were exposed to X-ray film as described in 
section 2.5.12.1.
2.5.13. D ensitom etric analysis of autoradiographs.
Autoradiographs obtained from experiments involving hybridisations to human 
genomic DNA were scanned, parallel to the direction of migration of blotted DNA, 
by the use of a Laser densitometer (2202 Ultrascan, LKB Bromma). Four readings 
were taken for each band on the autoradiograph. An example of a densitometric 
trace is shown in figure 4.5.B. The Laser densitometer was calibrated by Mr. J. 
Jardine.
2.5.14. N ucleotide sequence ana lysis  by the  S an g er chain  
term ination method.
Nucleotide sequence analysis was performed as described by Sanger et a l ., 
(1980). The DNA fragments to be sequenced were subcloned into the multiple 
cloning site of M13 replicative form DNA vectors (Norrander et a l 1983; 
Yanisch-Perron et a l ., 1985) and E. coli TGI cells transformed with the 
recombinant DNA. Plaques containing recombinant phages were selected and 
single-stranded phage DNA prepared. An oligonucleotide, the M l3 universal 
primer, was annealed to each of these DNA templates and extended in a 5' to 3'
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direction by the use of DNA polymerase I large fragment (Klenow) in the presence 
of one of four dNTP/ ddNTP mixes. Each of these mixes contains all four dNTPs 
(one radioactively labelled) but only one of the four ddNTPs. The reaction 
conditions are such that the newly synthesised DNA strands are terminated at 
random lengths but at base specific positions. The resulting families of DNA 
strands of different lengths, each terminated by a specific dideoxynucleotide, were 
separated by polyacrylamide gel electrophoresis. Gels were then fixed, dried down 
and autoradiographed and the DNA sequence determined. Sequence data was stored 
using a mainframe VAX computer. Sequences were analysed using the Staden 
program "ANALYSEQ" (Staden, 1986). This program enables the user to search 
nucleic acid sequences for tRNA genes, open reading frames, repeated motifs etc. 
The sequences and cloverleafs shown in figures 3.6., 3.8., 3.10. and 4.10. were 
generated using the ANALYSEQ program.
2.5.14.1. S ubcloning  DNA frag m en ts  in to  M 13 vecto rs  and  
transform ation of E. coli TG I.
Restriction digests and ligations of vector and insert DNAs were performed as 
described in sections 2.5.6. and 2.5.8. respectively. Half (5 |il) of each ligation 
mix was added to 300 jil of competent E. coli TGI cells (prepared as described in 
section 2.5.9.) and the mixture left on ice for 2-3 h. The cells were then heat 
shocked at 42 °C for 3 min and returned to ice. During this time the following were 
added to 3 ml of molten H-top agar (see section 2.2.1.) kept at 45 °C : 35 pi IPTG 
(100 mM), 35 jil X-gal (2% in dimethylformamide) and 200 |il fresh TGI cells. 
Immediately after mixing, the molten agar was added to the transformation mix and 
spread onto a prewarmed H-plate (see section 2.2.1.). The plate was allowed to set 
and incubated at 37 °C overnight. Transformed cells harbouring recombinant M l3 
phage appeared as opaque colourless plaques on a lawn of uninfected cells, while 
those containing religated or uncut vectors appeared as blue plaques.
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2.5.14.2. Preparation of single-stranded DNA templates.
A single white plaque was inoculated into 1.5 ml 2 x YT (see section 2.2.1.) 
containing 0.01 volume of an overnight culture of E. coli TGI. This culture was 
vigorously agitated for 4.5 h at 37 °C and the cells sedimented by centrifugation at
10,000 rpm for 5 min. The supernatant containing extruded phage was transferred 
to a fresh tube and recentrifuged to remove residual cells. The second supernatant 
was added to 200 |il of a solution of 20% (w/v) polyethylene glycol 6000 and 2.5 
M NaCl and the mixture left standing at room temperature for 15 min. The 
precipitated phage was then collected by centrifugation at 1 0 ,0 0 0  rpm for 5  min and 
the supernatant aspirated using a drawn out Pasteur pipette to ensure removal of all 
traces of polyethylene glycol. The phage was resuspended in 100 pi of TE, 
extracted once with phenol and once with chloroform, ethanol precipitated, dried, 
redissolved in 25 pi TE and stored at -20 °C.
2.5.14.3. Sequencing of single-stranded DNA tem plates.
Sequencing was carried out using the protocols supplied by Amersham pic in the 
M13 Cloning and Sequencing Handbook.
2.5.14.3.1. Annealing and sequencing reactions.
The primer used (5’d[GTAAAACGACGGCCAGT] 3') was the 17-mer M13 
universal primer with a sequence complementary to that of a region adjacent to the 
multiple cloning site of Ml 3. To anneal the primer to the template, single-stranded 
template DNA (approximately 1 pg) was mixed with 20 ng of the primer in a final 
volume of 10 pi in Klenow reaction buffer (10 mM Tris-HCl, pH 8.5; 5 mM 
M gC y, and incubated at 60 °C for 90 min. Subsequent steps were carried out at 
room temperature. After annealing, 15 pCi a - [ 3 5 S]-dATP (Amersham, 600 
Ci/mmol) and two units of Klenow fragment were added to the annealed
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primer/template. A 2.5 pi aliquot of the mixture was placed into each of four tubes 
marked A, G, C and T in a rack for an Eppendorf 5413 microcentrifuge. A 2 pi 
aliquot of the relevant dNTP/ddNTP mix (see below) was placed separately into 
each tube. A brief spin mixed the contents of the tube and started the reaction. After 
20 min, 2 pi of chase mix (a uniform 0.5 mM solution of all four dNTPs) was 
placed into each tube. After a second brief spin the chase was allowed to precede 
for 15 min. The chase reaction was stopped by the addition of 4 pi of formamide 
dye (0.03% xylene cyanol FF, 0.03% bromophenol blue and 20 mM EDTA in 
deionised formamide). The dNTP/ddNTP mixes used were varied according to the 
nature of the DNA template and the length of sequencing run needed.The basic 
mixes for sequencing with a-[35S]-dATP were made up as shown below:
Deoxy NTP mixes (A0, C°, G°, T°):
A® CO GO TO
0.5 mM dCTP 2 0  pi i p l 2 0  pi 2 0  pi
0.5 mM dGTP 2 0  pi 2 0  pi l p l 2 0  pi
0.5 mM dTTP 2 0  pi 2 0  pi 2 0  pi l p l
TE,■ pH 8 2 0  pi 2 0  pi 2 0  pi 2 0  pi
Dideoxy NTP working solutions were: 0.1 mM ddATP, 0.1 mM ddCTP, 0.3 
mM ddGTP and 0.5 mM ddTTP.
The standard dNTP/ddNTP mix was made up of equal volumes of a dNTP 
mix (A0, G°, C° or T°) and the corresponding ddNTP working solution. For 
sequencing DNA rich in G+C, the dGTP was replaced by the nucleotide 
analogue 7-deaza-dGTP at the same concentration. The use of 7-deaza-dGTP helps 
to prevent the "compressions" in a sequence caused by secondary structure 
formation in the template DNA, particularly in G+C rich regions (Martin, 1987). 
The ratio of [dNTP]:[ddNTP] was increased for longer sequencing runs. Reducing 
the concentration of ddNTP causes the average length of DNA chains synthesised 
to increase by making termination with a ddNTP less likely.
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2.5.14.3.2. Gel electrophoresis and autoradiography.
Polyacrylamide-urea denaturing gels were prepared as follows: a 40% stock 
solution of acrylamide was prepared (see section 2.5.7.1.) of which 7.5 ml was 
added to 21 g of urea (BRL ultra PURE) and the mixture made up to 50 ml with 1 x 
TBE buffer (see section 2.2.2.). To the mixture 300 |il of fresh 10% ammonium 
persulphate and 50 p.1 of TEMED were added and the gel (40 x 20 x 0.04 cm) 
poured between two clean glass plates, using a sharkstooth comb (BRL). The 
notched gel plate was treated with dimethyldichlorosilane to prevent the gel 
adhering to both plates. The gel was left for at least one hour to polymerise fully 
then transferred to the sequencing gel apparatus (61 x 53 Vertical slab unit 400; 
Shandon, Southern), the reservoirs of which were filled with 1 x TBE buffer. The 
sequencing reaction samples were boiled for at least 3 min then loaded immediately 
onto the gel. Electrophoresis was carried out at 30 mA and 40 W usually until the 
bromophenol blue reached the bottom of the gel. After electrophoresis and removal 
of the notched gel plate the gel was fixed by soaking in a two litre bath of 1 0 % (v/v) 
acetic acid; 10% (v/v) methanol for 15-20 min to remove the urea. The gel was 
drained for a few minutes, transferred onto a sheet of Whatman 3 MM paper, 
covered with cling film and dried under vacuum on a gel drier (model 1125B 
Bio-Rad) for 1 h at 80 °C. After drying the gel was exposed directly onto Fuji 
X-ray film overnight at room temperature. Longer exposures were used as 
necessary. Following autoradiography it was usually possible to read over 200 
nucleotides from one loading. Two separate loadings were necessary to maximise 
the length of sequence that could be read: the first loading was subjected to 
electrophoresis for 3-4 h and the second loading for 1.5-2 h.
2.5.15. The polymerase chain reaction (PCR).
The polymerase chain reaction is a powerful method for the in vitro 
amplification of specific DNA fragments (for review see White et a l ., 1989). The 
methods described in sections 2.5.15.1. and 2.5.15.2. are based on protocols 
given in Innes et a l ., (1990).
49
2.5.15.1. Basic PCR methodology.
Standard PCR amplification reactions were set up in a total volume of 100 pi. 
The reaction mix contained: 10 pi of Promega 10 x Taq DNA polymerase buffer 
(500 mM KC1, lOOmM Tris-HCl, pH 9, 15 mM MgCl2 , 0.1% gelatin (w/v), 1% 
Triton X-100), 0.2 mM dATP/dGTP/dCTP/dTTP, 2.5 units Taq DNA polymerase 
(Promega), 0.5 pg of each of the two oligonucleotide primers used and a suitable 
amount of target DNA. The components were added in the order shown. The 
amount of target used depended on the complexity of the DNA containing the DNA 
fragment to be amplified. Typical amounts used were 2 ng of recombinant plasmid 
DNA, 5 ng of recombinant X DNA and 0.2 pg of human genomic DNA. 
Amplifications were carried out using a programmable DNA thermal cycler (Perkin 
Elmer Cetus). The exact conditions used for amplification varied with the nature 
and length of the target sequence. For G+C rich targets the 0.2 mM dGTP in the 
mix was replaced with 0.2 mM 7-deaza-dGTP. The stages involved in the PCR 
were an initial denaturation of the target DNA at 94 °C, followed by repeated cycles 
of denaturation (94 °C), annealing of primers (50-60 °C), new DNA synthesis (72 
°C) and a final single extended period at 72 °C  to ensure that the majority of 
amplified products were of full length. A typical set of conditions used was: 94 °C 
for 3 min, 30 x [94 °C, lmin; 55 °C, 30 s; 72 °C, 2 min], 72 °C  for 5 min. 
Finally, samples were cooled to 4 °C to stop the reaction. PCR amplified DNA 
fragments were analysed by agarose or polyacrylamide gel electrophoresis.
2.5.15.2. Production of single-stranded DNA by asym m etric PCR.
The PCR can be used to produce single-stranded DNA which is a suitable 
template for sequencing by the Sanger chain termination method (see section
2.5.14.). The method used (McCabe, 1990) is termed asymmetric PCR since it 
involves the use of an unequal concentration of the two amplification primers. This 
modification of the PCR protocol leads to an initial amplification of double stranded
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product until the lower concentration primer becomes depleted, following which an 
excess of one of the two strands is generated, depending on which of the 
amplification primers was limited. This single-stranded DNA accumulates linearly 
and is complementary to the limiting primer which can subsequently be used to 
prime sequencing reactions. The complementary strand can be generated for 
sequencing by reversing the relative concentrations of the two primers. Asymmetric 
PCR was used in this study to sequence genomic copies of tRNA genes. The 
reaction mix for asymmetric PCR was prepared essentially as described in section
2.5.15.1. using 0.2 pg of target human genomic DNA. The ratio of limiting : 
non-limiting primer used was 20 : 1  (1 pg : 50 ng). The optimum conditions found 
for the amplification reaction were 94 °C for 3 min, 45 x [94 °C, lmin; 55 °C, 1 
min; 72 °C, 20 s], 72 °C for 3 min. After the addition of 2.5 units of fresh Taq 
DNA polymerase a further 10 cycles were performed. The amplified DNA 
fragments were precipitated by the addition of ammonium acetate to 2 M and 
isopropanol to 50%, pelleted by centrifugation at 10,000 ipm for 10 min at 4 °C, 
washed with 70% ethanol and dried. Analysis by agarose gel electrophoresis 
confirmed that one discrete band was predominantly amplified, although some 
background bands were visible. The single-stranded DNA prepared in this way 
proved to be suitable for sequence analysis without further purification.
2.5.16. In vitro transcription of tRNA genes.
2.5.16.1. HeLa S3 cell extract.
HeLa cell nuclear extract was prepared using an adaptation of the method of Weil 
et a l ., (1979). HeLa S3 cells (Gibco) were grown in suspension in 700 ml stirring 
flasks (Techne, Cambridge) in the Glasgow modification of Eagle's minimal 
essential medium (see Adams, 1980; provided by Gibco), supplemented with 10% 
calf serum, 1% glutamine, 1% non-essential amino acids and 1 M NaOH to give a 
pH of approximately 7.5. The cells were monitored daily by microscopic 
examination. Cell culture was carried out by Dr. R.L.P. Adams, Mrs. A. Rinaldi
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and Mrs. H. Lindsay. Cells from three litres of culture (at a density of 
approximately 5 x 105 cells/ml) were harvested and washed with cold PBS mix (see 
section 2.2.2.). The packed cell volume was measured after centrifugation at 1,000 
rpm in a Beckman TJ- 6  centrifuge for 5 min at 4 °C. The cells were then washed 
with hypotonic buffer (10 mM HEPES, pH 7.9, 10 mM K Q , 1.5 mM MgC^, 0.5 
mM DTT) and the cell pellet was resuspended in twice the packed cell volume of 
hypotonic buffer. The cells were allowed to swell for 10 min on ice and then 
disrupted in a Kontes all glass Dounce homogeniser by 18-20 strokes of the B 
pestle. The extent of cell lysis was generally 90-95% as monitored by light 
microscopy, while nuclear lysis was minimal. One tenth volume of a solution 
containing 0.3 M HEPES, pH 7.9, 1.4 M KC1 and 30 mM MgCl2  was added and 
the lysate was centifuged at 40,000 rpm in a Ti50 rotor of a Beckman 
ultracentrifuge for 1 h at 4 °C. The supernatant was placed in a fresh tube and 
glycerol added to 20% (v/v). The cell free extract was stored in 400 pi aliquots at 
-70 °C. All of the transcription assays mentioned in this study were performed 
using aliquots from a single HeLa cell extract preparation. The protein concentration 
of this crude extract preparation was determined as 1 mg/ml by Ms. C. Houlston 
using the method of Bradford (1976).
2.5.16.2. In vitro transcrip tion  assay.
The method used for the transcription assays described in this study was 
optimised in our laboratory by Dr. E. Gonos. The protocol was initially based on a 
consensus of the methods of Laski et a l ., (1983), Makowski et al ., (1983), 
Murphy and Baralle (1983), Schaak et a l ., (1984) and Segall et a l ., (1980). 
Transcription assays were normally performed in duplicate. A typical transcription 
reaction mixture (20 pi) contained final concentrations of 14 mM HEPES-KOH, 
pH 7.9, 80 mM KC1, 20 mM NaCl, 3.5 mM MgCl2, 10% (v/v) glycerol, 0.3 mM 
DTT, 600 pM  unlabelled ATP, CTP and GTP, 2.5 pCi of cc-[3 2 P]-U T P 
(Amersham, 400 Ci/mmol), 25 |iM unlabelled UTP, 10 mM creatine phosphate, 10 
pi HeLa cell free extract, the desired amount of supercoiled recombinant DNA and 
pUC19 DNA carrier to 100-200 ng of total DNA in the assay. (It was found that the 
addition of pUC19 carrier DNA (100-200 ng) to transcription assays increased the
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efficiency of transcription of recombinants several fold, without itself giving rise to 
any transcripts. Experiments also showed that transcripts could be produced from 
isolated restriction fragments containing tRNA genes used in in vitro transcription 
assays, but with a far lower efficiency than that found for supercoiled plasmid 
templates.) In preliminary assays a-amanatin (final concentration 10 pg/ml) was 
added to the transcription reaction mixture to eliminate the possibility that RNA 
polymerase II was responsible for the transcripts obtained (see Jacob, 1973). The 
mixture was incubated at 30 °C for 1 h (except in the case of time course assays) 
and the reaction stopped by the addition of 20 ill of a solution containing 1% SDS, 
proteinase K (2 mg/ml) and E. coli crude tRNA (1 mg/ml). The reaction mixture 
was maintained at 37 °C for 20 min and then an equal volume of 1 M ammonium 
acetate was added. The mixture was extracted once with phenol/chloroform and the 
aqueous layer was tranferred to a fresh Eppendorf tube. An equal volume of 0.5 M 
ammonium acetate was added to the phenol/chloroform and after the back extraction 
the second aqueous layer was added to the first. Cold ethanol was added to 70% 
and the RNA precipitated at -70 °C for 30 min and pelleted by centrifugation at
10,000 rpm for 15 min at 4 °C. The pellet was dried briefly, resuspended in 12 pi 
TE and mixed with 10 pi formamide dye mix (see section 2.5.14.3.1.). The 
samples were then loaded onto a 10% polyacrylamide-4M urea vertical gel 
(prepared essentially as described in section 2.5.14.3.2.) and electrophoresed at 
250 volts for 1.5-2 h using a BRL model V I61 gel apparatus. After electrophoresis 
one gel plate was removed, the gel covered with cling film and exposed to X-ray 
film (Fuji) in the presence of an intensifying screen at -70 °C. (Alternatively, 
samples were loaded onto a sequencing gel (section 2.5.14.3.2.) for better 
resolution of transcripts. The size of transcripts could be estimated by comparison 
to DNA fragments produced by a sequencing reaction and electrophoresed 
alongside the assay samples). The basic assay method shown above was adapted as 
necessary for the experiments described in Chapter five.
2.5.16.3. Analysis of tran scrip ts  by the use of a scin tillation  
coun ter.
Soon after autoradiography, autoradiographs were aligned to their corresponding
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gels by the help of radioactive markers and the regions of the gel containing the 
labelled transcripts were excised and transferred to scintillation vials. Other regions 
of the gel with the same dimensions (where no transcripts were detected) were also 
excised for use in calculating background. (The same basic approach was used in 
quantifying transcripts separated on sequencing gels which were subsequently dried 
down onto Whatman 3 MM paper). Samples were Cerenkov counted for 5 min in a 
Beckman LS6800 scintillation counter, and the background value subtracted from 
each sample. An average value was established for each set of duplicates, any decay 
factor calculated and finally the value of each transcript expressed in counts per 
minute (cpm).
2.5.16.4. Calculation of tRNA products.
The tRNA products derived from in vitro transcription assays were calculated 
according to a formula set out by Gonos (1989). The following example is for a 
transcription assay using a pUC19 recombinant pGLYl (see table 5.1.) which 
contains a tRNA<J>y gene:
In one hour, 2 ng of pGLYl produced 1300 cpm of transcripts. The efficiency 
of Cerenkov counting was found to be 35-40%. Therefore the transcripts produced 
per ng of DNA in one hour = 1733 dpm (A). In every 20 pi assay, 5 pCi of 
a -[3 2 P]-UTP (400 Ci/mmol) were used, which corresponds to 0.6 pM. In 
addition, 25 pM of unlabelled UTP were also used; therefore the total UTP 
concentration is 25.6 pM which corresponds to 512 pmol (B) in 20 pi .The 5 pCi 
of a-[32P]-UTP used corresponds to 1.1 x 107 dpm (C). It follows that [(A/C) x 
B] = 80.7 fmol UTP were incorporated into RNA (D). The tRNA^ly primary 
transcript contains 20 uridines (E) therefore (D/E) the transcripts produced by 1 ng 
pGLYl in 1 hour are 4.04 fmol tRNA (F). Since 1 ng pGLYl corresponds to 0.45 
fmol (G) (pGLYl molecular weight = 2.2 x 106) then (F/G) pGLYl produces 
approximately 9 transcripts/gene/hour.
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2.5.17. Gel shift assays.
Oligonucleotide primers complementary to either end of a 175 bp fragment from 
the 5' flank of a tRNA^ly gene from XHt363 (see section 5.6.3.) were end labelled 
as described in section 2.5.11.3. Two polymerase chain reactions were performed 
as described in section 2.5.15.1., using in each reaction one labelled and one 
unlabelled oligonucleotide primer, both using as target DNA a recombinant plasmid 
(pGLYl, see table 5.1.) containing the 175 bp fragment in its insert The products 
of the two reactions were the amplified 175 bp fragment, in one case labelled at the 
5' position of one strand and in the converse reaction at the 5' end of the other. 
Aliquots of these end labelled fragments were mixed with a HeLa cell free extract 
(containing 1.5-7.5 pg total protein) in a total volume of 20 pi and incubated for 30 
min at 30 °C. The same ionic conditions were employed as those used for in vitro 
transcription assays (see section 2.5.16.2.). The samples were added to 10 pi of 
loading buffer (see section 2.5.7.1.) and loaded onto a 10% polyacrylamide gel. 
The gels were run at 10 V/cm for 1-2 h using a BRL model V161 vertical gel 
apparatus. After electrophoresis gels were dried under vacuum on a gel drier (model 
1125B Bio-Rad) at 80 °C for one h and exposed to X-ray film (Fuji) without 
intensifying screens.
2.5.18. DNase I protection assays.
The method used was adapted from that described by Both well (1990). End 
labelled 175 bp fragments were incubated in a HeLa cell free extract as described in 
section 2.5.17. At 30 min 20 pi of 0.01 M MgCl2  and 1 pi of DNase I solution 
(varying between 0.05 and 2 pg per pi) were added. After 1 min at room 
temperature the DNase I digestion was stopped by the addition of 1 pi of 0.5 M 
EDTA and the samples placed on ice. The samples were then added to 10 pi of 
loading buffer and electrophoresed on a 1 0 % polyacrylamide gel as described in 
section 2.5.17. Gels were autoradiographed as described in section 2.5.16.2. The 
optimum DNase I amount used (the highest to give a gel shift pattern the same as 
that obtained in untreated samples) was found to be between 1 and 2  pg.
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Autoradiographs were aligned to the gels with the help of radioactive markers and 
the regions of the gel containing the free and protein-bound DNase I treated DNA 
fragments excised. The DNA was eluted in the following way. The gel fragments 
were crushed and placed in Eppendorf tubes with 0.5 ml of elution buffer (0.5 M 
ammonium acetate, 0.1 M EDTA, 0.1% SDS, 10 M-g/ml proteinase K and 5 M-g/ml 
carrier tRNA). Samples were incubated at 37 °C overnight. The eluted DNA was 
extracted once with phenol/chloroform and once with phenol, ethanol precipitated 
by the addition of two volumes of cold ethanol and pelleted by centrifugation at
10,000 rpm for 15 min at 4 °C. The pellets were washed with 70% ethanol and 
dried briefly. The samples were electrophoresed on a sequencing gel as described in 
section 2.5.14.3.2. and autoradiographs produced by placing X-ray film (Fuji) in 
contact with the dried gel at -70 °C with intensifying screens.
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c r a A i P T i m  3
RESTRICTION MAPPING AND SEQUENCING OF XHt363.
3.1. Background and aims.
The recombinant phage XHt363 was selected from a human genomic library, 
cloned in X Charon 4A (Lawn et a l ., 1978) using a mixed tRNA probe labelled by 
ligation of [32P]pCp (Goddard et a l ., 1983). The recombinant had been partially 
characterised (McLaren and Goddard, 1986; J.P. Goddard, A.McLaren, T.Carr and 
D.Livingstone, unpublished results). A 4.2 kb fragment had been subcloned into the 
plasmid vector pAT153 (Twigg and Sherratfc^SO). Restriction fragments within a 
1.65 kilobase (kb) region on this recombinant plasmid were shown to hybridise to a 
mixed tRNA probe. Three restriction fragments from within this 1.65 kb region had 
been sequenced. The sequences of two Eco KI-Hin d III restriction fragments of 246 
and 228 base pair (bp) had been determined on both strands. The 248 bp fragment 
contains a gene coding for tRNA^eu (McLaren and Goddard, 1986) and the 228 bp 
fragment a gene coding for tR N A ^11. A 439 bp Bam HI- Kpn I restriction fragment 
had been sequenced on one strand only and found to contain a gene coding for 
tRNA^ys. These features of the insert of XHt363 resemble those of a human tRNA 
gene cluster (cloned from the same genomic library) which has previously been 
reported on a recombinant termed XHt4 (Roy e ta l ., 1982, Buckland et a l ., 1983). 
This cluster contains the same three tRNA genes, coding for tRNA^ys, tRNA^ln 
and tR N A ^ 11, also within a 1.65 kb region. The published sequence from A.Ht4 
(Roy et a l ., 1982) appeared to be almost identical to that so far found on XHt363.
In addition to the 1.65 kb region mentioned above, an 800 bp Eco RI restriction 
fragment from XHt363 also hybridised to the mixed tRNA probe. This fragment had 
been partially sequenced and shown to contain the 3' end of a tRNAGty gene, 
consisting of 51 bases starting from one of the Eco RI sites and including a putative
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termination signal.
The aim of this part of the project was to complete the restriction map of the 
insert of XHt363. Once the map was finalised, the position of the tRNA genes 
within the insert would be established, and the sequencing of the genes and their 
flanking regions completed. These sequences and the restriction map could then be 
compared with the apparently similar human tRNA gene cluster published (Roy et 
al .,1982; Buckland et al ., 1983).
3.2. Restriction mapping of X Ht363.
3.2.1. Construction of a prelim inary restriction map of XHt363.
Restriction endonuclease digests were performed as described in section 2.5.6. 
A preliminary restriction map for the insert of XHt363 was constructed by the 
estimation of the fragment sizes produced by digestion with a series of restriction 
enzymes, singly and in combination. The enzymes used initially were the six-base 
cutters Bam  HI, Bgl II, Eco RI, Hin  d III and Kpn I. A unique site for the 
eight-base cutter Not I was also discovered within the insert. Restriction digests 
were analysed by agarose gel electrophoresis (see section 2.5.7.1.). Figure 3.1. 
shows the pattern of fragments observed on agarose gel electrophoresis of digests 
using each of these enzymes and table 3.1. shows the fragment sizes obtained. 
Restriction data for the enzymes Apa I and Sma I is also presented in figure 3.1 and 
table 3.1. These digests were performed at a later stage in the study when it became 
apparent that a large region of the insert of A.Ht363 had a high (G+C) content. Since 
the recognition sites for Apa I and Sma I consist only of C or G residues these 
enzymes were useful in refining the preliminary restriction map. The total insert size 
of the recombinant was estimated at this stage as 12.5-13.5 kb.
3.2.2. O rdering of restriction fragments from XHt363.
Having ascertained the numbers and sizes of the restriction fragments of XHt363,
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Figure 3.1. Restriction digests of XHt363 DNA.
This photograph shows an ethidium bromide stained 0.8% agarose gel where the 
following >.Ht363 restriction digests were electrophoresed: Apa I (A), Bam HI (B), 
Bgl II (Bg), Eco RI (E), Hin d III (H), Kpn I (K), Not I (N) and Sma I (S). The 
marker DNA fragment sizes are indicated (in kb). Ml = M13mpl8 DNAJHin f I, M2 
= X DNAJHin d III.
1 2  2 1 
M M  A B B g E H K N S M M
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Table 3.1.
Restriction fragment profile of /.H t3 6 3 .
Apa I Bam HI Bgl II Eco RI
1 2 .1 § 15§ 24.4§ 19.9*
1 0 .8 § 6 § 7.8 1 1 *
1 0 * 5.6* 4.9* 6 .2
3.7 4.8 2 .2 * 2.9
2 .6 4.2 1.9§ 2 .6
1.85 3.9* 1.3* 0 .8
1 .6 2.4 0.65* 0 .6
1.35 1.5* 0.47*
0.18 0.5* 0.36*
0 .1 2 0.06*
Hin d m K pnl Not I Sma I
2 2 .1 § 17.4* 29.5§ 2 0 .2 §
8.9§ 14.8§ 14.5§ 7.3*
5.7* 4.2 4§
4.2 3.5* 3.7
2.4 1.75§ 3.4
0 .6 1.5* 1.4
0.84 0.85
0.6
0.6
0.44
0.43
0.35
0.31
0.28
0.24
XHt363 total length =44 kb. Insert length =13 kb.
All sizes are expressed in kb. * denotes fragments wholly derived from the arms 
of X Charon 4A and § fragments derived in part from the X anns.
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these were then ordered using the end-labelling of isolated restriction fragments 
generated by single or double restriction enzyme digests (see section 2.5.11.2.). 
Either before or after end-labelling, isolated restriction fragments were completely or 
partially digested with a second restriction enzyme, and the resulting fragments 
separated by agarose gel electrophoresis. The gel was then dried down and 
autoradiographed. Figure 3.2. shows the autoradiograph obtained from one such 
experiment. As mentioned in section 3.2.1., the restriction enzyme Not I was found 
to have a unique site in the recombinant XHt363, located in the insert Digestion with 
Not I thus generated two fragments which were separated by agarose gel 
electrophoresis. End-labelling of these separated fragments, followed by further 
digests with a second enzyme or enzymes, was particularly useful in ordering 
restriction sites.
3.2.3. Refining the restriction map of ^H t363 .
The construction of a preliminary restriction map of XHt363 allowed the selection 
of a set of restriction fragments (five in total) spanning the whole insert. These were 
subcloned into pUC19 (see section 2.5.8.). Restriction digests of these subcloned 
fragments were used to remove any remaining ambiguities in the restriction map, 
which is shown in figure 3.3. The insert size of ^.Ht363 was estimated as 13kb ± 
300 bp. The positions of the five tRNA genes eventually found in the cluster are 
indicated in figure 3.3. (Earlier unpublished hybridisation data (J. P.Goddard, 
A.McLaren and T.Carr) indicated the restriction fragments which hybridised to a 
mixed tRNA probe). Figure 3.3. also shows the regions of XHt363 for which 
sequence data has been obtained (see section 3.3.) and the location of the pUC19 
subclones used in the construction of the restriction map.
3.3 Sequencing of the tRNA gene containing regions of A.Ht363.
Having constructed the restriction map of XHt363, and located the tRNA genes, it 
became possible to isolate the further subclones necessary for completion of the
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Figure 3.2. Analysis of end-labelled restriction digests of an isolated 
6.2 kb Eco  RI restriction fragm ent from XHt363.
A 6.2 kb Eco RI fragment from Mdt363 was isolated by agarose gel electrophoresis 
and digested with the restriction enzymes indicated below (Bam HI (B), Bgl II (Bg), 
Hin d III (H), Kpn I (K) and Sma I (S)). The resulting fragments were end-labelled 
with [32P]dATP by filling in the recessed ends left by restriction digests with the 
Klenow fragment of DNA polymerase I. The labelled fragments were separated by 
electrophoresis on a 0.8% agarose gel which was dried down and autoradiographed 
overnight. Marker DNAs were end-labelled by the same method with [35S]dATP. 
Fragment sizes are indicated (in kb). Ml = M13mpl8 DNA /Hin fl, M2 = X 
DNA/Hin d IE.
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sequencing of the genes and their flanking regions. Sequencing reactions were 
performed using the chain termination method (Sanger et a l ., 1980) as described in 
section 2.5.14.3. Restriction fragments were subcloned into the M13 vectors mplO, 
m p ll, m p l8  or m pl9 (Norrander et a l ., 1983; Yanisch-perron et a l ., 1985). 
Subcloning and the preparation of single-stranded DNA were performed as 
described in sections 2.5.14.1 and 2.5.14.2.
3.3.1. Sequencing of the tR N A ^Iy gene region.
Prior to the start of this project, the partial sequencing of an 800 bp Eco RI 
fragment had revealed an incomplete t R N A ^ l y  gene sequence (D.Livingstone, 
unpublished results). The remainder of the sequence of the t R N A ^ l y  gene and its 5' 
and 3' flanks was determined using subclones of a 713 bp Pvu U-Stu I fragment. 
Figure 3.4. shows an autoradiograph of a sequencing gel using single-stranded 
template DNA prepared from subclone M l (see figure 3.5. and table 3.2.) which 
contains the tRNAGly gene.The DNA was sequenced on both strands, reading 
through all restriction sites.The sequencing strategy is summarised in figure 3.5. and 
the M l3 subclones used are listed in table 3.2. The sequence is presented in figure
3.6., which also shows the position and orientation of the tRNAGly gene and the 
predicted cloverleaf secondary structure of the RNA-like strand of the gene.The 
sequence of the gene and its immediate flanks proved to be identical to a 397 bp 
sequence published during the course of this study (Doran et a l ., 1988). Both of 
these recombinants were cloned from the same genomic library, but the restriction 
maps of XHt363 and the recombinant cloned by Doran et a l . (X Ht9) differ 
sufficiently to show that they represent different parts of the genome (see section
3.4. and figure 3.11.). The tRNAGlyGCC g e n e  f r o m  XHt363 has an identical 
sequence to that of a human placental tRNA^^Q^c (Gupta et a l ., 1979).
3.3.2. Sequencing of a 1651 bp region containing three tRNA genes.
A 1.65 kb region containing tRNA genes coding for tRNA^ys, tRNAGln and
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i  i g u i  v n u i w i  a u i u ^ i  a p n  ui a  ocijucAitiiig gci«
This figure shows the autoradiograph of a sequencing gel for the M13mpl8 
subclone M l (see table 3.2.). The 237 bp Bam Hl-Sfw I insert of this subclone 
contains a t R N A G l y  gene. The sequence of the RNA-like strand of the gene is 
indicated, representing residues 503 to 573 inclusive of the sequence shown in 
figure 3.6.
A G  C T
tRNA
gene
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Figure 3.5. S trategy  used for sequencing a 713 bp region from  
XHt363 containing a tRNAGly gene.
This figure summarises the restriction sites used (Bam HI (B), Eco RI (E), Pvu II 
(P), Sma I (S) and Stu I (St)) to generate M13 subclones for sequencing a 713 bp 
region of XHt363. The arrows indicate direction and extent of sequence determined 
from each subclone (see also table 3.2.).
1 0 0  b p
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7 1 3
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M 4
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Table 3.2.
Subclones used in sequencing a 713 bp region containing the 
t R N A G l y  gene from M l t 3 6 3 .
Sub-Clone Insert Vector Sequenced reg ion
Ml Bam Hl-Sta I 477-713 M13mpl8 477-713
M2 Stul-Bam H l 713-477 M13mpl9 713-477
M3 EcoKL-PvuIl 528-1 M13mpl9 528-257
M4 Bam Hl-Pvu II 363-1 M13mpl8 363-1
M5 Sma VEco RI 304-528 M13mpl8 304-528
M6 PvuII-EcoBl 1-528 M13mpl8 1-317
This table summarises the subclones used in sequencing the region of XHt363 
containing the tRNAGly gene. The subclones are numbered as in the sequencing 
strategy shown in figure 3.5.The numbers given in the insert column refer to the 
residues in the sequence presented in figure 3.6.
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Figure 3.6. Nucleotide sequence of a 713 bp region from  X H t363  
containing a tRNAGly gene.
The nucleotide sequence of a 713 bp region from XHt363 is shown. The position, 
orientation and cloverleaf secondary structure of the tRNAGlyG C C  g e n e  ^  
indicated. The sequence was determined for both strands with appropriate overlaps 
(see figure 3.5.). The limits of an identical sequence containing another human 
tRNAGlyGGc  gene previously published (Doran et a l ., 1988) are indicated (*).
CAGCT GTGAA A TCAGAGACC A A T G G G G T T T C C T T C A A G C C CTC CCAAC GG C C C TCCG CAC C T T G G T T T i n
G TCG ACA CTT T A G T C T C T G G T T A C C C C A A A G G AAGTTCGG GAGGGTT GCC GGGAGGCGTG GAA CCAAAAC
1 0 2 0 3 0 4 0 5 0 6 0 7 0
TCACG AAGCC T T T C T T G C C A TC A T  AGCCCG AGCCGGGAOA GGCACAGAC C T TGAGGAGGG G G C T C C C A T T
AG TG CTTCG G AAAGAACGGT AG TATC GG G C TC G G C C C T C T C C G TG TC TG G AA C T C C T C C C CCGAU GGTA A
8 0 9 0 1 0 0 n o 1 2 0 1 3 0 1 4 0
TGGGA TCAG G GCCCC CAGCA C A T C C C A C C T C T C C G T C C T T CAG CC AAATG GGAACRC AAA T G T G T R ! CCC
A
G - C
A C C C TA G TC C CGGRGGTC GT GTA GGGTGGA GAGGCAGGAA G T C G G T T T A C C C T T G C G T T T ACACAGAGGG C - G
1 5 0 1 6 0 1 7 0 1 8 0 1 9 0 2 0 0 2 1 0 A - T
CATCAG CCCC CG CC GCCCCC C TC C T T G G G A A CC TG G G CTC G G G C TG A ATT T T T C T C A C C T G C A C G C G A t ; ;
T -  A 
T - A
GT AGTCGGGG GCGGCGGGGG GAGGAACCCT TGGACCC GA G C C C G A C T T A A AA A GA GTSG A C G T G C G C 1 CC G - C
2 2 0 2 3 0 2 4 0 2 5 0 2 6 0 2 7 0 2 8 o G - C  T T  A
* T GGCCC
CTGGGGGCCC CC G G C T G T T C GCACC CG GGT GTGGGGCCGC CC CTG GCCAT ATGGGGCGGC T T T A T G G C C C TG A G * M  M
GACCCCCGGG GGCCGACAAG CGTGGGC CCA C A C C C C G G i X GGGACCGGT A TACCCCGCCG AAA TACCGGG C T T G  CCGGG G
2 9 0 3 0 0 3 1 0 3 2 0 3 3 0 3 4 0 .’■SO ! ! ! +  C TT t
G GAAT G
GGTGGCCGGA TCCGGACGAG AGG AAGGATG A C T T G G C G C T CCACCCA CRG C A A C C A T T C G GGACCACT1  (. G TA  T
CCACCGGCCT AG G CCTG CTC T C C T T C C T A C TG AACCGCGA GGTG GGTG CC U T T G G T A A R C CCTGG TG AAG C - G A  G
3 6 0 3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 T + G
CCTGG CC TAC A C C G T TG C C T G TCCG G G TCC G C C T C A A C C T C T T A C A A T T T RAG AT AG GA T (inCCGGAG  A A
C —G 
G - C
GGACCGGATG TG GCAACGGA CAG.GCCCAGG CG GAGTTGGA G A A T G T T A G A G T C T A T R C T A G G GGCGTCTT C - G
4 3 0 4 4 0 4 5 0  civ * 6 0  
tRNA 7 ----------
4 7 0 4 8 0 4 VO c  i;
T 6
T C T T T A A G C T
AGAAA TTCG A
5 0 0
G C G C A T T G R T
CGCGTAACCA
G G TTC A G TG G  T A G A A T T C T C  
C C A A G TC A C C  A T C T T A A G A G
GCCTG CCACG
CGGACGGTG r.
CGGGAGGCCC
RCXCTC CG GG
GGGT TC G AT r  
CC C A A fiC TA A
GCC
5 1 0 320 5 3 0 5 4 0 5 5 0 360
CCC GGCCAAT G CACG AG TAC A G T T T T C T T T  T C T C C C C T C C  AAAAAAAOGA T A A T A T A T T T  G G T A G C A T T 1 
GGGCCGGTT A CRT G C TC A TG  TC A A A A G A A A  AGAGGGGAGG T T T T T T T C C T  AT T A TA TA A A  C C A T (.:G i AAA
 37(5------ 380 5 9 0 6 0 0 610 6 2 0  6 3 0
*
C TA AG AAACA T C T T C A C T T A  A A T A T T T C T A  C C A A A T A T T A  A T f .T T A A C C T  T T T G A C T A T A  G C A G A U T IT G
n A T T C T T T G T  A G AAG TG AA T T T A T A A A G A T  G G T T T A T A A T  TA G A A T T G G A  AAACT PAT AT CG TC TCAAAC
6 4 0  6 5 0  6 6 0  6 7 0  6 3 0  6 9 0  7 0 0
CAGCCCCAGG CCT  
GTCG GGGTC C GGA 
7 1 0
6 8
tRNA^eu (see section 3.1.) had been isolated from ^Ht363 as part of a 4.2 kb 
Bam  HI fragment and partially sequenced. Fig. 3.7. summarises the sequencing 
strategy used to obtain the complete sequence of 1651 bp and table 3.3. lists the 
M l3 subclones constructed. The sequence itself is shown in figure 3.8. The DNA 
was sequenced on both strands, reading through all restriction sites. Figure 3.8. also 
shows the position and orientation of the tRNA genes found within this region and 
the predicted cloverleaf secondary structures of the RNA-like strands of the genes. 
As mentioned in section 3.1., the sequence data previously established for this 
region of XHt363 appeared to be almost identical to a previously published 1650 bp 
sequenced region carrying the same tRNA genes on a recombinant termed XHt4 
(Roy et al .,1982). A comparison of the complete 1651 bp sequence from AHt363 
with the corresponding region on XHt4 revealed only two differences, indicated on 
figure 3.8. Both differences occur in the flanks of the tRNA genes rather than the 
coding sequences. In relation to XHt4, XHt363 has an insertion of a G residue after 
T7 and a G at position 898 replacing a C at the equivalent position in A.Ht4. (The 
residue numbers refer to those given in figure 3.8.). XHt363 and XHt4 were both 
cloned from the same genomic library, but the restriction map of XHt4 (Buckland et 
al ., 1983) differs sufficiently from that of XHt363 to show that they represent 
different parts of the genome (see section 3.4. and figure 3.11.).
3.3.3. Sequencing of the tRNA^rg gene region.
An in vitro transcription assay (see section 2.5.16.2.) was performed using a 
pUC19 recombinant pCLUl, (so termed since it contained a tRNA gene cluster, see 
section 5.4.) with an insert consisting of a 4.2 kb Bam HI fragment from ^Ht363. 
The 1651 bp region containing the tRNA genes coding for tRNA^ys, tR N A ^n and 
tRNA^ 11 (see figure 3.8.) is located within this 4.2 kb fragment. As described in 
section 5.4., transcripts were obtained from this recombinant which did not 
correspond to any of the three genes known to be present. Isolated restriction 
fragments were used in transcription assays to localise the source of the extra 
transcripts to a Hin d HI- Mst I fragment, which had not previously been shown to 
hybridise to a mixed tRNA probe. This fragment was sequenced on both strands, 
reading through all restriction sites. The sequencing strategy used is summarised in
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Figure 3.7. S trategy  used for sequencing a 1651 bp region from  
XHt363 con ta in ing  genes coding fo r tR N A ^ys^  tR N A ^ In  an(j
tR N A ^eu
The restriction sites used to generate M l3 subclones for sequencing a 1651 bp 
region from ^Ht363 are shown {Aha E l (A), Bam  HI (B), Eco RI (E), Hin d III 
(H), Kpn I (K), Ssp I (Ss) and Sma I (S)). The arrows indicate the orientation and 
extent of sequence determined from each subclone (see also table 3.3.). The 
discontinuous arrow indicates sequence determined from a subclone which was 
generated using a restriction site from outwith the boundaries of the figure.
100 bp
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Table 3.3.
Subclones used in sequencing a 1651 bp region from  > .H t3 6 3  
containing tR N A ^y s, tR N A ^ ln  and tR N A ^eu  genes.
Subcim ife Insert-- l e c to r , Sequenced region
M20 Hin d IU-Hin d IH 1651-1020 M13mpl8 1651-1394
M21 Bam HI-55/? I 1-245 M13mpl9 1-245
M22 Aha HI -Bam HI 482-1 M13mpl8 482-222
M23 Hin d Jll-Kpn I 1020-440 M13mpl8 1020-774
M24 Eco RI-Eco RI 1406-796 M13mpl8 1406-1192
M25 Aha HI- Eco RI 1203-1406 M13mpl8 1203-1406
M26 Aha HI-Eco RI 1207-796 M13mpl8 1207-984
M27 Hin d m-Eco RI 1020-1406 M13mpl8 1020-1281
M28 Eco RI- Bam HI 796-1 M13mp 19 796-470
M29 Kpn I -Hin d IE 440-1020 M13mpl9 440-810
M30 Bam HI -Kpn I 1-440 M13mpl8 1- 296
M31 Kpn I-JSam HI 440-1 M13mpl9 440-203
M32 Ssp I-Aha III 245-482 M13mpl8 245-482
M3 3 Ssp \-Bam HI 245-1 M13mpl8 245-1
M49 Eco RI-£a? RI 1406-* M13mpl0 1406-*
This table summarises the subclones used in sequencing the region of XHt363 
containing the tRNA genes coding for tRNA^ys, tRNA^ln and tR N A ^ 11. The 
subclones are numbered as in the sequencing strategy shown in figure 3.7. The 
numbers in the insert column refer to the sequence presented in figure 3.8. Subclone 
M49 was used to read through the terminal Hin d HI site of this 1651 bp region into 
the contiguous sequence shown in figure 3.10.: * denotes a residue outwith the 
1651 bp sequence shown in figure 3.8.
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Figure 3.8. Nucleotide sequence of a 1651 bp region from  M lt3 6  
containing genes coding for tRN A ^ys, tR N A ^ln  an(j tRN A ^eu.
The nucleotide sequence of a 1651 bp region from X.Ht363 is shown opposite.Th 
positions, orientations and cloverleaf secondary structures of the tRNA genes fror 
within this region are indicated. The sequence was determined for both strands wit 
appropriate overlaps (see figure 3.7.). Residues which differ from an almoj 
identical sequence determined earlier (Roy et a l ., 1982), are indicated (*).
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GGA7CC7GGG CGGGAGCCCA GG7G7CCGGG A7CT GGGCCA 7 I HbutiiiL i b UliOAGU<>Al.l. IC ICAGAl.AA
CC7AGGACCC GCCCTCGGGT CCACAGGCCr. TAGAr.CCGiiT HAT LGCTGAC c c c T u c n r . G AGAGICTC1T
10 2 0 3 0 40 5 0 6 0 70
GCCCA7AGCC CGCAGCGGCC CCGCGCGGCC GG77CCGGCG CCGCAC7G77 CCAGCC7C7A CTATGG7ACA
CGGG7A7CGG GCG7CGCCGG GGCGCGCCGG CCAAGGCCGC GGCG7GACAA GGTCGGAGA7 GA7ACCATIST
8 0 90 1 0 0 n o 1 2 0 1 30 1 40
G7CCC7GCG7 CGCAGCC7CG GCGGGGGC7C 7AAGAACGGG AGGCAGAAAA AGC7CAATCA GCAGCAGGCG
CAGGGACGCA GCG7CGGAGC CGCCCCCGAG A77C 7TGCCC 7 C C G 7C7777 7CGAGT7AG7 CG7CG7CCGC
150 1 6 0 1 70 180 1 9 0 2 0 0 2 1 0
AGC77CACCC GC7GC77CCA AA7C7G7GCC AAAA7A T7C7 A7GC7GCACA GA7AAAA7CC 7C7G7CGG77
7CGAAG7GGG CGACGAAGG7 77AGACACGG 7777A7AAGA 7ACGACG7G7 C7A7 777AG G AGACAGCCAA
2 2 0 2 3 0 2 4 0 2 5 0 2 6 0 2 7 0 2 8 0
C7ACAAGCC7 CGC7 777CC7 A7AGAGAACC C7C77A7AAG CAAAAAG7AA AGC7C7CG7G AAGA GCCCGG
GA7G77CGGA CCGAAAAGGA 7A7CTC77G G GAGAA7A77C G 7 7 7 7 7 C A 7 7 7CGAGAGCAC 77C1 CGGGCC
. 390 3 0 0 3 1 0 3 2 0 3 3 0 3 4 0 3 5 0II** '  --- ----
A7AGC7CAG7 CGG7AGAGCA TCAGACTTTT AATCTGAGGG TCCAGGGTTC AAGTCCCTGT 
TATCGAGTCA GCCATCTCGT AGTCTGAAAA TTAGACTCCC AGGTCCCAAG TTCAGGGACA
3s53 6 0 3 7 0 TKT Tnt
TCGGGCGUCA
AGCCCnrCGT
430
TGTCTTTGCT TTTGGGTACC GCACTTCGCA TAAAATGGTA ACAAAAATAG TTACTAGTTT  
ACAGAAACGA AAAGCCATGG GGTGAAGCGT ATTTTACCAT TGTTTTTA TC  AATGATCAAA 
4 3 0  4 4 0  4 5 0  4 6 0  ' 4 7 0  4 8 0
77AAAGC7AG
AATTTCGATC
4 90
GTGATACAGA AACTTGATTT CCACAAAATA CAGCAAACGA CGGTGGAGGG TAATAAACAT ACTTTAAAAC
CACTATGTCT TTGAACTAAA GGTGTTTTAT GTCGTTTGCT GGCACCTCCC ATTATTTG TA TGAAATTTTG
5 0 0  5 1 0  5 2 0  5 3 0  5 4 0  5 5 0  5 6 0
AGTACAAACG CGAGCCGTA7 7A7CGAA777  ACATTTTCTG GTAGCCACAT 7ACAAAGAA7 AAAAAGCAAG
TCATGTTTGC GCTCGGCATA ATAGCTTAAA TGTAAAAGAC CATCGGTGTA ATGTTTC TTA TTTTTCGTTC
5 7 0  5 8 0  5 9 0  6 0 0  6 1 0  6 2 0  6 3 0
. CGAAATTAAT TTCACGGATC TATTT TACTT  ACCCTAATAT ACCAAAATCT TATTTTAACA TATAATCAAC-
GCTT.TAATTA AAGTGCCTAG ATAAAATGAA TGGGATTATA TGGTTTTAGA ATAAAATTGT ATATTAGTTG
6 4 0  6 5 0  6 6 0  6 7 0  6 8 0  6 9 0  7 0 0
ATTCTAAAAA TATTAATGAA ATTTT AAG TC-7 -7 7 77 G 77 7G  TACAAAGCCT TCCTTCAAAA GAAGATGTGT
TAAGATTTTT ATAATTACTT TAAAATTCAG AAAAACAAAC ATGTTTCGGA AGGAAGTTTT CTTCTACACA
7 1 0  7 2 0  7 3 0  7 4 0  7 5 0  7 6 0  7 7 0
ATTTAGAAGC TGGCAATACA TCTGAATTCA TATATTTCAA GTGCTCGATA ACGGTGTCTA CCATATCCAA
7AAATCTTCG ACCGT7A7G7 AGAC77AAG7 A7 A7AAAG77 CACGAGC7A7 TGCCACAGA7 GG7A7AGG77
7 6 0  7 9 0  8 0 0  8 1 0 . .  8 2 0  8 3 0  8 4 0
CAGCAGAC77 7 G 7 7 7 7 G 7 7 7  7CG7777AAG 7GACGGG7G7 GGAAGACACG CAAAA7aI ! a A 7G7CCAG7AA
G7CG7C7GAA ACAAAACAAA AGCAAAA77C AC7GCCCACA CC7 7C7G7GC G T 7 7 7 A 7 C 7 7  ACAGG7CA77
8 5 0  8 6 0  8 7 0  8 6 0  CI.  8 9 0  9 0 0  9 1 0tl« ----»-
TG7ACACAA7 C7TGAAAGCC CCCACGAGGG IG G77CCA7G G7G7AA7GG7  
ACA7G7G77A GAAC777CGG GGG7GC7CCC l )cCAAGG7AC CACA77ACCA  
9 2 0  9 3 0  • 9 4 0
7AGCAC7C7G GAC7C7GAA7  
A7CG7GAGAC C7GAGAC77A
9 9 0 1 0 0 0 1 0 1 0
77AA77GA77 77CACAGAGG GGA7AC7CC7
AA77AAC7AA AAG7G7C7CC CC7A7GAGGA
1 06 0 1 0 7 0 1 0 8 0
GACAC7ACCA A 7 7A 777G7G C7777CC7AC
C7G7GA7GG7 7AA7AAACAC GAAAAGGA7G
1 1 3 0* 1 1 4 0 1 1 5 0
CAA7AAA77A 777AAA7A7G 77GGAAG77G
G77A777AA7 AAA777A7AC AACC77CAAC
1 20 p 1 2 1 0 1 2 2 0
AGAAACGAAA 7AA7AGAGA7 G77A7GAAGA
7 C 77 7 G C 77 7 A77A7C7C7A CAA 7AC77C7
1 2 7 0 1 2 8 0 1 2 9 0
7C7GGGA7GG A7GCAGGCC7 A7GA7C7C7C
AGACCC7ACC 7ACG7CCGGA 7AC7AGAGAG
1 3 4 0 1 3 5 0 1 3 6 0
AGGGGAA77C G7AAAA77AC 777C7GC A7G
7CCCC77AAG CA7 777AA7G AAAGACG7AC
1 4 1 0 1 4 2 0 1 4 3 0
GCAGG7GCG7 AA7CCACCAG AAAAAC7CCA
CG7CCACGCA 77AGG7GGTC 777TTGAGGT
14 80 1 4 90 1 5 0 0
9 5 0
1020
1 0 9 0
1160
1 2 3 0
1 3 0 0
1 3 7 0
9 6 0 9 7 0 9 8 0
7 7 7 C 7 7 7 7 A A 7A7CAGCA7G 77G AA7 A77G
AAAGAAAA77 A7AG7CG7AC AAC77A7AAC
1 0 3 0 1 0 4 0 1 0 5 0
A7AA7ACGAC AAAAAAAAAA AG7AAAC7AG
7A77A7GC7G 7 7 7 7 7 7 7 7 7 7 7CA777GA7 C
1 1 0 0 1 1 1 0 1 1 2 0
AG7CC7A7AA CACAG7G77A AGAGAACG7A
7CACGA7A77 G7G7CACAA7 7C7C77GCA7
1 1 7 0 1 1 8 0 1 1 9 0
7GAAAACA7G 77AAAA7AGA GA7G77A7CA
AC 7777G 7A C AA 7 7 77 A 7 C 7 C7ACAA7AC7
1 2 4 0 1 2 5 0 1 2 6 0
7GC77CAGCA C77ACCA7CA GG7C77AGC7
ACGAAG7CG7 CAA7GG7AG7 CCAGAA7CGA
1 3 1 0 1 3 2 0 1 3 3 0
AACACGGAAG A7GA7GG7GA AACCA77ACC
77G7GC C77C 7AC7ACCAC7 77GG7AA7GG
1 3 8 0 1 3 9 0 1 4 0 0
7AACC7AACA GAAC7G77 AA CAGAAC7G7 A
A77GGA77G7 C77GACAA77 G7C77GACAT
1 4 5 0 1 4 6 0 1 4 7 0
C7CCGAAGAG 
G A G G r i T r r c
1 5 1 0 1 5 2 0 1 5 3 0
AC7GGAGCC7 AAA7CCAGCG CCT7AGACCG CTCUGCCACG CTACCUGCAC GAAAACtTAC
7GACC7CGGA T77AGGTCGC GfiAATCTGliC GAGCCGGTGC GATGOjACGTO C T777GAATG
1 5 6 0  1 5 7 0  1 58 0  1 5 9 0  1 6 0 0i: tmtcu
1 5 4 0
7RTCCCCG7T
ACAGGGGCAA
1 6 1 0
G7CC7CCTAA GAGAC7AGAA GTAAGGAATG GGGCAAAGCT 
CAGGAGGATT CTCTGA1C1T CATTCCTTAC CCCGMTCGA  
1 6 2 0  1 63 0  1 6 4 0  1 65 0
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figure 3.9. and table 3.4. lists the M13 subclones constructed. The 1271 bp 
sequence, contiguous with the 1651 bp region described in section 3.3.2., is 
presented in figure 3.10. This region contains a gene coding for tR N A ^g, the first 
tRNA^rg gene to be isolated from the human genome. The presence of this gene 
accounted for the extra transcripts found from the XHt363 subclone described 
above. The gene contains an intron, the first recorded in a tR N A ^g  gene for any 
organism.
3.4. Discussion.
3.4.1. Comparison of XHt363 with other recom binants containing 
hum an tRNA genes.
XHt363 represents the largest human tRNA gene cluster cloned to date, with 
five tRNA genes within 7 kb of each other. The genes code for tRNA^ysuuu» 
tRNAGlnCUG, tR N A L e \,AG, tRNAArgu a J  and tRNAG 1yG cc . Four of the genes 
have exactly the same coding sequence as human tRNA genes previously reported.
The tRNAGlyGCC gene from >,Ht363 has an identical coding sequence and 
identical 5' and 3' flanking sequences to a tRNAGly GCC Sene previously reported 
and an identical coding sequence to a second tRNAGlyQ^ gene cloned by the same 
group (Doran et a l ., 1988). The 5* and 3' flanks of this second tRNAGly gene 
show no significant sequence homology to the flanking regions of the tRNAGly 
gene from XHt363.
The 1651 bp region from ^.Ht363 which contains the tRNA^ys, tRNAGln and 
tRNA^eu genes differs in only two residues from another human tRNA gene cluster 
(Roy et a l ., 1982) on a recombinant termed ^.Ht4. The differences are in the 5' 
flanking regions of the tRNA^ys and tRNAGln genes, at distances of 336 and 44 bp 
respectively from the coding sequences (residues 8  and 898 in figure 3.8.). Like the 
recombinant ^Ht9 cloned by Doran et a l ., (1988) which contains the tR N A G ly^^ 
gene identical to that on ^Ht363, ^Ht4 was cloned from the same genomic library 
(Lawn et a l ., 1978) as >Jlt363. This raises the possibility, in view of the sequence 
similarity between the clones, that the same genomic fragments could have been
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Figure 3.9. Strategy used for sequencing a 1271 bp region of XHt363
containing a tRNA^rg gene.
The restriction sites used (Hin d III (H), Mst I (M), Sau 3A  (Sa) and Sma I (S.)) to 
generate M l3 subclones for sequencing a 1271 bp region of AHt363 are shown. The 
arrows indicate direction and extent of sequence determined from each subclone (see 
also table 3.4.). Discontinuous arrows indicate sequence determined from subclones 
generated using restriction sites outwith the boundaries of the figure.
1 0 0  bp
H Sa S a S S M
1652 2922
M40
M41
M42
M43
M45 M44
M46 M12
M47
M48
Table 3.4.
Subclones used in sequencing a 1271 bp region from  X H t3 6 3  
containing a gene coding for tRNA^rg.
SubdflHfe Insert
M40 Hin d lU-Mst I 1652-2922
M41 Mst 1 -Hin d III 2922-1652
M42 Sma I -Sma I 2686-2346
M43 Sma I-Sma I 2346-2686
M44 Sau 3A-Eco RI 2302-*
M45 Sau 3A-Hin d HI 1999-1652
M46 Sau 3 A -Sau 3 A 1999-2302
M47 Sau 3 A-Sau 3A 2302-1999
M48 Sma I -Hin d ID 2346-1652
M49 Eco Rl-Eco RI
■YfCtor Sequenced region
M13mpl0 1652-2020
M13mpl 1 2922-2650
M13mpll 2686-2346
M13mpl0 2346-2686
M13mpl8 2302-2592
M13mpl9 1999-1652
M13mpl8 1999-2302
M13mpl8 2302-1999
M 13mpll 2346-1964
M13mpl0 *-1662
This table summarises the subclones used for sequencing a 1271 bp region which 
contains the tRNA^rg gene from XHt363. The subclones are numbered as in the 
sequencing strategy shown in figure 3.9. The numbers in the insert column refer to 
the sequence presented in figure 3.10. Residues from outwith the sequence shown 
in figure 3.10. are denoted by *. The subclone M49 was used to read through the 
terminal Hin d III site of this 1271 bp region from the contiguous sequence shown 
in figure 3.8.
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Figure 3.10. Nucleotide sequence of a 1271 bp region from >.Ht36
containing a t R N A ^ r g  gene.
The nucleotide sequence of a 1271 bp region from XHt363 is shown opposite. Th 
position, orientation and cloverleaf secondary structure of the t R N A ^ r g  gene ai 
indicated. The position of the intron within this gene is also marked. The nucleotid 
sequence was determined for both strands with appropriate overlaps (see figui 
3.9.).
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cloned more than once. The genomic library used was constructed by adding Eco RI 
linkers to genomic fragments generated by a partial digest with Hoe HI and Alu I, in 
effect generating almost random fragments which were size fractionated prior to 
cloning into Eco RI digested >.Charon 4A (Maniatis et al .,1978). Given that 
overlapping fragments will be present in the library it is conceivable that the insert of 
XHt363 might be a genomic fragment which overlaps the inserts of XHt4 and XHt9. 
If this were the case then the genes shared by the different recombinants would be 
identical. Figure 3.11. shows a comparison of the restriction maps of XHt363, A.Ht4 
and XHt9. This comparison shows that the restriction maps of XHt4 and ^Ht9 
correspond to that of XHt363 in the areas close to the tRNA genes but differ 
sufficiently outwith these regions to confirm that the genes on XHt363 are in a 
different genomic environment to those on XHt4 and XHt9. (In the case of XHt363 
and Mlt4 there are also the sequence differences detailed above). This assumes 
firstly that none of the recombinants have undergone rearrangements relative to the 
original genomic DNA and secondly that the different copies are not allelic. These 
possibilities were investigated as described in sections 4.2. and 4.3.
3.4.2. The tRNA^rg gene from XHt363.
The tRNA^rg gene from ^.Ht363 was not recorded as being present on XHt4. 
However, as figure 3.11. shows, this gene comes from the region of apparent 
homology between the two recombinants. (In fact, as will be shown in section
4.4.4.,the tRNA-^g gene is almost certainly present on XHt4). It is possible that the 
presence of this gene was not recorded because of its poor hybridisation to a tRNA 
probe. The tRNA^rg gene was only found on >.Ht363 through a transcription 
assay, having remained undetected through a series of hybridisation experiments 
(J.P. Goddard, A.McLaren and T.Carr, unpublished results). A mixed tRNA probe, 
labelled with [3 2 P]pCp (see section 2.5.11.4.) will hybridise to a restriction 
fragment containing the tR N A ^g gene from A.Ht363, but as shown in figure 3.12. 
the other tRNA genes in the cluster show a greater intensity of hybridisation. The 
most likely explanation for this poor hybridisation is that the presence of an intron in 
the gene interferes with hybridisation with a mature tRNA probe. (It has previously 
been reported (Hovemann et a l ., 1980) that secondary structure formation in a
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tRNA gene cluster can interfere with hybridisation of a tRNA probe to one of the 
genes in the cluster. However,this is unlikely to be an explanation in the case of the 
tRNA^rg gene from A.Ht363, since the hyridisation is also poor when using the 
individually subcloned gene in hybridisations, as seen in figure 3.12.). This raises 
the possibility that the low number of human tRNA genes cloned with an intervening 
sequence may reflect a technical problem in their detection rather than their actual 
representation in the genome. (The converse may be true for tRNA gene clusters. 
The presence of several tRNA genes on a single recombinant may aid its selection 
using a mixed tRNA probe). Roy et a l ., (1982) used a probe containing a Xenopus 
tRNA gene cluster to select the recombinant A.Ht4, in contrast to the mixed tRNA 
probe used to select XHt363 (Goddard et a l ., 1983 and section 2.5.11.4.). The 
Xenopus tRNA gene cluster, containing eight tRNA genes, is described in section 
1.4.3. It is interesting that apparently neither of these different probes hybridised 
well enough to the tRN A ^S gene to detect its presence in either copy of this tRNA 
gene cluster.
3.4.3. The G+C rich nature of XHt363.
A notable feature of the restriction map of XHt363 is the high frequency of sites 
for restriction enzymes which recognise G+C rich sequences. The 5.5 kb at the right 
hand end of the recombinant contains 10 Sma I sites (CCCGGG) and four Apa I 
sites (GGGCCC) as well as the unique site for the rare cutter enzyme Not I 
(GCGGCCGC) (see figure 3.3). An 841 bp Sma I fragment from within this region 
showed weak hybridisation to the mixed tRNA probe (J.P.Goddard and T.Carr, 
unpublished results).
This region was therefore sequenced (on one strand only) but did not contain any 
tRNA-like structures (data not shown). The sequence proved to be over 70% 
(G+C), as opposed to an average figure of 40% for mammalian DNA (Adams et 
a l ., 1986). These features are consistent with the presence of a CpG-rich island, a 
feature characteristic of the flanking regions of mammalian genes transcribed by 
RNA polymerase II (Bird, 1986). This observation may be of no particular 
relevance for the tRNA genes themselves, since there have been no consistent 
reports of any bias in base composition in the genomic environment of tRNA genes,
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F igure 3.12. H ybrid isa tion  of a m ixed tRNA probe to pUC19 
subclones containing tRNA genes from >.Ht363.
Figure 3.12.A Duplicate restriction digests of a set of pUC19 subclones were 
electrophoresed on a 1% agarose gel. Lanes 1-5 correspond to lanes 6-10 
respectively. Each of the pUC19 subclones (described in table 5.1) was digested to 
release the insert containing the tRNA gene from the plasmid vector. Lanes 1,6 = 
pLYSl digested with Bam HI and Kpn I, lanes 2,7 = pGLNl digested with Eco RI, 
lanes 3,8 = pLEUl digested with Eco RI and Hin d IE, lanes 4,9 = pARGl digested 
with Eco RI and Hin d III, lanes 5,10 = pGLYl digested with Bam HI and 
Hin d III.The marker DNA fragment sizes (kb) are indicated. M = X DNA/Bst E n. 
Figure 3.12.B shows two parts of the autoradiograph obtained from hybridisation of 
the blotted gel to a mixed tRNA probe. The lanes are numbered as in figure 3.12.A. 
The marker DNA fragment sizes (kb) are indicated.
B
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although Gamulin e t a l (1983) reported the characterisation of yeast tRNA genes 
in an A+T rich environment. It is however possible that the highly G+C rich nature 
of the 841 bp Sma I fragment (which overlaps with residues 2686-2922 of the 
sequence shown in figure 3.10.) leads to its spurious hybridisation to a mixed tRNA 
probe. This could arise since the coding regions of a number of tRNA genes are 
relatively G+C rich (Sprinzl et a l ., 1989).
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CHAIPTIEIR roH M
ASPECTS OF TH E GENOM IC ORGANISATION O F TH E tRNA 
GENE CLUSTER FROM 3lHt363.
4.1. Background and aims
The results discussed in section 3.4. suggest that the cluster of tRNA genes found 
on XHt363 occurs in at least two copies in the human genome, despite the fact that 
in situ hybridisation experiments (see section 4.4.3.) have shown that probes from 
XHt363 only hybridise to one chromosomal location. This interpretation depends 
on the integrity of the inserts of the relevant recombinant phages XHt363, XHt4 and 
XHt9. If any of these inserts has undergone rearrangements relative to the original 
genomic DNA then a comparison of restriction maps would be meaningless. 
Evidence that the insert of >.Ht363 has not undergone any rearrangments was 
provided by two lines of investigation. The first involved Southern hybridisations 
of labelled restriction fragments containing tRNA genes to genomic DNA digested 
with a range of restriction enzymes. The second method made use of the 
polymerase chain reaction (PCR) using primers specific for different parts of the 
tRNA gene cluster with genomic DNA as the target for amplification. These 
experiments, including the cloning of two human tRNAGln genes as a by-product 
of the main study, are described in sections 4.2. and 4.3.. Southern hybridisations 
were also used in order to attempt to determine the copy number of the cluster as a 
whole and of the individual genes if they occur outwith the cluster.
The versatile PCR is useful for a number of techniques in which genomic 
sequences can be analysed without their prior cloning (see section 2.5.15.). Section
4.3.2. describes the use of the PCR in an attempt to determine the nature of the 
intervening sequence in genomic copies of the tR N A ^g gene family.
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4.2. Genomic Southern hybridisations.
4.2.1. The use of restriction fragments from A,Ht363 as probes.
Restriction fragments from XHt363 were labelled with a - [ 3 2 P]-dCTP as 
described in section 2.5.11.1. The labelled restriction fragments were hybridised to 
genomic DNA samples digested with different restriction endonucleases, separated 
by agarose gel electrophoresis and fixed on nylon filters (see sections 2.5.6., 
2.5.7. and 2.5.10.). Figure 4.1. shows the results of a hybridisation experiment 
using a 440 bp Bam WJKpn I fragment from XHt363 containing the tRNA^ys gene 
(corresponding to sequence residues 1 to 440 in figure 3.8.). A number of 
fragments in each lane have hybridised to the probe. The bands marked (1,2) (Bam 
HI/Eco RI 0.85 kb, Bgl UJEco RI 1.3 kb, Hin d III/Bam  HI 1 kb) are those 
corresponding in size to restriction fragments predicted on the basis of the 
restriction maps of XHt363 and ^.Ht4, both of which contain the 440 bp fragment 
used as a probe. The 2.5 kb Eco Bl/Hin d III band marked (2) corresponds to a 
restriction fragment size predicted from the restriction map of AHt4 but not from 
that of XHt363. The band corresponding to the Eco RI/Hin d HI 4 kb fragment 
predicted on the basis of the map of XHt363 is marked (1). The Eco Bl/Hin d HI 
genomic digest is the only one shown for which different hybridising bands can be 
predicted for XHt363 and XHt4. For the other digests shown, either the 
recombinants share the relevant restriction sites and therefore the same predicted 
fragment sizes, or restriction enzymes have been used which are not shown on the 
published map of XHt4 (Buckland et a l ., 1983). Bands marked (3) ( Apa VEco RI 
1.5 kb, Not I/Bgl II 4.8 kb and Sma VEco RI 2.3 kb) are those which correspond 
to sites predicted by the restriction map of XHt363 for which no prediction was 
possible from the map of ^ .Ht4. In similar experiments, restriction fragment probes 
from elsewhere in the insert of XHt363 also detected bands from genomic digests 
which corresponded in size to fragments consistent with the restriction maps of the 
inserts of ^.Ht363, ^.Ht4 (Buckland et a l ., 1983) and XHt9 (Doran et al .,1988).
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tR N A Lys gene from XHt363 to restriction digests of human genomic
DNA.
This figure shows the hybridisation of a labelled 440 bp Bam H I-Kpn I fragment 
(corresponding to the insert of pLYSl: see table 5.1.) to a series of double 
restriction digests of human genomic DNA. The restriction enzymes used were Apa 
I (A), Bam HI (B), Bgl II (Bg), Eco RI (E), Hin d HI (H), Kpn I (K), Not I (N) 
and Sma I (S). Restriction fragments of genomic DNA were electrophoresed on a 
0.8 % agarose gel before being blotted onto a nylon membrane. Genomic DNA 
fragments of the sizes predicted from the restriction maps of XHt363 and ^.Ht4 
(Buckland et a l 1983) are labelled 1, 2 or 3 to the right of the bands in question. 
Restriction fragments corresponding to the map of XHt363 are labelled 1, and those 
fragments corresponding to the map of XHt4 are labelled 2. Limited restriction data 
for ^Ht4 precluded assignment of some bands; bands labelled 3 are those which 
correspond to fragment sizes predicted on the basis of the restriction map of XHt363 
for which no prediction was possible from the map of ^Ht4. No fragments are 
indicated in the Bam YQ/Kpn I lane: fragments of the expected hybridising fragment 
size, 440 bp, would have run off the gel. Marker DNA fragments were end-labelled 
with [32P]dATP. The marker fragment sizes (kb) are indicated. Ml = X DNAJHin d 
ID, M2 = X DNAJBst E II.
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4.2.2. The use of PCR generated probes.
The coding sequence of tRNA genes spans only 70-95 bp. It follows that for 
restriction fragments of greater than 180 bp carrying a tRNA gene the majority of 
sequence represented will be outside the coding region of the gene. The 
consequence of this is that when such restriction fragments are used as probes 
against digests of genomic DNA as described in section 4.2.1. the pattern of 
hybridisation will reflect the nature of the sequence flanking the tRNA gene rather 
than the gene itself. In order to make a rough estimate of the genomic copy number 
of the tRNA genes from XHt363, it was desirable to construct a probe for each gene 
consisting only of the coding region. Such a probe in theory should recognise all of 
the genomic copies of the gene in a Southern hybridisation. A rough estimate of 
minimum copy number can be made by counting the number of bands detected in 
genomic DNAs cut with different restriction enzymes.
The most convenient method found of constructing such gene-specific probes 
for the five tRNA genes in the cluster was to use the PCR. Oligonucleotide primers 
were designed for the 5’ and 3' ends of each gene (see table 4.1. and section 4.3.) 
and the PCR used to amplify the gene sequence as described in section 2.5.15.1. 
The amplified fragments (shown in figure 4.2.) were labelled as described in 
section 2.5.11.1. and hybridised to genomic DNA . Figure 4.3. shows the results 
of a hybridisation experiment using a labelled probe consisting of the tRNA^rg 
gene sequence. The marked bands {Bam HI 4.2 kb, Bgl II 8.1 kb, Eco RI 2.6 kb 
and Hin d III 2.5 kb) show restriction fragments corresponding in size to fragments 
which would be predicted to hybridise to this probe on the basis of the restriction 
map of XHt363.
Similar hybridisation experiments were performed for each of the tRNA genes 
from XHt363. The largest number of bands that could be detected in a single 
genomic digest was taken as an estimate of minimum copy number. On the basis of 
these results, all of the genes from XHt363 appear to be present in multiple copies 
in the genome, and in different genomic environments. The minimum copy 
numbers estimated were tRNA^ys = 9 , tRNA^ln = 10, tRNA^ 11 = 10, tR N A ^S 
= 7 and t R N A ^ ly  = 8 .
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Table 4.1.
Oligonucleotide primers used in polymerase chain reactions to 
amplify gene specific probes.
P rim er Position in tRNA eene Seauence reference
A 5' end of tRNA^ys gene (residues 1-17) 345-361 figure 3.8.
B 3' end of tRNA^ys gene (residues 73-57) 417-401 figure 3.8.
C 5 ' end of tRNA^ln gene (residues 1-17) 942-958 figure 3.8.
D 3' end of tRNA^ln gCne (residues 72-56) 1013-997 figure 3.8.
E 5' end o f tR N A ^ 11 gene (residues 1-17) 1585-1569 figure 3.8.
F 31 end of tR N A ^ 11 gene (residues 82-66) 1504-1520 figure 3.8.
G 5' end of tRNA^rg gene (residues 1-17) 2115-2131 figure 3.10.
H 3’ end o f tRNA-^g gene (residues 88-72) 2202-2186 figure 3.10.
I 5' end o f t R N A ^ l y  gene (residues 1-17) 503-519 figure 3.6.
J 3' end of t R N A ^ l y  gene (residues 71-55) 573-557 figure 3.6.
This table summarises the oligonucleotide primers constructed for use in the 
polymerase chain reaction and lists the positions of the 17-mer oligonucleotides 
within the tRNA genes. Primers for the 5' ends of the tRNA genes have the same 
sequence as the tRNA-like strand so it follows that for the polymerase chain 
reaction primers for the 3’ ends of the tRNA genes must have the same sequence as 
the coding strand. The sequences of these primers can be found in the sequence 
data presented in the figures listed above.
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Figure 4.2. Amplification of tRNA genes from XHt363.
Oligonucleotide primers specific for amplification of each of the five tRNA genes 
from XHt363 were used with target XHt363 DNA in the polymerase chain reaction. 
The primers used are listed in table 4.1. The amplified products are shown after 
electrophoresis through a 10% polyacrylamide gel and ethidium bromide staining. 
The numbered lanes are 1 = tRNA^ys gene, 2 = tRNA^ln gene, 3 = tRNA^eu 
gene, 4 = tRNAArS gene, 5 = tRNA^ly gene. The residual primers are visible at 
the bottom of the gel. Marker DNA fragment sizes (bp) are indicated. M = 
M13mpl8 DNA/Hin f I.
Figure 4.3. Hybridisation of the ^.Ht363 tRNA^rg gene to restriction
digests of human genomic DNA.
This autoradiograph shows the result of a hybridisation of the tRNA^ r 8  gene 
amplified from XHt363 by the PCR to a Southern blot of restriction digests of 
human genomic DNA. The restriction digests used were Bam HI (B), Bgl II (Bg), 
Eco RI (E) and Hin d III (H). Genomic restriction fragments of the sizes predicted 
by the restriction map of XHt363 are indicated (*) to the right of the bands. Marker 
fragment sizes (k DNAJ Bst E II) are shown (in kb).
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4.2.3. Estimation of the tRNA gene cluster copy number.
An estimate of the copy number for the tRNA gene cluster from XHt363 was 
made by comparing the intensity of hybridisation of a restriction fragment 
containing part of the cluster to genomic DNA with the intensity of hybridisation to 
a series of standards. Three different amounts of genomic DNA (4, 2 and 1 |ig) 
were digested with Bam HI. DNA from the recombinant XHt363, also digested 
with Bam  HI, was used as standards in amounts ranging from 10-100 pg. The 
digests were run in parallel on a 0 .8 % agarose gel with suitable size markers (see 
figure 4.4.). The digests of ^Rt363 DNA were electrophoresed in the presence of 
undigested X carrier DNA. The separated DNA fragments were blotted onto a nylon 
membrane as described in section 2.5.10.1. and hybridised to an a-[3 2P]-dCTP 
labelled probe. The probe used was a 4.2 kb Bam HI fragment from XHt363 
containing the genes coding for tRNA^ys, tRNA^ln tRNA^ 11 and tR N A ^g (see 
figures 3.3., 3.8. and 3.10.). Under the hybridisation conditions used, the probe 
hybridised only to a 4.2 kb band in each of digests (see figure 4.4.). The intensity 
of the 4.2 kb bands on the autoradiograph was quantified as described in section 
2.5.13. An example of a densitometer tracing is shown in figure 4.5. together with 
the graph produced from the densitometer readings.The results were processed as 
follows. Using the standard curve shown in figure 4.5., the intensity of 
hybridisation for a given amount of genomic DNA (A) was related to the amount of 
^.Ht363 DNA giving a corresponding densitometer reading (B). The gene cluster 
copy number could then be estimated using this equation:
A x cluster copy number =  B
m.w. human DNA m.w. ^Ht363
The results obtained with three different amounts of genomic DNA (1, 2 and 4 |ig) 
gave estimated copy numbers for the tRNA gene cluster as 2.6, 3.1 and 2.5 
respectively, giving an average copy number of 2.7 per haploid genome.
A similar experiment was undertaken using a Bam Hl-Sta I restriction fragment of 
356 bp as a probe. This restriction fragment corresponds to the insert of pGLY2 
(see figure 5.9.), containing the tRNA^ly gene from XHt363 together with 285 bp 
of flanking sequence. This sequence is identical with the corresponding region from 
XH\9 for at least as far as the published sequence for this recombinant (Doran
91
Figure 4.4. H ybridisation of the 4.2 kb Bam  H I fragm ent from  
XHt363 to Bam  HI digested human genomic and >.Ht363 DNA.
Figure 4.4. A shows three different amounts of human genomic DNA digested with 
Bam HI and electrophoresed in parallel with five different amounts of XHt363 DNA 
also digested with Bam HI. Lanes 1-3 genomic DNA ( 1 = 4  jig, 2 = 2 jig, 3 = 1  
(ig) Lanes 4-8 XHt363 DNA (4 = 10 pg, 5 = 25 pg, 6 = 50 pg, 7 = 75 pg, 8 = 100 
pg). The Mdt363 digests were electrophoresed in the presence of X DNA carrier. 
Marker DNA fragment sizes (kb) are indicated. M = X DNA/Eco Rl+Hin d HI.
B shows the autoradiograph derived from hybridisation of a 4.2 kb Bam HI probe 
containing the tRNA^ys, tRNA^^n, tRNA^eu tRNA^rg genes from ^Ht363 
to a blot of the gel described in A. Marker DNA fragment sizes are indicated, as are 
the positions of the wells (W).
A_ M 1 2 3 4  5 6 7 8  M
B_ 1 2 3  4 5 6 7 8
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Figure 4.5. Estimation of the copy number of the tRNA gene cluster.
A standard curve derived from XHt363/Bam HI digestions is shown in A. Error 
bars indicate ± one standard deviation for four densitometric readings from the 
autoradiograph shown in figure 4.4. jB. Arrows represent the densitometric 
readings obtained from the 4.2 kb bands from 1, 2 and 4 jig  of genomic DNA 
digested with Bam HI. The equation for the estimation of copy number is given in 
section 4.2.3. Figure 4.5.B shows an example of a densitometric trace.
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et a l ., 1988) overlaps with that from XHt363 (343 bp; see figure 3.6.). The probe 
was labelled and hybridised to a filter similar to that described above, except that the 
genomic and XHt363 DNAs were digested with Bam HI andStu I. However, this 
probe appeared to detect several bands in genomic digests, and no accurate 
quantification of hybridisation was possible.
4.3. Use of the polym erase chain reaction (PCR) in the 
characterisation of the human tRNA gene cluster.
4.3.1. Com parison of fragm ents amplified from  XHt363 and from  
genomic DNA.
Oligonucleotides for use as specific primers for different regions of XHt363 
were synthesised as described in section 2.4.4. Table 4.1. lists the primers used 
with reference to the sequence data presented in Chapter three. These primers were 
used in different combinations using either XHt363 (10 ng) or genomic DNA (0.2 
pg) as a target to ascertain whether the same sizes of fragments were amplified. 
This served as another method to look for rearrangements within the regions coding 
for the tRNA genes (see sections 4.2. and 4.2.1.). Among the combinations of 
primers used were the three which yielded the amplified fragments shown in figure 
4.6. using either A.Ht363 or genomic DNA as a target. The first primer 
combination, C + F, gives an amplified fragment with the PCR of 644 bp 
corresponding to the sequence between the tRNA^ln gene 5' and the tRNA^eu 
gene 5'. The second combination, C + H, gives an amplified fragment of 1260 bp 
corresponding to the sequence between the tRNA^ln gene 5f and the tRNA^rg 
gene 3'. Finally, the primer combination A + H gives an amplified fragment of 
1857 bp corresponding to the sequence between the tRNA^ys gene 5' and the 
tRN A ^rg gene 3'. As shown in figure 4.6., XHt363 DNA and genomic DNA 
targets both gave rise to amplified fragments of the same size. The tRNA^ly gene 
proved to be too far from the tRNA^rg gene (about 5 kb) to amplify the region 
between the genes using the PCR with either XHt363 or genomic DNA as a target. 
This may be due to the G+C rich nature of the sequence between these two genes 
(see section 3.4.3.). The conditions for the PCR were modified to attempt to 
overcome this problem by replacing aGTP in the reaction mix with 7-deaza-dGTP
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Figure 4.6. Com parison of fragm ents am plified by the polymerase 
chain reaction using XHt363 or genomic DNA as targets for the same 
p rim ers .
A set of polymerase chain reaction products were analysed by electrophoresis 
through a 1% agarose gel. The oligonucleotide primer combinations used for PCR 
amplification (see table 4.1.) were as follows: lanes 1 and 2, primer C + primer F, 
lanes 3 and 4, primer C + primer H, lanes 5 and 6, primer A and primer H. Target 
DNA for the PCR was either ^.Ht363 (lanes 1, 3 and 5) or human genomic DNA 
(lanes 2, 4 and 6). Marker DNA fragment sizes are indicated (bp). M = 123 bp 
ladder (BRL Ltd.).
M 1 2 3 4  5  6
Ms
l*30
bis
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(see section 2.5.15.1.) but no discrete products could be observed even when using 
XHt363 DNA as the target for amplification.
In all of the cases when amplified fragments were generated by the PCR, the 
fragments were of the same size whether genomic DNA or XHt363 DNA were the 
targets. This supports the results obtained from Southern hybridisations (sections
4.2.1. and 4.2.2.) suggesting that the insert of XHt363 has not undergone any 
rearrangement relative to the original genomic DNA.
4.3.2. Amplification of genomic copies of the tR N A ^rg gene 
fam ily.
Oligonucleotide primers G and H, specific for the 5’ and 3' ends of the tRN A ^S 
gene, were constructed as described (see section 2.4.4. and table 4.1.). These 
primers were then used to amplify target genomic DNA. The rationale behind this 
experiment was that if genomic copies of the tR N A ^g gene exist without an intron 
then two different sizes of fragment should be amplified. (Shortly after the 
completion of this work, Green et al ., (1990) described the cloning of 
intron-containing tRNA^ 11 genes using a PCR technique in much the same way). 
The fragments would be sufficiently different in size (73 and 8 8  bp) to be resolved 
on a 10% acrylamide gel. In the event, only one fragment of 8 8  bp was amplified 
from genomic DNA. This would suggest that all of the genomic copies of tRNA-^S 
genes recognised by the primers specific for the tRN A ^S gene from XHt363 have 
an intron. The band amplified from genomic DNA is indistinguishable in size and 
sharpness from that amplified using XHt363 as the target DNA (see figure 4.2.). 
This suggests that within the resolving limit of the gels used (approximately ± 1 bp) 
the introns in the genomic copies of all of the tR N A ^S genes appear to be of the 
same size.
Further information on the nature of the introns in genomic copies of the 
tRNA^rg gene family was obtained using a direct sequencing method involving 
asymmetric PCR (see section 2.5.15.2.). The substrate for the sequencing reaction 
was predominantly single stranded DNA amplified from genomic DNA using the 
oligonucleotide primers G and H specific for the tRN A ^S gene. This DNA should 
consist of a mixed population of amplified fragments corresponding to all of the
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genomic members of the tR N A ^g gene family. The asymmetric PCR technique 
can be used to give sequence information from both strands of the amplified DNA. 
Figure 4.7. shows the results of a sequencing reaction using genomic DNA, in 
which the tRNA^rg gene coding strand was preferentially amplified, as template 
and oligonucleotide H as primer. The sequence can be read unambiguously as far 
as the end of the coding sequence of the gene. If differences occur in either the 
length or the sequence of the intron in any of the copies of the tRNA-^S gene then 
the sequence from a mixed population of amplified fragments would show these 
differences. The results obtained by sequencing both strands of the tR N A ^g genes 
amplified from genomic DNA suggest that all of the members of this gene family 
have identical introns since a unique sequence can be read for the whole length of 
the coding region. Bands can be seen in the autoradiograph shown in figure 4.7. 
extending further than the sequence corresponding to the coding region of the 
tRNA-^rg gene. These artifacts presumably arise through priming of DNA 
synthesis in the sequencing reaction from fragments amplified incorrectly in the 
asymmetric PCR, since fragments amplified specifically should only extend as far 
as the end of the primers used.
4.3.3. Amplification and cloning of two hum an tR N A ^ln  genes.
The PCR was used to generate gene-specific probes for each of the tRNA genes 
from XHt363 as described in section 4.2.2. The oligonucleotide primers C and D 
(see table 4.1.) specific for the 5' and 3' ends of the tRNA^ln gene, were used in 
one set of PCR experiments. When XHt363 or the plasmid construct pGLNl (see 
table 5.1.) containing the tRNA^ln gene from XHt363 were used as the target 
DNA, only one band was amplified. When the same primers were used with 
genomic DNA as the target, two amplified bands resulted (see figure 4.8.). The 
smaller band amplified in all of the reactions corresponds in size to the tRNA^ln 
gene coding sequence (72 bp). The larger band found when genomic DNA was the 
target for amplification was estimated to be 620 bp ± 20 bp. This 620 bp band was 
eluted from a low melting point agarose gel as described in section 2.5.7.2., and 
itself used as a target for a PCR using the two primers described above. This 
fragment again generated two amplified bands, of 72 bp and 620 bp.
These results could be explained if there existed in the genome two tRNA^hi 
genes within 620 bp of each other. A proportion of the amplified PCR products
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F igure 4.7. D irect sequencing o f tR N A ^ r g  gene cop ies am plified  
from  hum an genom ic DNA.
The oligonucleotide primers G and H (table 4.1) were used in asymmetric 
polymerase chain reactions to amplify predominantly single stranded DNA  
corresponding to the coding sequences of a mixed population of genomic tR N A ^g 
genes. The autoradiograph shows the products of one such reaction, sequenced by 
the Sanger chain termination method using oligonucleotide H as primer and analysed 
by polyacrylamide gel electrophoresis in parallel with products from a standard 
sequence analysis of M13mpl8 (M). The region corresponding to the tRNA^rg 
gene, including the intron, is indicated.
M AG C T
Figure 4.8. Polymerase chain reaction am plification of two genomic 
DNA fragm ents using prim ers specific for a tRNAGIn gene.
The oligonucleotide primers C and D were used in polymerase chain reactions for 
three different target DNAs and the products analysed by electrophoresis through a 
2% agarose gel. The target DNAs were : lane 1, pGLNl (see table 5.1); lane 2, 
human genomic DNA; lane 3, ^,Ht363. Marker DNA fragment sizes are indicated 
(bp). Ml = X DNA IDraI, M2 = PCR amplified tRNA-^g gene DNA.
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would be expected to correspond in length to the distance from the 5' end of one 
gene to the 3' end of the other. Since neither primer alone gave any amplified 
product with any of the target DNAs this explanation is possible only if these two 
genes were in the same orientation.
Sufficient amounts of the 620 bp amplified band were eluted from low melting 
point agarose gels to allow digestion of the fragment with restriction enzymes and 
to produce a preliminary restriction map. The restriction fragments listed in table
4.2. were cloned into M13 vectors and sequenced as described in section 2.5.14. 
The sequencing strategy used is summarised in figure 4.9. and the nucleotide 
sequence shown in figure 4.10. The sequence was determined on both strands, 
reading through all restriction sites. Two identical human tRNA^ln genes, in the 
same orientation, were found on this 623 bp sequence. The genes have completely 
different flanking DNA to that of the tRNA^ln gene from A.Ht363 (although only 
one flank of each gene is present on this 623 bp fragment). Both genes differ in a 
single residue from the coding sequence of the tRNA^ln gene from XHt363. The 
difference, indicated on figure 4.10., is in the anticodon. These novel human tRNA 
genes code for tRNA^^nuuG rather than tRNA^lnCUGt it should be noted that 
since this fragment was isolated using the PCR, the residues corresponding to the 
positions of the primers (1-17 and 607-623 on figure 4.10.) will not necessarily 
have the sequence present in the original genomic DNA.
4.4. D iscussion.
4.4.1. The integrity of the insert of XHt363.
Human tRNA genes are members of complex multigene families, and as yet no 
clear pattern of genomic organisation has been established for tRNA genes in 
humans or in any other mammalian system. The results discussed in section 3.4. 
suggest that the genes from the tRNA gene cluster represented on >Ht363 occur in 
at least two copies in the genome. This interpretation depends firstly on the integrity 
of the inserts of ^.Ht363, ^.Ht4 and ^.Ht9. If any rearrangements have occured 
during the cloning of these recombinants then comparisons of their restriction maps 
will be meaningless. Secondly, this interpretation of the results depends on the
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Table 4.2.
S u b clo n es u sed  in seq u en c in g  a 623  bp fragm en t o f  h u m an  genom ic  
D N A  co n ta in in g  tw o  tR N A ^ In  genes.
Subclone In s e r t V ec to r Sequenced region
M50 Sau 3A-Sau 3A 136-45 M13mpl8 136-45
M51 Sou 3 A-Sau 3 A 45-136 M13mpl8 45-136
M52 Pst I-Sau 3A 187-136 M13mpl0 187-136
M53 Pst I -Sau 3 A 187-596 M13mpl0 187-540
M54 Sau 3 A  -Pst I 596-187 M13mpll 596-203
M55 Sau 3 A-Pst I 136-187 M13mpll 136-187
M56 Pst I-L.end 187-1 M13mpl0 187-1
M57 Sau 3 A-Sau 3 A 596-136 M13mpl8 596-176
M58 L.end-P^r I 1-187 M13mpll 1-187
M59 Pst I-R.end 187-623 M13mpl0 187-602
M60 R.end-Sau 3A 623-596 M13mpll 623-596
This table summarises the subclones used to sequence a 623 bp fragment of human 
genomic DNA containing two tRNA^ln genes. The subclones are numbered as in 
the sequencing strategy shown in figure 4.9. The numbers in the insert column 
refer to the sequence presented in figure 4.10. L.end and R.end denote the blunt 
ends (at the left and right of the fragment as shown in figure 4.9.) which occured as 
a result of the method used in cloning this fragment (see section 4.3.3.).
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Figure 4.9. Strategy used for sequencing a PCR amplified 623 bp
fragment of human genomic DNA containing two tRNA^In genes.
This figure summarises the restriction sites used (Pst I (Ps) and Sau 3 A  (Sa)) to 
generate M l3 subclones for sequencing a PCR amplified 623 bp fragment of 
human genomic DNA. BE denotes blunt end. The arrows indicate the direction and 
extent of sequence determined from each subclone (see also table 4.2.).
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Figure 4.10. Nucleotide sequence of a  623 bp fragment of human
genomic DNA containing two tRNAGln genes.
The nucleotide seqence of a 623 bp fragment of human genomic DNA is 
shown.The positions, orientation and cloverleaf secondary structure of the 
tRNAGlnuuG genes are indicated. The sequence was determined for both strands 
with appropriate overlaps (see figure 4.9.). The difference in gene sequence from 
the tRN A ^^cuG  Sene ° f  ^ Ht363 is marked (*).
t R N A G l n
GGTTCCATGG TGTAATGGTT AGCACTCTGG ACTTTGAATC CAGCGATCCG
CCAAGGTACC ACATTACCAA TCGTGAGACC TGAAACTTAG GTCGCTAGGC
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tRNA genes in question not being alleles showing restriction site polymorphisms, 
although the number of differences in the restriction maps of ^Ht363, XHt4 and 
XHt9 (shown in figure 3.11.) suggests that this is not particularly likely.
Southern hybridisations of genomic DNA can be used to address both of these 
questions. If no rearrangements have occured in the recombinant then the sizes of 
genomic restriction fragments hybridising to probes derived from XHt363 can be 
predicted from the restriction map shown in figure 3.3. Probes that appear to 
represent sequences common to XHt363 and XHt4 or XHt9 should hybridise to the 
same genomic restriction fragments. Conversely, probes including sequences 
outside regions of similarity should detect additional genomic fragments where the 
restriction maps of the recombinants differ. The genomic DNA used in this study is 
from a different individual to the source of the DNA used to make the XCharon 4A 
library. If high frequency restriction site polymorphisms exist between different 
alleles, and therefore between different individuals, then the pattern of hybridisation 
obtained using probes derived from XHt363 would not necessarily correspond to 
that predicted by the restriction map. This follows because the restriction map is 
derived from the DNA of the original ^Charon 4A library.
The genomic hybridisation results presented in sections 4.2.1. and 4.2.2. are 
consistent with predictions made on the basis of the restriction maps of XHt363, 
^Ht4 and ?cHt9  in that the probes used detect restriction fragments of the expected 
sizes (see section 4.2. and figures 4.1. and 4.3.). However, a complex pattern of 
genomic hybridisation generally occurs with labelled tRNA gene probes, as a 
consequence of their multigene family nature. This appears to be true for some 
small restriction fragments containing tRNA genes as well as for gene-specific 
probes generated by the PCR containing only the tRNA gene coding sequence. It is 
difficult therefore to draw too many definite conclusions from limited hybridisation 
data. When a number of bands hybridise to a probe there is a possibility that the 
"expected" bands may be other genomic fragments hybridising to the probe with a 
coincidental resemblance in size to fragments predicted on the basis of restriction 
maps. In the case of this study, a range of genomic digests were used as targets for 
the hybridisation of both tRNA gene-specific probes and of restriction fragments 
containing tRNA genes. Fragments of genomic DNA corresponding to the 
restriction map of AHt363 were detected for each digest, so despite the reservations 
expressed above the experimental evidence is consistent with the insert of A,Ht363 
representing an unaltered stretch of human genomic DNA.
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4.4.2. Copy numbers of the tRNA genes from A.Ht363.
The discovery that tRNA gene-specific probes produced using the PCR 
hybridised to multiple genomic fragments (section 4.2.2.) was not unexpected. As 
described in section 1.4., tRNA genes generally belong to multigene families. If 
these occur in different parts of the genome then different restriction fragments will 
hybridise to a tRNA gene probe in a genomic Southern hybridisation. The number 
of restriction fragments detected in a genomic digest gives an estimate of minimum 
copy number for the tRNA gene used as a probe. It can be seen in figure 4.3. that 
the hybridisation of the probe to genomic fragments is not of uniform intensity. 
This suggests that two or more members of a tRNA gene family may share 
common genomic environments so that they are located on the same size of 
restriction fragment for one or more restriction endonucleases. The total number of 
bands hybridising to a tRNA gene probe therefore represents a minimum estimate 
of copy number, since each band may be the result of hybridisation to more than 
one genomic restriction fragment. (The intensity of the bands produced in these 
experiments was not quantified because of the high background seen on the 
autoradiographs. This high background, occurring even under stringent 
hybridisation conditions, may be a consequence of the use of short (71-88 bp) gene 
specific probes for Southern hybridisations). It should be noted that hybridisation 
to genomic fragments could be due to probes detecting either tRNA pseudogenes 
resembling the genes in the cluster, or members of another gene family of 
isoaccepting tRNA genes of similar sequence to those occurring on XHt363. 
(Section 4.3.3. describes how two human tRNAGln genes differing in only one 
residue from that on XHt363 were cloned). If pseudogenes or different isoacceptor 
tRNA genes are detected by a gene specific probe then the estimate of minimum 
copy number for the tRNA genes found on XHt363 would be affected.
As already discussed in section 3.4., the tRNA gene cluster cloned on XHt363 
appears to be present in at least two copies in the human genome. The results from 
the quantification of the copy number of part of the cluster, presented in section
4.2.3., are consistent with this. The actual figure of 2.7 copies per haploid genome 
is obviously subject to some experimental error, since the true copy number must
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be an integer. Likely error sources are in the spectrophotometric quantification of 
the DNA, in loading samples onto agarose gels, in uneven hybridisation to the 
nylon membrane and in the densitometry itself since slightly different results can be 
obtained by scanning different parts of the same band. Two or three copies per 
haploid genome may be the true figure. Under the conditions used, only one 
genomic fragment from a Bam HI digest hybridised to the 4.2 kb Bam HI probe 
from XHt363. This would be expected on the basis of the restriction map of 
XHt363, but not necessarily that of XHt4 since only one of the Bam  HI sites is 
present on this recombinant. The second Bam  HI site, if it occurs in the same 
position in both copies of the cluster, would not be present in the insert of XHt4 
(see figure 3.11.). Since only one fragment was detected in a Bam  HI genomic 
digest, it appears that the organisation of the two clusters is the same over at least 
4.2 kb.
As described in section 4.2.3., no estimate of genomic copy number was 
obtained for a probe which should detect the tRNA^ly genes from XHt363 and 
XHt9. It may be that the relatively short length of this probe (356 bp as opposed to 
the 4.2 kb fragment mentioned above) caused problems with cross-hybridisation to 
other members of the tRNA^ly gene family.
4.4.3. Chromosomal location of the tRNA gene cluster from  
XHt363.
Probes derived from XHt363 have been used in a collaborative study to map 
human tRNA genes to their respective chromosomes. Two regions of XHt363, 
subcloned into pUC19, were used for this purpose. One subclone (pCLUl; see 
section 5.4.) contained the 4.2 kb Bam HI fragment from XHt363 which carries the 
genes coding for tRNA^ys, tRNA^^n, tRNA^eu tRNA^rg. The other 
subclone contained a 1.3 kb insert which includes the tRNA^ly gene. This insert 
consists of the sequence from the Pvu II site to the 5' of the tRNA^ly gene (see 
figure 5.9.) to the Eco RI site marking the start of the right arm of the X 
recombinant (see figure 3.3.). In situ hybridisation experiments carried out by 
Norma Morrison, as described in Morrison et a l ., (1991) mapped both of these 
probes to the same site on the short arm of chromosome 17, 17pl2-pl3.1. (This
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localisation has subsequently been refined to 17pl3.100-105 using hybridisation of 
the 4.2 kb probe to somatic cell hybrid DNAs; Dr. D.H. Ledbetter, personal 
communication). Since both of these probes were isolated from one recombinant it 
is not unexpected that they both map to the same chromosomal site. However, the 
resolution of in situ hybridisation using light microscopy is only at the megabase 
level, so this result does not actually prove that the two probes recognise sequences 
within a few kb of each other in the genome, although the result is obviously 
consistent with this interpretation. What this does suggest is that all of the copies of 
this tRNA gene cluster may occur in the same part of the genome since the 4.2 kb 
probe used is thought to represent DNA common to XHt363 and AHt4, and the 1.3 
kb probe DNA common to XHt363 and ^Ht9. These fragments are thought to be 
the same or very similar in the different recombinants on the basis of sequence, 
restriction map and hybridisation data. It was not possible to use probes covering 
only regions where sequence identity had been established between the 
recombinants because of the limitations of the in situ hybridisation method used. 
Probes below a certain size will not hybridise sufficiently well to a chromosomal 
site to give a significant signal, and 1.3 kb is at about the lower limit for successful 
use in this technique (N. Morrison and E.Boyd, personal communication).
The coding sequence of tRNA genes only covers 70-95 bp. It follows that for 
most restriction fragments carrying tRNA genes the sequence 5’ and 3' of the gene 
will be larger than the gene itself. The consequences of this for Southern 
hybridisations were briefly discussed in section 4.2.2. The point made there, that 
hybridisation will depend more on the nature of the region flanking the gene than on 
the gene itself, applies at least equally to in situ hybridisation experiments. In such 
experiments, it is the genomic environment of a tRNA gene which is being mapped 
to a chromosomal locus, rather than an individual tRNA gene. This explains why 
another group, using tRNA gene probes against DNA from somatic cell hybrids, 
mapped a human tRNA^ly gene with an identical coding sequence, but different 
flanking sequences, to chromosome 16 (McBride et a l ., 1989). In the study 
described by Morrison et a l ., the tRNA^ly gene from ^Ht363 mapped solely to 
chromosome 17.
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4.4.4. Investigations into tRNA gene organisation using the 
polymerase chain reaction.
The results obtained using tRNA gene probes in genomic Southern 
hybridisations suggest that the insert of XHt363 has not undergone any 
rearrangements (see section 4.2.). The results of experiments using the PCR to 
compare amplified fragments from XHt363 and genomic DNA were consistent with 
this interpretation. All of the combinations of oligonucleotide primers (designed 
using sequence data from XHt363) which produced an amplified fragment using 
XHt363 DNA as a target produced the same size of amplified fragment with a 
genomic DNA target.
Investigations into the nature of genomic copies of tR N A ^rg genes 
demonstrated the usefulness of the PCR approach for rapidly characterising 
genomic sequences without having to clone them. The results presented in section
4.3.2. are not entirely unexpected since it has been shown for yeast tRNA genes 
that the size and sequence of introns are often conserved in different members from 
within one tRNA gene family, although not between different tRNA genes (Szekely 
et a l ., 1988). (This is not true for all intron-containing tRNA gene families; for 
example, members of a Drosophila tRNA^yr gene family have introns of different 
sizes (Suter and Kubli, 1988)). No human tRNA^rg genes have previously been 
cloned, and no intron-containing tRN A ^rg genes have been found in any 
organism. As mentioned in section 3.4.2., this may reflect problems in detecting 
intron containing genes in a genomic DNA library rather than their actual occurrence 
in eukaryotic genomes. The results from this study suggest the existence of a 
human tR N A ^g gene family with at least seven members, all of which contain an 
intron of the same size and sequence (see sections 4.2.2. and 4.3.2.). It was 
mentioned earlier (section 3.4.) that no tR N A ^g gene is recorded on XHt4 despite 
the fact that it is within the region of similarity between XHt4 and XHt363 (see 
figure 3.11.). DNA from this region of the insert of XHt4 was kindly supplied by 
Dr. R. Buckland. When this DNA was used as a target for the PCR, with primers 
G and H (see table 4.1.) specific for the tRNA^rg gene, a tR N A ^S  gene sized 
fragment was amplified. This suggests that the tRNA gene cluster on XHt4 does 
include a tR N A ^S gene, amplifications of XHt4 DNA using other primers which 
correspond to sequences within the cluster indicate that the tR N A ^g gene is in the
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same position relative to the other tRNA genes on ^.Ht4 as it is on XHt363. 
Presumably the tR N A ^g gene was not originally detected on AJlt4 for the same 
reason as it was originally missed on XHt363, i.e. poor hybridisation to the tRNA 
probes used (see section 3.4.2.).
The use of the PCR to clone novel tRNA genes has recently been discussed 
(Green et a l ., 1990). These authors suggest that if two tRNA genes are located 
together but in opposite orientations then a single PCR primer targeted for either the 
5' or the 3f end of the tRNA gene should amplify the tRNA gene dimer. These 
authors also suggest that if two genes coding for the same tRNA are located 
together in the same orientation then the'PCR amplification of the smaller 
monomeric gene would be greatly favoured over that of the tRNA gene dimer. The 
results presented in section 4.3.3. show that this is not entirely true. Even under 
conditions favourable for the amplification of short DNA fragments a fragment 
corresponding to a tRNA gene dimer can be amplified sufficiently to be easily 
detectable. The fragment described, containing two tRNAGln genes, has not been 
characterised beyond its sequence. This is largely because no full length fragments 
could be cloned. (Figure 4.9. shows the subclones which were obtained for 
sequencing). The most likely reason for this problem is the instability of 
recombinants containing the full fragment due to the direct repetition of the 72 bp at 
either end of the fragment.
The small size of tRNA genes and their large copy number in the genome make 
these genes particularly suitable for cloning using the PCR. This is further 
discussed in section 6 .1.4.
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CHAPTER HVB
IN  VITRO  TRANSCRIPTION ASSAYS.
5.1. Background and aims.
An homologous in vitro transcription assay using a HeLa S3 cell extract is 
described in section 2.5.16.2. Aliquots of one cell extract preparation (see section
2.5.16.1.) were used for all of the experiments described in this chapter.
The initial aim of the transcription assays was to establish that each of the tRNA 
genes from XHt363 was transcriptionally active in the in vitro system used, and if 
so to determine the maximum transcriptional efficiency for each of the genes (in 
terms of transcripts per gene copy per hour) as described in section 5.3. 
Establishing this maximum transcriptional efficiency would allow comparison of 
the rates of transcription of the individual genes to those of the same genes when 
transcribed as a cluster.
Figure 5.1. shows the gene products from the five tRNA genes on XHt363 
separated by polyacrylamide gel electrophoresis.When the gene products from 
transcription assays are separated by electrophoresis, especially when using 
sequencing gels (see section 2.5.14.3.2. and figures 5.6. and 5.7.) it is apparent 
that the majority of the products formed are precursor tRNAs. It was therefore 
hoped to investigate the processing of the tRNA genes from XHt363, by 
re-incubation of 32p. labelled gene products in a non-radioactive transcription assay 
(see section 5.5.). In particular it was hoped to investigate the processing of the 
tR N A ^g gene, because of the presence of an intron within this gene.
The final group of transcription assays were to investigate the effect of genetic 
manipulations in the 5' flank of the t R N A ^ l y  gene on its transcriptional efficiency. 
This gene in particular was selected partly on the basis of having a series of 
convenient restriction sites in its 5* flank, and therefore being amenable to genetic 
manipulation. Doran et a l . (1988) also reported transcriptional differences between 
a t R N A ^ l y  gene identical to that from XHt363 and a second human t R N A ^ t y  gene
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Figure 5.1. Autoradiograph of transcripts of the five tRNA genes
from XHt363.
In vitro transcription assay products were electrophoresed in duplicate on an 8% 
denaturing polyacrylamide gel. Each standard assay (section 2.5.16.2.) contained 
approximately equimolar amounts of gene template. Lanes 1 and 2, pGLNl (5.7 
ng); lanes 3 and 4, pLEUl (5 ng); lanes 5 and 6, pLYSl (5.3 ng) lanes 7 and 8, 
pARGl (6.7 ng); lanes 9 and 10, pGLYl (5.9 ng). (See table 5.1. for a 
description of the subclones used). Approximate sizes of the products are shown in 
nucleotides.
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with the same coding sequence but different 5' and 3' flanking sequences. This 
suggests that the flanking regions of these human tRNA^ly genes may influence 
their transcription, providing a second reason for selecting the tRNA^ly gene from 
XHt363 for this investigation.
5.2. Construction of recombinants for transcription assays.
All of the quantitative transcription assays performed in this study used 
supercoiled plasmid DNA as described in section 2.5.16.2. In order to minimise 
any effect that vector DNA might have in causing transcriptional differences, all of 
the tRNA genes used were subcloned into the same vector, pUC19 
(Yanisch-Perron et al .,1985). This vector was also used as non-specific "carrier" 
DNA in transcription assays (see section 2.5.16.2.). Subcloning was carried out as 
described in section 2.5.8. The recombinants listed in table 5.1. were those used 
for all of the transcription assays described in this chapter except for those 
involving four genes transcribed as a cluster (see section 5.4.), those involving 
variants of the tRNA^ly gene (see sections 5.6.1. and 5.6.2.) and those involving 
a variant of the tRNA^ln gene (see section 5.6.4.). The restriction sites used for 
subcloning can be located on the restriction map of XHt363 (figure 3.3.) and in the 
sequence data presented (Chapter 3, figures 3.6., 3.8. and 3.10.) and all either 
occur in the multicloning site of pUC19 or are compatible with enzymes cutting 
within this site.
5.3. Determination of transcriptional efficiency.
5.3.1. Concentration assays.
When increasing amounts of template DNA are used in transcription assays, the 
transcriptional apparatus eventually becomes saturated. When the availability of 
RNA polymerase HI and/or transcription factors begins to be limiting, sub-optimal 
transcriptional efficiency results. For experimental determination of the maximum
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Table 5.1.
pUC19 subclones used in single gene transcription assays.
Sjibclim e G ene
pLYSl tRNA^ys
pGLNl tRNAGln
pLEUl tRNALeu
pARGl tRNAArg
pGLYl tRNAG'y
Insert
Bam VH-Kpn 1440 bp 
Eco RI-Eco R I617 bp 
Eco Rl-Z/m d in  247 bp 
Hin d YQ.-Mst 1 1277 bp 
Pvu U-Stu 1713 bp
Sequence reference
1-440 figure 3.8. 
794-1410 figure 3.8. 
1405-1651 figure 3.8. 
1652-2922 figure 3.10. 
1-713 figure 3.6.
This table lists the subclones employed in transcription assays performed to 
establish the maximum transcription rate for the five individual tRNA genes from 
XHt363. All of the inserts listed were cloned into the multiple cloning site of 
pUC19 (see figure 2.2. and section 2.5.8.). The numbers in the sequence reference 
column correspond to the nucleotide residue numbers in the sequence indicated.
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transcription rate of tRNA genes it is therefore necessary to use an amount of DNA 
low enough so that the number of gene copies present in the assay is the factor 
determining the amount of transcript produced.
To establish the range of DNA amounts low enough to be non-saturating in a 
transcription assay, concentration curves were produced for each of the five tRNA 
genes from XHt363. Increasing amounts of plasmid DNA were incubated in a 
standard transcription assay (see section 2.5.16.2.). The radioactivity incorporated 
in the transcription products was measured as described in section 2.5.16.3., and 
plotted against the amount of DNA, and hence the gene copy number, present as 
template in each assay. Figure 5.2. shows an autoradiograph of transcripts in such 
a concentration assay performed for the tRNA^eu gene. Similar results were 
obtained for transcripts from each of the other four tRNA genes from XHt363. (The 
upper band seen in each lane in figure 5.2. was initially thought to be a precursor of 
tRNALeu. The exact nature of this approximately 150 nucleotide band is uncertain, 
but it does not appear to be a RNA polymerase II transcript on the grounds that the 
band is still produced in the presence of 10 |ig/ml a-amanatin. The 245 bp insert of 
the pLEUl recombinant (see table 5.1.) does not contain any RNA polymerase III 
gene other than that for the tR N A ^11. This band also appears to be processed in 
experiments of the type described in section 5.5. and may represent a minority 
transcript originating from transcriptional read-through of the major transcription 
termination signal rather than being a tRNA^eu precursor. The sequence of the 
tRN A L«u gene and its flanking regions is shown in figure 3.8. A putative 
secondary transcription termination site (T4 ) can be seen between residues 1413 and 
1416, 87 bp 3' of the end of the coding sequence of the gene. Termination at this 
site may be responsible for the larger transcript seen in figure 5.2).
The graphs shown in figure 5.3. summarise the results of two duplicate 
concentration assays for each of the five tRNA genes. Assays using each of the 
genes gave a similar shape of curve, showing an initial linear increase in cpm with 
increasing amounts of DNA, tailing off into a plateau as the extract becomes 
saturated. (If still greater amounts of DNA are added, the total number of transcripts 
produced falls: E.S. Gonos and J.P. Goddard, personal communication, and data 
not shown). These results allowed the selection of suitable amounts of DNA from 
the linear part of the curve to be used in time course assays.
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Figure 5.3. Analysis of DNA concentration assays.
The amounts of p 2P] labelled gene transcripts in cpm derived from transcription of
0-50 ng of the indicated subclones are shown (+). Error bars indicate ± one standard 
deviation for four results (duplicates of each of two independent assays).
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5.3.2. Time course assays.
Time course assays were performed for each of the tRNA genes from XHt363 
using incubation times between 0 and 120 minutes. All assays used 5 ng of DNA 
except for those involving the pGLYl recombinant (see table 5.1.) where 2 ng of 
plasmid DNA was found to be an appropriate value with reference to the range of 
concentrations from the linear part of the graphs shown in figure 5.3. Figure 5.4. 
shows the transcripts generated from the recombinant pLEUl in transcription 
assays with incubation times between 0 and 120 minutes. Similar results were 
obtained for transcripts from the other tRNA genes from XHt363. The amount of 
transcript was quantified as described in section 2.5.16.3., and plotted as cpm 
against times of incubation. The graphs in figure 5.5. summarise the results of the 
time course assays for the five tRNA genes. The graphs all show a similar shape of 
curve, with an initial lag (due presumably to the time taken for the formation of 
transcription complexes) followed by a linear increase in labelled transcripts with 
time. The upper time limit for a continued linear increase in transcripts was not 
determined. The radioactivity incorporated into transcripts per hour for each gene 
were determined by taking the difference between cpm recorded at 60 and 1 2 0  
minutes.
Knowing the amount o f transcripts produced by a given number o f gene copies 
per hour, it is possible to calculate the maximum transcriptional efficiency for each 
gene using the method given in section 2.5.16.4. These figures are shown in table
5.2. for the five genes in terms o f transcripts per gene copy per hour. The 
maximum transcription rates vary by greater than 5-fold from the least efficient to 
the most efficient gene (tRNA^ys and tRNA^ly respectively).
5.4. Resolution of transcrip ts on sequencing gels and transcrip tion 
assays of four tRNA genes as a cluster.
One of the recombinants constructed by subcloning into pUC19 was designated 
pCLUl, because it carries a 4.2 kb Bam HI fragment from XHt363 which had 
previously been partially characterised and shown to contain a cluster of three tRNA 
genes coding for tRNA^ys, tRNA^ln and tRNA^ 11 (see section 3.1.).
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Figure 5.5. Analysis of time course assays.
The amounts of P^P] labelled gene transcripts in cpm derived from transcription of 
the subclones indicated for 0,20,40,60, 80,100 and 1 2 0  minutes of incubation are 
shown (+). Error bars indicate ± one standard deviation for four results (duplicates 
of each of two independent assays).
2400
2200
2000
1800
1600
B 1400
a  1200 
w 1000 
800 
600 
400 
200
1200 n
1000
800
& 600
400
200
100 120806020
pGLNl (5 ng) incubation time (min)
40020 40 60 80 100 120  
pLYSl (5 ng) incubation time (min)
2400
2200
2000
1800
1600
e 1400eL 1200 
w 1000 
800 
600 
400 
200
1201 0080604020
pLEUl (5 ng) incubation time (min)
0 20 40 60 80 100 120  
pARGl (5 ng) incubation time (min)
2400 
2200 
2000 
1800 
1600 
£  1400
£• 1200 
1000 
800 
600 
400 
200 
0
12010080604020
pGLYl (2 ng) incubation time (min)
1 1 9
Table 5.2.
Maximum transcription rates for the five tRNA genes from XHt363.
Gene Transcripts per Relative transcriptional Relative transcriptional 
gene copy per efficiency (individual efficiency (four genes
hour tRNA genes) transcribed as a cluster)
tRNA^ly 
tRNAArg 
tRNALeu
tRNA®n 
tRNALys
9.0 5.3
3.8 2 .2 2.4
3.5 2 .0 2 .1
3.3 1.9 1.7
1.7 1 .0 1 .0
This table lists the maximum transcription rates for the five tRNA genes from 
XHt363 in terms of transcripts per gene copy per hour (see section 5.3.). The 
recombinants used for the relevant transcription assays were those listed in table
5.1. Table 5.2. also lists the relative transcriptional efficiency for each gene (taking 
the least active, the tRNALys gene as 1.0). Where appropriate, the relative 
transcriptional efficiencies for the genes when transcribed as a cluster are also 
tabulated (see section 5.4.).
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Figure 5.6. shows an autoradiograph of labelled transcripts derived from pCLUl 
separated on a sequencing gel. The autoradiograph also shows transcripts from the 
recombinants pLYSl, pGLNl and pLEUl (see table 5.1.) which contain the three 
individual genes known at this stage to be carried on pCLUl, and from the 
recombinant pGLYl which contains the tRNA^ly gene from XHt363. It can be 
seen from this autoradiograph that some transcripts are obtained from pCLUl 
which do not correspond in size to transcripts from the three genes known to be 
present on this recombinant. As described in section 3.3.3., the region responsible 
for producing these bands was subcloned and sequenced and found to contain a 
tR N A ^S gene which accounted for the additional transcripts observed. It can also 
be seen in figure 5.6. that the tRNA precursors produced by in vitro transcription 
of the tRNA genes from XHt363 can be resolved on a sequencing gel.
Figure 5.7. shows an autoradiograph from a sequencing gel on which transcripts 
from pCLUl have been electrophoresed in parallel with those from the 
recombinants (described in table 5.1.) containing the five individual tRNA genes 
from XHt363.The different transcripts from pCLUl are sufficiently resolved to 
make it possible to quantify the transcripts from each individual gene. In table 5.2. 
the ratios of transcriptional efficiencies of the five individual tRNA genes from 
XHt363 are shown in addition to the corresponding ratios from the four tRNA 
genes found on pCLUl. Within the limits of this experimental system it appears 
that these genes are transcribed with similar relative efficiency in a cluster as they 
are as individual genes despite their close proximity.
5.5. Processing of tRNA precursors.
Figures 5.6. and 5.7. show that the transcripts derived from the tRNA genes 
used in this study are made up of what appears to be a mixture of precursor tRNAs. 
One approach to investigate the processing of these putative precursors is to take 
transcripts from a standard transcription assay as described in section 2.5.16.2. and 
re-incubate in the HeLa S3 extract in the absence of a -[3 2P]-UTP so that new 
transcripts are not labelled, and any size change in the labelled transcripts with time 
can be monitored. The sizes of transcripts were determined by running the products 
of a standard sequencing reaction (section 2.5.14.3.1.) alongside the tRNA gene 
products on a sequencing gel as shown in figure 5.6. In particular it was decided to
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Figure 5.6. Preliminary characterisation of transcripts from subcloned
tRNA genes.
Transcripts were obtained using standard assay conditions from the t R N A ^ l y ,  
tRNALeu5 tRNA^ln ancj tRNA^ys genes on recombinants pGLYl, pLEUl, 
pGLNl and pLYSl (see table 5.1.). These transcripts were electrophoresed on a 
sequencing gel in parallel with transcripts from the recombinant pCLUl, a pUC19 
recombinant containing a 4.2 kb Bam HI fragment from ^.Ht363 (see section 5.4.) 
which at this stage of the study was thought to contain only the tRNA^ys, tRNAGln 
and tR N A ^ 11 genes. Lanes 1 and 10, pGLYl (2 ng); lanes 2 and 9, pLEUl (5 ng); 
lanes 3 and 8, pGLNl (5 ng); lanes 4 and 7, pLYSl (5 ng) and lanes 5 and 6, 
pCLUl (5 ng).The products of a standard sequencing reaction for the M13mpl8 
subclone M l (see table 3.2. and figure 3.4.) were run in parallel (tracks A,G,C and 
T) to estimate the approximate size of transcripts, indicated in nucleotides.
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Figure 5.7. Autoradiograph of the products of transcription from the
five tRNA genes subcloned from XHt363.
The transcription products of four of the tRNA genes from ^.Ht363, subcloned as a 
cluster (pCLUl, see section 5.4.) and of the five individually subcloned genes 
(pGLNl, pLEUl, pLYSl, pARGl and pGLYl; see table 5.1.) were obtained using 
standard assay conditions, using, in the case of the individually subcloned genes, 
approximately equimolar amounts of gene template. Lane 1, pCLUl (5 ng); lane 2, 
pGLNl (5.7 ng); lane 3, pLEUl (5 ng); lane 4, pLYSl (5.3 ng); lane 5, pARGl 
(6.7 ng) and lane 6, pGLYl (5.9 ng). Products were separated on a sequencing gel; 
their approximate sizes are shown in nucleotides.
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look at the changes in size of the precursors for tR N A ^g, since the removal of the 
intron and splicing of the resultant half molecules causes the most obvious 
differences in precursor size.
5.5.1. Processing of tR N A ^rg  gene products.
Figure 5.8. shows the results of re-incubating the products of a one hour 
transcription assay using pARGl (see table 5.1.) for times between 0 and four 
hours. The sizes of the products are indicated in figure 5.8. There is an 
accumulation with time of a product of the size of tRNA^rg, and the expected loss 
of the largest precursor corresponding in size to the tRNA coding sequence plus 
intron plus 10 nucleotides of flanking sequence. A similar pattern of changes was 
observed when the pARGl recombinant was used in time-course assays of the type 
described in section 5.3.2. Re-incubation experiments for the other tRNA genes in 
the cluster gave similar results, with the eventual accumulation of tRNA-sized 
products after prolonged re-incubation (data not shown).
The approximate sizes of the bands seen in figure 5.8. were 98, 83, 73,44 and 
39 residues, together with some faint intermediate bands and indeterminate products 
of less than 39 residues which are visible after two hours of re-incubation. These 
sizes and the order in which the tRNA-^S precursors appear are consistent with the 
following scheme of processing. Firsdy, the intron is removed from the primary 
transcript of 98 bases to yield two tRNA half molecules of 44 and 39 bases, and 
presumably release the 15 base intron although no intron-sized band was resolved 
on the gel (see figure 5.8.). The two half molecules are spliced to produce the 83 
base product which still has the 5' leader and 3' extension sequences. These are 
apparently removed together since no intermediate products can be seen between the 
83 base band and the tRNA-sized product of 73 residues. It is uncertain whether the 
addition of the CCA tail found at the 3' terminus of mature tRNAs occurs in the in 
vitro system used. O'Connor and Peebles (1991) report that splicing of tRNA half 
molecules can take place either before or after 5' and 31 end trimming. The presence 
of products of less than 39 residues could be explained by the occurence of either 5* 
or 3* end maturation before splicing of the tRNA half molecules.
The total length of the 5’ leader plus 3' trailer in the primary tRNA^rg
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Figure 5.8. Autoradiograph of the products of processing of
precursor tRNAs derived from pARGl.
The products of a transcription assay using pARGl (10 ng) were reincubated in a 
HeLa cell extract in the absence of [32P]UTP for 0-4 h. Duplicate samples were 
removed at the times indicated and separated by electrophoresis through an 8% 
denaturing polyacrylamide gel. Approximate product sizes are indicated in 
nucleotides.
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transcript was 10 residues (assuming that the CCA tail had not been added to this 
98 residue transcript). This suggests that there are only four potential transcription 
start sites for the tR N A ^g gene, the purine residues (G in each case) at -7, -4, -3 
or -2 (see figure 3.10.). The residue at -7 may be the best candidate for the start site 
since the termination signal for the tRNA^rg gene occurs one bp 3' of the end of 
the coding sequence, so the 3' extension is unlikely to extend much beyond this 
point. Assuming that this is the case the 44 base product corresponds to the 5' 
tRNA half molecule and the 39 base product the 3' half molecule.
5.6. The effect of the 5 1 flank of the tR N A ^ ly  gene on 
transcription.
5.6.1. Construction and transcription of variant tR N A ^ly gene 
recombinants.
Variants of the pGLYl recombinant (table 5.1.) were constructed using 
restriction sites in the 5' flank of the tRN A ^ly gene. Figure 5.9. lists the 
recombinants constructed, with differing amounts of the 5f flank removed. pGLY3 
differs from the other constructs in that part of the 5' flank (125 bp bounded by the 
two Bam  HI sites denoted by Bl and B2  in figure 5.9.) has been placed in the 
opposite orientation to that found in AHt363. The Mst I site used in the construction 
of pGLY5 cuts exactly flush with the start of the coding sequence of the gene, so in 
this recombinant the entire 5’ flank is replaced with unrelated vector DNA. 
Transcription assays were performed, using the same amount of DNA for each 
variant, and the efficiency of transcription of the variants pGLY2, 3, 4 and 5 
relative to pGLYl calculated. Figure 5.10. shows an autoradiograph o f  the 
products of a transcription assay using these 5' variants. The percentage efficiencies 
(the mean of duplicates from two independent assays) were as follows: pGLYl = 
100%, pGLY2 = 102%, pGLY3 = 51%, pGLY4 = 83% and pGLY5 = 78%. As 
well as differences in the amounts of transcript, variants appeared to produce 
slightly different patterns of precursors (see figure 5.10.). It has previously been 
reported that changes in the 5’ flank of tRNA genes can lead to the utilisation of 
alternative sites for the start of transcription and hence different sizes of tRNA 
precursor (Hofstetter et a l ., 1981; Hipskind and Clarkson, 1983).
1 2 6
Figure 5.9. Construction of pUC19 recombinants containing  
tRNAGIy gene variants.
The restriction sites indicated (Bam HI (B1 and B2), Mst I (M) Pvu II (P) and Stu I 
(St)) were used to construct the pUC19 recombinants pGLYl-pGLY5, with the 
variations shown in the 5' flank of the tRNAGIy gene. The inversion of the Bam 
HI fragment B ^ B 2  in pGLY3 is indicated (♦-). The tRNAGIy gene itself is 
represented by a solid box.
Figure 5.10. Autoradiograph of the transcription products from
tR N A ^ly gene variants.
The recombinants pGLYl-pGLY5 (see figure 5.9.) were used in in vitro 
transcription assays and the products analysed on a sequencing gel. The products 
for two different amounts of each recombinant (2 ng and 5 ng) are shown. Lanes
1-5 correspond to recombinants pGLYl-pGLY5.
2 ng 5 ng
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These results largely agree with previous reports, referred to in section 1.5.6., in 
that deleting DNA from the 5' flank of the gene and replacing it with unrelated 
vector DNA causes a slight reduction in transcription. This effect is not very 
marked, since in pGLY5 the entire 5' flank is replaced causing only a 22% decrease 
in transcripts. However, a more marked decrease in transcription was observed for 
pGLY3, in which part of the flanking sequence has been placed in the opposite 
orientation to the original. This raises the possibility that the 125 bp Bam  HI 
fragment involved may play a role in transcription complex formation.
5.6.2. Com petition assays
Since the 125 bp Bam HI fragment from the 5' flank of the tRNA^ly gene 
appeared to have an effect on transcription, a recombinant was constructed by 
subcloning this fragment into the Bam HI site of pUC19. This recombinant, termed 
pGLY5'F as it contained part of the tRNA^ly gene 5' flank, was used as a 
competitor in a series of transcription assays. Increasing amounts of the pGLY5'F 
recombinant (0-200 ng) were added to transcription assays containing 5 ng of 
pGLYl. (Adding equivalent amounts of pUC19 had previously been shown to 
have no effect on transcription). An autoradiograph of the transcription products 
from such assays is shown in figure 5.11.A. These products were quantified and 
the results are summarised in the graph shown in figure 5.1 l.B. The addition of 
pGLY5'F to the transcription assays does appear to interfere with the transcription 
of the tR N A d y  gene on pGLYl. The addition of 200 ng of pGLY5'F, 
representing an approximately 40-fold molar excess over the tRNAGly gene, was 
sufficient to reduce transcription to less than 10% of the original level. In 
subsequent experiments, the pGLY5'F construct was used as a competitor with the 
other tRNA genes from XHt363. Very similar results were obtained, implying that 
the fragment of tRNAGly gene 5' flanking sequence subcloned in pGLY5'F may 
be able to sequester some general tRNA transcription factor present in the HeLa cell 
extract.
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Figure 5.11. A utoradiograph of products of transcrip tion  of pG LY l 
in the presence of increasing am ounts of pG LY 5'F and analysis of 
com petition assays.
A Standard transcription assays of pGLYl (5 ng) were performed in the presence 
of 0-200 ng pGLY5'F competitor DNA (see section 5.6.2.). The transcription 
products, shown in duplicate, were separated on an 8% polyacrylamide gel.
B The amounts of [32P] labelled gene transcripts in cpm derived from transcription 
of pGLYl (5 ng) with 0, 10, 50, 100 and 200 ng of pGLY5'F competitor DNA are 
shown (+). The error bars indicate ± one standard deviation for four results 
(duplicates of each of two independent assays}
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5.6.3. Gel-shift and DNase I protection assays.
The results shown in section 5.6.2. suggest that the 125 bp Bam  HI fragment 
from the 5' flank of ?iHt363 may be able to associate with some factor or factors 
present in the crude HeLa cell extract used in the transcription assays. Two 19-mer 
oligonucleotides were designed in order to specifically amplify the 175 bp region 
immediately 5' of the tRNA^ly gene using the polymerase chain reaction (see 
section 2.5.15.1.). The oligonucleotides correspond to residues 328-346 of the 
upper (tRNA-like) strand and 502-484 of the lower strand of the nucleotide 
sequence shown in figure 3.6. and hence can be used to amplify a region which 
includes the 125 bp Bam HI fragment from the tRNA^ly gene 5’ flank. This 175 
bp amplified fragment was end-labelled at the 5' position of one strand with 
Y-[32P]-ATP as described in section 2.5.11.3. and incubated with the HeLa cell 
extract prior to use in gel shift and DNase I protection assays (see sections 2.5.17. 
and 2.5.18.). Figure 5.12. shows that a mobility shift does occur after incubation 
of the end-labelled fragment in the crude extract. As well as the free labelled DNA, 
two lower mobility bands can be seen on the autoradiograph. The intensity of these 
retarded bands increases with increasing protein concentration, and figure 5.12. 
also shows that the faster migrating of the two putative protein/DNA complexes 
appears after incubation with a lower concentration of protein from the crude 
extract. This smaller band also appears after a shorter incubation time with a given 
amount of extract (data not shown).
This pattern of bands would be consistent with that obtained from the sequential 
binding of two different proteins (or two molecules of the same protein) to the 
end-labelled restriction fragment. To assess the specificity of the interaction causing 
the gel shift, competition assays were performed. The competitor DNAs used were 
a specific competitor (the amplified 175 bp fragment from the 5’ flank of the 
tR N A Gly gene, unlabelled and used at up to 40-fold molar excess) and a 
non-specific competitor (a 141 bp Sau 3A fragment of pUC19, again unlabelled and 
used at up to 40-fold molar excess). Unexpectedly, the non-specific competitor 
DNA served to displace the end-labelled 175 bp amplified fragment from the 
protein/DNA complexes almost as well as the specific competitor at a 20- and 40- 
fold molar excess (data not shown). This finding would argue against a strong, 
specific association of the fragment from the t R N A ^ l y  gene 51 flank with a putative 
transcription factor or factors.
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F igure 5.12. A u to rad iograph  from  a gel shift assay of protein 
interaction with part of the tR N A ^Iy gene 5' flank.
Increasing amounts of a HeLa cell extract (0, 1.5, 3, 4.5, 6 and 7.5 |ig of protein) 
were incubated with a 175 bp PCR amplified fragment of t R N A ^ l y  gene 5' 
flanking DNA (see section 5.6.3.) end-labelled with 32p. The resulting gel shift 
pattern was analysed by electrophoresis on a 10% polyacrylamide gel. The 
positions of the free DNA (F) and of the putative protein-DNA complexes (1 and 2) 
are indicated.
In order to further investigate the possible binding of proteins in the HeLa cell 
extract to the 175 bp amplified fragment, DNase I protection (footprinting) assays 
were carried out as described in section 2.5.18. The pattern of DNase I digestion 
appeared to be identical for the free and the bound fractions of the 5 ' end-labelled 
175 bp fragment as shown in figure 5.13. for DNA labelled on the complementary 
strand of the tRNA^ly gene 5' flank. The same was true for DNA labelled at the 5' 
end of the opposite strand. Again this would suggest that the protein/DNA 
interaction may not be a strong one, since the binding of the protein(s) does not 
appear to give any significant DNase I protection to the DNA fragment.
5.6.4. The effect of the 5' flank of the tR N A ^Iy  gene on 
transcription of a second tRNA gene.
The recombinant pGLN2 was constructed by taking a 528 bp Pst l-M st I 
fragment from the recombinant pGLYl, comprising 502 bp of the t R N A ^ l y  gene 
5' flank and 26 bp of vector sequence, and subcloning it into pGLNl (see table
5.1.) digested with Pst I and Sma I, using the Pst I and Sma I sites from the 
multicloning site of pUC19. The net effect of these manipulations was to place the 
complete immediate 5' flank of the t R N A ^ l y  gene, corresponding to residues 1- 
502 in figure 3.6., 182 bp upstream of the coding sequence of the tRNAGln gene 
from pGLNl. The transcriptional efficiencies of pGLNl and pGLN2 were then 
compared by using a range of D N A  concentrations for the two recombinants in a 
series of transcription assays (see figure 5.14.). The transcription products derived 
from the two recombinants were quantified as described in section 2.5.16.3. and 
these results indicated that there was no significant difference between the 
transcriptional efficiencies of pGLNl and pGLN2.
5.7. Discussion.
5.7.1. The transcriptional efficiency of the tRNA genes from 
^.Ht363.
The in vitro transcription assays used in this study give reproducible and
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A 175 bp PCR amplified fragment of tRNA^ly gene 5' flanking DNA, end-labelled 
with 32P, was subjected to gel shift analysis after incubation with 1.5 pg of HeLa 
cell extract protein (see figure 5.12.). The bound (B) and free (F) fractions were 
eluted from a polyacrylamide gel and treated (as described in section 2.5.18.) with 
two different amounts of DNase I (1 pg and 2 pg) and the resulting DNA fragments 
resolved on a sequencing gel.
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Figure 5.14. Autoradiograph of transcripts from pGLNl and pGLN2.
Varying amounts, as shown, of recombinants pGLNl and pGLN2 (each containing 
the tRNA^ln gene fr0m kHt363 but differing in 5’ flanking sequence; see section
5.6.4.) were used as templates in standard duplicate transcription assays and the 
products electrophoresed on an 8% polyacrylamide gel. Lanes 1,2,5,6,9 and 10 = 
pGLNl products, lanes 3,4,7,8,11 and 12 = pGLN2 products.
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internally consistent results for each of the tRNA genes characterised from XHt363, 
agreeing well with previous experiments using the same system (Gonos, 1989; 
Gonos and Goddard, 1990c). However, this does not necessarily mean that the 
results accurately reflect the way that the genes are transcribed in vivo . It has been 
shown that tRNA genes are transcribed differently using different cell extracts 
(Raymond and Johnson, 1983; Johnson et a l ., 1984; Schaack and Soli, 1985; 
Drabkin and RajBhandry, 1985a andl985b; Gonos and Goddard, 1990c) and it is 
thought that transcription may be regulated by species-, tissue- or developmental 
stage-specific factors which may not be present in any given cell extract. It may 
therefore be dangerous to overstate the significance of in vitro transcription results. 
A considerable degree of difference was recorded in the maximum transcriptional 
efficiencies of the five tRNA genes from A,Ht363, although all of the genes yielded 
more than one transcript per gene in a one hour period, indicating that multiple 
rounds of transcription were occurring. Table 5.2. shows that a greater than 
five-fold difference was found in the numbers of transcripts per gene per hour 
between the least active gene in this system, coding for tRNA^ys, and the most 
active, coding for tRNA^ly. The high activity of the tRNA^ly gene in this system 
was interesting since Doran et a l ., (1988) had reported a low transcriptional activity 
for an identical human t R N A ^ l y  gene, with the same flanking sequences. It is 
noticable that the order of transcription rates (table 5.2.) follows the order of the 
tRNA genes on XHt363 from left to right (see figure 3.3.). Whether or not this is of 
any significance is doubtful. In any case the tRNA^ 11 gene (figures 3.3. and 3.8.) 
is transcribed on the opposite strand and therefore in the opposite direction from the 
other genes in the cluster.
Russo et a l ., (1987b) reported differences in the transcription of tRNA genes 
when their positions within a cluster were altered. No such experiments have been 
attempted for the genes from XHt363. The relative transcription rates for the four 
most closely spaced genes on the cluster remained the same when the genes were 
transcribed individually (section 5.4.). However, in the recombinants used the 
genes still retained at least 100 bp of 5' and 3’ flanking sequence. The fact that the 
same relative transcription rates were maintained may reflect the fact that the genes 
still have their original control regions, rather than being unaffected by their 
immediate genomic environment. It is possible that the differences seen in the 
transcriptional efficiencies of the tRNA genes from \Ht363 reflect differences in 
their internal promoter regions and not in the flanking sequences of the genes. This
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would explain why four of the tRNA genes maintained the same relative 
transcription rates when transcribed either separately or together from a single 
recombinant. The box B regions of the five genes are compared below with the 
consensus sequence for this part of the internal promoter. No comparison was 
attempted for the box A element since this region is less tightly conserved (see 
section 1.5.2.). Nucleotides in the box B elements of the tRNA genes from XHt363 
which differ from the consensus sequence are shown in bold type and underlined.
Box B consensus: GGTTCGANTCC
XHt363 tRNALys box B: GGTTCAAGTCC 
XHt363 tR N A G l n  boxB: AGTTCAA A Td
XHt363 tRNALeu box B: GGTTCGAATCC 
XHt363 tR N A ^g box B 
XHt363 t R N A d y  box B
GGTTCGAATCC
GGTTCGATTCC
The box B regions of the tRNALys and tRNAGln genes differ from the box B 
consensus sequence in one and three nucleotides respectively. These are the two 
tRNA genes from ^.Ht363 with the lowest transcriptional efficiencies (see table
5.2.) but there is probably no significant correlation of box B sequence with 
observed transcription rate. The tRNA^cu^ tRNA-^rg and t R N A ^ l y  genes have 
identical box B sequences but as table 5.2. shows the t R N A ^ l y  gene is transcribed 
with greater than two-fold efficiency when compared to either of the other genes. In 
contrast, the box B regions of the tRNALeu an(j tRNAGln genes differ in three 
positions but the genes have a very similar transcriptional efficiency in the in vitro 
transcription system used.
The spacing of boxes A and B in the tRNA^ 11 and tRNA-^g genes from the 
?iHt363 cluster (42 and 48 residues respectively) is larger than that found in the 
other tRNA genes because of the presence of a large variable arm in tRNA^ 11 and 
an intron in the tR N A ^S gene. However, these distances fall within the optimum 
range for transcription complex formation (34-53 nucleotides; see section 1.5.3.).
5.7.2. Processing of tRNA precursors.
The processing of tRNA precursors in a HeLa cell extract may not reflect the in
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vivo situation for similar general reasons to those discussed with reference to 
transcription in section 5.7.1. It has been shown that the optimum conditions for 
transcription may not be optimum for processing, and that optimum conditions for 
processing may differ in different systems (van Tol et al .,1987). The conditions 
used in the in vitro transcription system described in section 2.5.16.2. do not 
appear to be conducive to efficient processing. No significant accumulation of 
mature tRNA-sized products was observed for any of the tRNA genes from 
XHt363 with less than two hours re-incubation.
The tRN A ^S gene products from the in vitro transcription system did appear 
to be processed in that the sizes of discrete bands changed with increasing times of 
re-incubation in the HeLa cell extract (section 5.5.1.). The size changes observed 
were consistent with the pattern of processing described in section 5.5.1. although 
it should be stressed that no direct confirmation of the sequence of any of the 
transcripts generated in this study has been made. It is therefore not possible to say 
with certainty what is represented by any particular precursor tRNA. Hegg and 
Thurlow (1990) have shown that tRNAs may have residual secondary structures in 
denaturing 8M urea/TBE polyacrylamide gels, leading to the presence of variant 
minor bands. The sizes of tRNAs and tRNA precursors were determined in this 
study by comparison to single-stranded DNA fragments generated in a standard 
sequencing reaction (see section 2.5.14.3.). If the tRNAs and pre-tRNAs do 
maintain some secondary structure in the denaturing gels used then inaccuracies in 
size determination may have occurred.
5.7.3. The role of the 5' flank of the tR N A ^ ly  gene in the control of 
tran scrip tio n .
Transcription assays using constructs with changes in the flank of the 
tRNA^ly gene gave one potentially interesting result. The construct pGLY2 (table
5.1.) had a significantly higher transcription rate than construct pGLY3 which has 
the same amount of 5f flanking DNA. The only difference between the constructs is 
that a 125 bp Bam  HI fragment (spanning residues -21 to -145 relative to the 
tRNA^ly coding sequence) has been "turned around" in pGLY3 to the opposite 
orientation to that found in the original genorriic DNA. This change has a greater
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effect on transcription than the removal of the entire 5' flank of the gene and its 
replacement with unrelated DNA (see section 5.6.1.). It is possible that the region 
-21 to -145 of the 5' flank of this human tRNA^ly gene contains an element or 
elements involved in transcription complex formation or stability, and that the effect 
of these putative element(s) is dependent either on orientation relative to the coding 
sequence of the gene or on distance upstream of the gene.
Preliminary experiments to further investigate potential control elements in the 
5' flank of the tRNA^ly gene are described in sections 5.6.2., 5.6.3. and 5.6.4. If 
the 125 bp Bam  HI fragment reversed in pGLY3 is capable of binding to any 
transcription factors in the HeLa cell extract then it should be capable of competing 
for these factors with other tRNA genes. The results presented in figure 5.1 l.B 
show the effect of adding different amounts of pGLY5'F DNA to a transcription 
assay with a fixed amount (5 ng) of pGLYl DNA (see section 5.6.2.). pGLY5’F 
does appear to interfere with the transcription of the t R N A ^ l y  g e n e  on pGLYl, but 
only when in a 20-fold molar excess does the reduction equal that found in pGLY3. 
pGLY5'F appears to compete with the other tRNA genes from AHt363 to the same 
extent as it competes with the tRNA^ly gene (data not shown). The effect of 
pre-incubating pGLY5’F in the HeLa cell extract prior to adding the gene to be 
competed was tested, but the pre-incubation step did not appear to affect the results 
of the competition assays (data not shown).
These experiments suggest that if a control element is carried on the 125 bp Bam 
HI fragment from the t R N A ^ l y  gene 5f flank then firstly its effect is much greater 
in cis and secondly its effect in trans does not appear to be gene-specific. The 
tRN A dy 5 * flank was placed upstream of, and therefore in cis with, the tRNA^ln 
gene in the recombinant pGLN2 described in section 5.6.4., with no apparent effect 
on transcription. However, since the tRNAGln gene jn pGLN2 retains 163 bp of its 
immediate 5' flank it is likely that any control element placed 51 of this region 
would be too far upstream to affect the transcription of the gene.
Crude gel-shift and footprinting assays were used to attempt to establish 
whether the 175 bp amplified fragment from the 5' flank of the t R N A ^ l y  gene does 
associate with a protein or proteins in the HeLa cell extract (Section 5.6.3.). These 
experiments gave apparently conflicting results. Figure 5.12. shows that a mobility 
shift did occur when the end-labelled fragment was incubated in the HeLa cell 
extract. Despite this apparent evidence for protein binding, the autoradiograph in 
figure 5.13. shows that the bound fragment did not appear to be protected from
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DNase I digestion. A range of DNase I concentrations were used in protection 
assays but none gave evidence of any footprint. It may be that a protein/DNA 
association can cause a mobility shift without significantly protecting the DNA from 
DNase I, possibly because either the association is weak or the protein binds in 
such a way that still allows DNase I access to the DNA.
The major problem in proposing a model which can explain the differences 
observed in the transcription of the t R N A ^ l y  gene 5' flank variants lies in 
reconciling results which appear to be mutually contradictory. Experimental 
evidence indicates that part of the 5' flank can reduce transcriptional efficiency 
when inverted relative to the gene, and when used in competition assays, but can be 
entirely replaced by unrelated DNA without significantly reducing transcription. 
There is evidence that the 175 bp fragment from the 5' flank of the tRNA gene 
does bind to a protein or proteins in the HeLa cell extract, but this binding is 
insufficient to give any DNase I protection. A model consistent with the available 
data is given below.
The results presented in sections 5.6.2. and 5.6.3. would suggest that there 
may be an element (or elements) within the region between 21 and 145 bp upstream 
of the t R N A ^ l y  gene capable of binding a factor (or factors) which can influence 
either the rate of transcription complex formation or the stability of the transcription 
complex. The effect of this putative element depends on either its position relative to 
the coding sequence of the gene or its orientation relative to the gene (or a 
combination of both). The fact that the t R N A ^ l y  gene js the most transcriptionally 
active of all the genes tested in this study may reflect the presence of a 
positively-modulating element in its 5’ flank. If such an element exists, this would 
explain the ability of the recombinant pGLY5’F (which contains the relevant part of 
the 5' flank of the t R N A ^ l y  gene) to compete with other tR N A  genes in a 
transcription assay. When added in a large enough excess, pGLY5'F may be able 
to sequester a factor present in the HeLa cell extract which contributes to 
transcription, possibly interfering with nascent transcription complexes when used 
to compete with complete tR N A  genes. If this putative factor is absolutely essential 
for transcription it must be capable of binding alternative sequences since the entire 
5' flank of the tRNA^ly gene can be replaced with unrelated DNA without a large 
fall in transcription rate. The "loose” protein association with the 175 bp fragment 
from the 5' flank of the tRNA^ly gene suggested by preliminary footprinting 
experiments may be due to the putative factor being unable to bind tightly to the
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isolated fragment in the absence of any transcription complex.
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CHAPTER SIX
DISCUSSION.
In this chapter an overall analysis of the results presented in Chapters three, four 
and five will be given and suggestions made for future work to address questions 
raised by these results. The genomic organisation and in vitro expression of the 
tRNA genes investigated will be discussed in the light of current work in these areas.
6.1. Genomic organisation of the human tRNA genes from XHt363.
6.1.1. Nucleotide sequence analysis of the tRNA gene cluster from 
M It363.
Sequence analysis of part of the insert of the recombinant bacteriophage Xftt363 
revealed the presence of five human tRNA genes within a 7 kb region, representing 
the largest human tRNA gene cluster so far described. Four of the genes have 
identical coding sequences to human tRNA genes described previously (Roy et a l ., 
1982; Doran et a l ., 1988) and as discussed in sections 3.4. and 4.4. it appears that 
all five genes from XHt363 represent second copies of tRNA genes, of which four 
have been previously characterised in different genomic environments and the fifth is 
almost certainly present in a characterised cluster. The occurrence of tRNA genes in 
small clusters (defining a cluster in this sense as two or more genes within a few kb 
of each other) appears to be a common feature in eukaryotic genomes (see section
1.4.). As mentioned in section 3.4.2., the fact that a number of such clusters have 
been cloned may reflect the relative ease of their detection by hybridisation to a tRNA 
probe in comparison to dispersed genes, rather than being a real indication of the way 
in which most eukaryotic tRNA genes are organised. As yet, no particular pattern of 
distribution has emerged for tRNA genes in the genomes of higher eukaiyotes.
The nucleotide sequence data obtained in this study (Chapter three and Chapter
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four) was analysed using the program ANALYSEQ (Staden, 1986; see section 
2.5.14.). In addition to a tRNA gene search, the sequence data from XHt363 was 
examined for restriction endonuclease recognition sites, open reading frames, RNA 
polymerase m  gene conserved sequences, direct and inverted repeats and finally for 
the presence of consensus sequences characteristic of Alu repetetive elements (Kariya 
et a l ., 1987) which have been found in close proximity to several human tRNA 
genes (Chang et a l ., 1986; Arnold et a l ., 1986; Doran et a l ., 1987; Shortridge et 
a l ., 1989; Craig et a l ., 1989). Apart from the tRNA genes, no sequence motifs of 
especial interest were discovered, but parts of the insert did prove to be very G+C 
rich (see section 3.4.3.). The fact that some of the tRNA genes from XHt363, in 
particular the t R N A ^ l y  gene, are in such a G+C rich environment may have no 
significance for their expression. However, a recent report (Besser et a l ., 1990) 
suggests that the methylation status of CpG dinucleotides in a chicken tRNA^ys gene 
(either within the coding sequence or in the 5’ flank of the gene) can affect its 
transcription. The effect of methylation of CpG rich islands on the transcription of 
eukaryotic RNA polymerase II genes is well documented (for review see Bird, 
1986). The methylation status of genomic DNA can be investigated either by genomic 
sequencing (Church and Gilbert, 1984; Saluz and Jost, 1989) or by comparison of 
the patterns of hybridisation of a probe to genomic DNA cut with one or other of a 
pair of restriction enzymes with the same recognition site but different sensitivity to 
methylated nucleotides within that site (Bird, 1978; Bird and Southern, 1978). It may 
be appropriate to apply these methods to the genomic DNA represented in the insert 
of ^.Ht363 to investigate whether or not CpG dinucleotides in this region are 
methylated in vivo . The sequence data is available to construct oligonucleotides for 
use in genomic sequencing, and suitable restriction enzyme sites could be selected for 
the hybridisation approach. The effect of DNA methylation on in vitro transcription 
could also be investigated.
6.1.2. Comparison of the tRNA genes from >.Ht363 with members of 
the same human tRNA gene families cloned on different genomic 
fragments.
The results presented in Chapters three and four show that the tRNA genes
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present on ^Ht363 are apparently second copies of tRNA genes which had 
previously been characterised. A comparison of the restriction maps of the 
recombinants involved, XHt4 and AHt9 (Buckland et a l ., 1983; Doran et a l ., 1988), 
with that of ?iHt363 is discussed in section 3.4.1. and an investigation into the 
possibility of rearrangements having occurred within the insert of XHt363 is 
described in Chapter four. The overall conclusions from these results were that the 
insert of ?iHt363 represents a different region of genomic DNA from those present in 
the inserts of XHt4 and XHt9, and that no apparent rearrangement had occurred. It 
was also shown in a collaborative study (Morrison et a l ., 1991; see section 4.4.3.) 
that probes from the tRNA gene cluster found on ?iHt363 could be located solely to 
one site on the short arm of chromosome 17 (17pl2-pl3.1) by in situ hybridisation. 
This chromosomal assignment has been confirmed and refined (using hybridisation 
of a probe from XHt363 to a somatic cell hybrid panel) to 17pl3.100-17pl3.105 (Dr.
D. H. Ledbetter, personal communication).This result raises the possibility that 
different copies of this cluster of five tRNA genes are themselves clustered in the 
genome. A small tRNA gene cluster in the rat is contained within a 13.5 kb repeated 
unit which is thought to be arranged as ten tandem repeats (Sekiya et a l ., 1981; 
Shibuya et a l ., 1982 and 1985) and a human tRNA^sn gene family is thought to be 
located on large (180 kb) repeat units, organised in tandem arrays (Buckland, 1989). 
The localisation of the tRNA gene cluster from ^Ht363 to a single chromosomal site 
would be consistent with a genomic arrangement as tandem repeats of the two to three 
copies of the cluster. This could be investigated using hybridisations of probes from 
the tRNA gene cluster to large genomic DNA fragments generated by restriction 
endonucleases with few sites in human genomic DNA. The restriction endonuclease 
Not I, which has a unique site in the insert of XHt363 might be particularly suitable 
for this purpose since, as figure 4.1. shows, a probe containing a tRNA gene from 
the cluster hybridises to high molecular weight fragments in a Bgl II/Not I genomic 
digest. Pulse field gel electrophoresis would be the most suitable method of resolving 
large fragments of genomic DNA. If a tandem arrangement of the cluster does exist 
then it should be possible to use the hybridisation of a probe derived from within the 
tRNA gene cluster to partial digests of genomic DNA to demonstrate that the 
hybridising bands consist of multiples of the repeat unit size.
As described in section 3.4.1., the restriction maps of A,Ht363, XHt4 and >Ht9 
differ outwith the areas which contain the tRNA genes (see figure 3.11.). By a 
combination of cross-hybridisation experiments, fine restriction mapping and finally
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nucleotide sequence determination it should be possible to determine the nature of the 
DNA at the boundaries of the regions of similarity. The sequences found in these 
regions might give some idea as to the mechanism behind the evolution of different 
copies of the tRNA gene cluster. If the different copies arose through duplication of 
an ancestral cluster the extent of the accumulation of neutral base changes in the 
regions surrounding the tRNA genes would give an indication of the evolutionary 
timing of the duplication event. It has been suggested that many human tRNA genes 
arose by RNA-mediated transposition events and represent functional retrogenes 
(McBride et a l ., 1989). If the tRNA genes found on XHt363 were retroposons then it 
would be expected that target site reduplications would be found to flank the tRNA 
genes.
The in situ hybridisation work referred to above (Morrison et a l ., 1991) 
localised probes containing tRNA genes from XHt363 to a single chromosomal site. 
This technique could be used to map other restriction fragments derived from the 
inserts of XHt363, XHt4 and XHt9 which either come from wholly outside the 
regions of similarity in the restriction maps or span the areas covering divergence 
points. If any of these probes proved to hybridise to chromosomal sites apart from 
17pl3.100-17pl3.105 it would suggest that the organisation of the tRNA gene 
cluster may be more complex than a tandem repeat.
6.1.3. Copy numbers and organisation of the tRNA gene families 
represented on XHt363.
Each of the tRNA genes found on XHt363 appears to belong to a multicopy gene 
family with members occurring in different genomic environments (see sections
4.2.1. and 4.2.2.). This pattern, or lack of pattern of organisation seems to be the 
general rule for human tRNA genes in common with other eukaryotes; most 
characterised human tRNA gene families have copy numbers of the order of 10-20 
per haploid genome (Arnold et a l ., 1986; Krupp et a l ., 1988; Zasloff and Santos, 
1980; Gonos and Goddard, 1990a). The part of the tRNA cluster found on both 
3-Ht363 and JlHt4 containing the tRNALys, tRNA<JIn, tRNALeu and tRNAArS 
genes has a copy number of 2-3 per haploid genome as determined by genomic 
hybridisations (results shown in section 4.2.3.). The copy number of the genomic
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fragment containing the t R N A ^ l y  gene common to X,Ht363 and ^Ht9 was not 
determined. The problem of cross-hybridisation of the probe from ^H t363, 
presumably to other members of the tRNA^ly gene family were described in sections
4.2.3. and 4.4.2. If such cross-hybridisation occurs it may be an indication of 
homologies in the flanking regions of different members of the t R N A ^ l y  gene 
family.
The tRNA^rg gene from XHt363 and its gene family are of particular interest 
since no tRNA-Arg gene from any source and only two other human tRNA gene 
families had previously been shown to possess introns. It should be noted that as 
discussed in section 3.4.2. this tRNA gene hybridises poorly to a tRNA probe, 
suggesting that the lack of characterised tRNA genes with introns may be due in part 
to technical difficulties in their cloning rather than reflecting their actual representation 
in the genome. It is interesting that of the three human tRNA gene families shown to 
have introns, two were characterised using methods that did not directly involve 
hybridisation (this study and Green et a l ., 1990) and the third, for tRNA^yr was 
isolated using a Xenopus laevis tRNA^yr gene probe which itself contained an 
intron (MacPherson and Roy, 1986).
The presence of an intron in the tRNA^rg gene from AHt363 did not appear to 
affect its in vitro transcription and the precursor tRNAs produced by the gene were 
processed to a mature tRNA sized product (see sections 5.3. and 5.5.1.). The role of 
introns in tRNA genes is uncertain except for the specific case of the intron of 
tRNA^yr genes (see section 1.5.5.). It has been suggested that the lack of introns in 
most higher eukaryote tRNA genes could be due to the origin of multi-gene families 
by RNA-mediated transposition. Those introns still present in higher eukaryote tRNA 
genes could represent evolutionary relics (McBride et a l ., 1989). However, there is 
no specific evidence to support this speculation.
6.1.4. Applications of the PCR in characterising human tRNA genes.
The sequences of genomic copies of the tR N A ^g gene family were determined 
as described in section 4.3.2. and the sequencing artifacts from templates generated 
by asymmetric PCR (figure 4.7.) were also briefly mentioned. The pattern of 
"artifact” bands outside the coding region of the gene is not uniform; as can be seen in
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figure 4.7. regions of apparently readable sequence are interspersed with regions of 
strong compressions. It is uncertain whether these observations have any real 
significance. The "artifact" sequence seen outside the coding region did not appear to 
correspond to any of the flanking regions of the tR N A ^g gene from XHt363 but as 
figure 4.7. shows the sequence data obtained from this part of the autoradiograph is 
ambiguous, in contrast to that corresponding to the coding sequence of the tRNA^rg 
genes. Since the templates for sequencing were generated by PCR amplification, only 
the region between the primers, in this case the coding region of the tRNA-^S gene 
should be present to be sequenced. When the amplified DNA from aysmmetric PCR 
was analysed by agarose gel electrophoresis a number of faint bands were visible in 
addition to one strong band, which presumably corresponded to the specifically 
amplified single-stranded DNA product. It may be that the sequencing artifacts seen 
could have been avoided by purifying the major band from an agarose gel prior to 
sequencing. The conditions used for the asymmetric PCR (see section 2.5.15.2.) are 
prone to produce artifacts during amplification because of the large number of cycles 
involved (55 as opposed to 25-30 for a standard PCR amplification).
The cloning of two human tRNA^ln genes using the PCR was described in 
section 4.3.3. These genes were isolated as a result of a chance observation that 
primers specific for the tRNA^ln gene from ^Ht363 amplified two fragments of 
human genomic DNA rather than the one fragment expected. It may be that the use of 
tRNA gene-specific primers on genomic DNA could prove to be a rapid method of 
cloning tRNA genes where two isoacceptors are sufficiently close to each other in the 
genome, as in the case of the tRNA^ln genes mentioned above. The fact that some 
tRNA genes are clustered in the human genome might encourage such experiments. 
As Green et a l ., (1990) pointed out, if two members of a tRNA gene family in close 
proximity in the genome lay in opposite orientations to each other then one primer 
would suffice to amplify the genomic fragment containing the genes, either the 5' or 
the 3' specific primer depending on the orientation of the genes. This method could 
be extended by using combinations of primers specific for different tRNA genes to 
attempt to amplify human genomic DNA fragments containing these genes. Recent 
work in our laboratory (A. Alloueche and J.P. Goddard, unpublished results) 
suggests that this approach might prove viable.
The use of the PCR as mentioned above is essentially a random method for 
cloning new tRNA genes, completely dependent on there being suitable combinations 
of genes close enough together to be amplified. A more systematic method for
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potentially characterising all of the members of a human tRNA gene family would be 
to use inverse PCR. This technique can be used to amplify the regions flanking a 
known DNA sequence. The basic method (Ochman et a l ., 1990) involves the 
digestion of target DNA with restriction enzymes and circularisation of the cleavage 
products to yield molecules that can act as templates for primers orientated in the 
opposite way to those normally employed for the PCR. Specifically, human genomic 
DNA would be digested with a restriction enzyme known to have no sites in a 
particular tRNA gene, and the intramolecularly ligated products subjected to an 
amplification reaction using tRNA gene-specific primers orientated so that extension 
proceeded outwards from the coding region of the gene. Restriction enzymes which 
cut human genomic DNA frequently would be the most suitable for this purpose since 
smaller target sequences allow more efficient amplification using the PCR. Different 
members of a tRNA gene family, in different genomic environments, would give rise 
to amplified fragments with sizes depending on the distance between the nearest 
flanking sites in the genome for the restriction enzyme used to cleave the genomic 
DNA. The net result would be a population of amplified fragments containing the 
immediate 5' and 3' flanking regions of all of the members of one tRNA gene family. 
The tRNA genes themselves could be isolated using the PCR once sequence data had 
been obtained from the flanking regions. The cloning of complete gene families 
would allow comparisons of flanking sequences and the possible correlation of such 
sequences with the in vivo and in vitro expression of the genes, in particular with 
tissue specific expression in vivo , perhaps by using the primer extension method 
described by Schmutzler and Gross (1990). The genomic distribution of the tRNA 
gene family could also be ascertained by the use of in situ hybridisation.
6.2. In  vitro expression of the tRNA genes from  A,Ht363.
6.2.1. In  vitro transcrip tion  assays.
The in vitro transcription experiments detailed in Chapter five of this study gave 
internally consistent results which were in broad agreement with previous studies 
using this particular system (Gonos, 1989; Gonos and Goddard, 1990c). However,
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the fact that the tRNA genes from XHt363 were transcriptionally active in vitro does 
not necessarily give an accurate reflection of their transcription in vivo and in 
particular does not address the question of tissue specific expression. The same is 
true for a heterologous in vivo transcription system such as Xenopus oocyte 
microinjection. It is possible to determine the levels of in vivo transcription of 
specific tRNA genes against the background of transcripts from other members of the 
same tRNA gene family. The primer extension method was used by Schmutzler and 
Gross, (1990) to study in vivo expression of human tRNA^al genes. However, this 
technique depends on different members of a gene family having a different 
immediate 5' flanking sequence in order to distinguish their primary transcripts. It 
would be interesting to see if the differences in transcriptional efficiency of the tRNA 
genes recorded in section 5.3. also occur in vivo , and if the same pattern exists in 
different tissues.
The limitations of an in vitro assay in the determination of transcription may also 
apply to the processing of transcripts in the system used, in that the results found in 
an artificial system may not give an accurate picture of what actually occurs in the 
whole organism. The precise nature of processing intermediates was not determined 
in this study so the processing pathway proposed for the tR N A ^S gene transcripts in 
section 5.5.1. was based purely on the changes in size of the processing 
intermediates. One method of specifically identifying intermediates would be to use 
hybridisation of oligonucleotides to tRNA precursor molecules isolated from a 
polyacrylamide gel. The synthesis of several different oligonucleotides specific for 
different parts of the precursor should allow rapid identification of processing 
intermediates, either through hybridisation or the primer extension method. 
Oligonucleotide primers have also been used to identify in vivo processing 
intermediates and splice junctions via PCR amplification (Delp et a l ., 1991).
In the in vitro system used in this study, the four most tightly grouped tRNA 
genes cloned from the cluster showed the same relative transcription rates as separate 
genes as when transcribed together on a cloned restriction fragment from ^Ht363 (see 
section 5.4.). It might be expected that closeiy spaced tRNA genes in a cluster will 
compete for transcription factors in vivo . Since the internal promoters of tRNA genes 
are highly conserved it is probable that elements in the gene flanking sequences will 
be important if such competition occurs. When the separate tRNA genes from 
^.Ht363 were used in transcription assays they still had the same 5' and 3' flanking 
sequences as in the original cluster, spanning at least 1 0 0  residues upstream and at
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least 60 downstream from the coding sequence. Because the immediate flanking 
sequences of the genes are the same even when the tRNA genes are taken out of the 
cluster, elements affecting transcriptional differences between the genes may still be 
present, explaining the maintenance of the relative transcriptional efficiencies.
It is not known whether there is any evolutionary or functional significance in the 
occurrence of tRNA gene clusters. It may be that clusters arose through duplication of 
an ancestral tRNA gene followed by sequence divergence. Alternatively, since 
retroposons have a tendancy to integrate into sites where other retroposons occur 
(Rogers, 1985; Weiner et a l ., 1986) tRNA gene clusters may have arisen through 
several retroposition events involving different genes. It is also possible that tRNA 
gene clusters are selectively favoured because a group of genes together in the 
genome can sequester transcription factors more efficiently in vivo .
6.2.2. The role of the 5' flank of the tRNA^ly gene from >.Ht363.
The experiments described in section 5.6. did not give a straightforward picture of 
the role of the 5' flanking sequence in transcription of the t R N A ^ l y  gene from 
XHt363. Several lines of evidence pointed towards part of this region being involved 
in controlling the transcription of the t R N A ^ l y  gene. The inversion of a 125 bp Bam 
HI fragment from the flank of the gene significantly reduces transcription, and this 
isolated fragment has been shown to compete, albeit not strongly, with other tRNA 
genes in a transcription assay. A larger region (175 bp, including the 125 bp Bam HI 
fragment) of the immediate 5' flank of the t R N A ^ l y  gene appears to bind to a protein 
or proteins in the HeLa cell extract used for transcription assays (see sections
5.6.3.). However, it is difficult to present a model which satisfactorily explains all of 
the results obtained. The 5' flank of the t R N A ^ l y  gene could be completely replaced 
with unrelated DNA (in recombinant pGLY5) without this having a large effect on 
transcription (see section 5.6.1.) and no footprint was observed when the 175 bp 
fragment of the t R N A ^ l y  gene 5' flank was used in DNasel protection experiments 
(see section 5.6.3.). In addition, the isolated Bam HI fragment from the tRNA^ly 
gene flank only competed significantly with tRNA genes in a transcription assay 
when used in a considerable molar excess (a 2 0 -fold molar excess was needed to 
cause the same reduction in transcription of the t R N A ^ l y  gene in a competition assay
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as that observed in a recombinant (pGLY3) with the 125 bp Bam HI fragment 
inverted).
The problem of relating the results of in vitro experiments to the actual situation in 
vivo has already been referred to several times in this chapter. Such problems may 
apply particularly to investigations into the role of flanking sequences in the control of 
tRNA gene expression since if regions outwith the gene sequence are involved in the 
modulation of transcription it is likely that in some cases the effect will be 
tissue-specific. Tissue-specific factors involved in the transcription of a particular 
tRNA gene might not be present in an in vitro transcription assay depending on the 
source of the cell-free extract used. However, the HeLa cell extract used in this study 
does appear to contain proteins that can associate with part of the t R N A ^ l y  gene 5' 
flank.
In one set of experiments, described in section 5.6.4., 502 bp of the 5' flank of 
the t R N A ^ l y  gene from XHt363 (from the Pvu II site to the residue immediately 5' of 
the coding sequence of the gene; see figure 5.9.) was placed in the 5* flank of the 
tRNA^ln gene fx0m XHt363 in the recombinant pGLN2. This recombinant showed 
no difference in transcriptional efficiency from an unaltered tRNA^ln gene in the 
recombinant pGLNl (see table 5.1.). However, pGLN2 retained 163 bp of the 
original immediate 5' flanking sequence of the tRNA^ln gene, so even if control 
elements are found in the tRNA^ly 5' flanking DNA they might have no effect when 
placed at this distance from a tRNA gene. More meaningful experiments would 
involve the complete replacement of the 5' flank of one tRNA gene with that of 
another. In the absence of convenient restriction sites such recombinants could be 
constructed by using the PCR to amplify the 5’ flanking region of a tRNA gene, and 
cloning the resulting blunt ended fragments into the nearest suitable restriction site to 
the 5' end of another tRNA gene. Recombinants constructed in such a way could then 
be used in in vitro transcription assays. If such an approach were used for the tRNA 
genes in the cluster on ^Ht363 it should be possible to determine whether the 
observed differences in transcriptional efficiencies were caused by elements in the 5' 
flanks of the tRNA genes. The same approach could be used to look for control 
elements in the 3' flanking regions of the same genes.
151
Abelson, J. (1979) Annu. Rev. Biochem. 48, 1035-1069.
Adams, R.L.P. (1980) Cell Culture for Biochemists. Elsevier/N.Holland 
Biomedical Press.
Adams, R.L.P., Knowler, J.T. and Leader, D.P. (1986) The Biochemistry of the 
Nucleic acids. Chapman and Hall, London.
Adeniyi-Jones, S., Romeo, P.H. and Zasloff, M. (1984) Nucleic Acids Res. 12, 
1101-1115.
Allison, D.S., Goh, S.H. and Hall, B.D. (1983) Cell 34, 655-664.
Allison, D.S. and Hall, B.D. (1985) EMBO J. 4, 2657-2664.
Amstutz, H., Munz, P., Heyer, W.D., Leupold, U. and Kohli, J. (1985) Cell 40, 
879-886.
Arnold, G.J., Schmutzler, C., Thomann, U., Toll, H.V. and Gross, H.J. (1986) 
Gene 44, 287-297.
Arnold, G.J. and Gross, H J. (1987) Gene 51, 237-246.
Arnold, G.J., Schmutzler, C. and Gross, H.J. (1988) DNA 7, 87-97.
Atkinson, T. and Smith, M. (1984) in Oligonucleotides Synthesis, a Practical 
Approach, pp. 35-81, Gait,M.J.(ed.), I.R.L. Press.
Baker, R.E. and Hall, B.D. (1984) EMBO J. 3, 2793-2800.
Baker, R.E., Gabrielsen, O. and Hall, B.D. (1986) J. Biol. Chem. 261, 
5275-5282.
Baker, R.E., Hall, B.D., Camier, S. and Sentenac, A. (1987) Proc. Nat. Acad. Sci.
U.S.A. 84, 8763-8767.
Baldi, M.I., Mattocia, E., Ciafre, S., Attardi, D.G. and Tocchini-Valentini, G.P.
(1986) Cell 47, 965-971.
Bartholomew, B., Kassavetis, G.A., Braun, B.R. and Geiduschek, E.P. (1990) 
EMBOJ. 9, 2197-2205.
Besser, D., Gotz, F., Schulze-Forster, K., Wagner, H., Kroger, H. and Simon, D.
(1990) FEBS Lett. 269,358-362.
Bieker, J.J., Martin, P.L. and Roeder, R.G. (1985) Cell 40, 119-127.
1 5 2
Bird, A.P. (1978) J. Mol. B io l 118, 49-60.
Bird, A.P. (1986) Nature 321, 209-213.
Bird, A.P. and Southern, E.M. (1978) / .  M ol B io l 118, 27-47.
Bogenhagen, D.F., Sakonju, S. and Brown, D.D. (1980) Cell 19, 27-35.
Bogenhagen, D.F., Wormington, W.M. and Brown, D.D. (1982) Cell 28, 
413-421.
Bogenhagen, D.F. (1985) J. B io l Chem. 260, 6466-6471.
Bothwell, A. (1990) in Methods for Cloning and Analysis of Eukaryotic Genes, pp. 
177-179, Bothwell, A., Yancopoulos, G.D. and Alt, F.W. (eds.), Jones and 
Bartlett, Boston.
Boyd, E., Theriault, A., Goddard, J.P., Kalaitsidaki, M., Spathas, D.H. and 
Connor, J.M., (1989) Hum. Genet. 81, 153-156.
Bradford, M.M. (1976) A nal Biochem. 72, 248-254.
Brodeur, G.M., Sandameyer, S.B. and Olson, M.W. (1983) Proc. Nat. Acad. Sci. 
U.S.A. 80, 3292-3296.
Brown, D.D. (1984) Cell 37, 359-365.
Buckland, R.A., Cooke, H.J., Roy, K.L., Dahlberg, J.E. and Lund, E. (1983) 
Gene 22, 211-217.
Buckland, R.A. (1989) Am. J. Hum. Genet. 45, 283-295.
Burke, D.J., Schaak, J., Sharp, S., Soli, D., (1980) J. Biol. Chem. 258, 
15224-15231.
Burke, D.J. and Soil, D. (1985) J. Biol. Chem. 260, 816-823.
Camier, S., Gabriel sen, O., Baker, R.E. and Sentenac, A. (1985) EMBO J. 4, 
491-500.
Camier, S. Baker, R.E. and Sentenac, A. (1990) Nucleic Acids Res. 18, 
4571-4578.
Carey, M.F., Gerrard, S.P. and Cozzarelli, N.R. (1986) J. Biol. Chem. 261, 
4309-4317.
Carrara, G., Di Segni, G., Otsuka, A. and Tocchini-Valentini, G.P. (1981) Cell 
27, 371-379.
Castagnoli, L., Ciliberto, G. and Cortese, R. (1982) Nucleic Acids Res. 10, 
4135-4145.
Chang, Y.N., Pirtle, I.L. and Pirtle, R.M. (1986) Gene 48, 165-174.
1 5 3
Choffat, Y., Suter, B. Behra, R. and Kubli, E. (1988) Mol. Cell. Biol. 8, 
3332-3337.
Church, G.M. and Gilbert, W. (1984) Proc. Nat. Acad. Sci. U.S.A. 81, 
1991-1995.
Ciliberto, G., Traboni, C. and Cortese, R. (1982) Proc. Nat. Acad. Sci. U.SA. 
79, 1921-1925.
Ciliberto, G., Castagnoli, L. and Cortese, R. (1983a) Curr. Topics Dev. Biol. 18, 
59-87.
Ciliberto, G., Costanzo, R.F., Dente, L. and Cortese, R. (1983b) Cell 32, 
725-733.
Clark, B.F.C. and Klug, A. (1975) Proc. 10th FEBS meeting, Paris, 183.
Clarkson, S.G. and Kurer, V. (1976) Cell 8, 183-195.
Clarkson, S.G., Kurer, V. and Smith, H.O. (1978) Cell 14, 713-724.
Clarkson, S.G. (1983) in Eukaryotic genes: their structure, activity and regulation. 
pp 239-261, Maclean, N., Gregory, S.P. and Flavell R.A. (eds.), 
Butterworths Press, London.
Cooley, L., Schaack, J., Burke, D.J., Thomas, B. and Soil, D. (1984) Mol. Cell. 
Biol. 4, 2714-2722.
Craig, L.C., Wang, L.P., Lee, M.M., Pirtle, I.L. and Pirtle, R.M. (1989) DNA 8, 
457-471.
Cribbs, D.L., Leung, J., Newton, C.H., Hayashi, S., Miller, R.C. and Tener, 
G.M. (1987) J. Mol. Biol. 197, 397-404.
Dagert, M. and Erlich, S.D. (1979) Gene 6, 23-28.
De Franco, R., Schmidt, O. and Soil, D. (1980) Proc. Nat. Acad. Sci. U.SA. 77, 
3365-3368.
De Franco, D., Sharp, S. and Soil, D. (1981) J. Biol. Chem. 256, 12424-12429. 
De Robertis, E.M. and Olson, M.V. (1979) Nature 278, 137-143.
De Robertis, E.M., Black, P. and Nishikura, K. (1981) Cell 23, 89-93.
Dean, N. and Berk, A.J. (1987) Nucleic Acids Res. 15, 9895-9907.
Dean, N. and Berk, A.J. (1988) Mol. Cell. Biol. 8, 3017-3025.
Del Rey, F.J., Donahue, T.F. and Fink, G.R. (1982) Proc. Nat. Acad. Sci. U.SA. 
79, 4138-4142.
Delp, G., Igloi, G.L. and Kossel, H. (1991) Nucleic Acids Res. 19, 713-716.
154
Deutscher, M.P. (1984) Crit. Rev. Biochem. 17, 45-71.
Dingermann, T., Burke, D.J., Sharp, S., Schaack, J. and Soli, D. (1982) J. Biol.
Chem. 257, 14738-14744.
Dingermann, T., Sharp, S., Schaack, J. and Soil, D. (1983) / .  Biol. Chem. 258, 
10395-10402.
Dingermann, T. and Nerke, K. (1987) Anal. Biochem. 162, 466-475.
Doering, J.L., Jelachich, M.L. and Hanlin, K.M. (1982) FEBS Lett. 146, 47-51. 
Doran, J.L., Wei, X. and Roy, K.L. (1987) Gene 56, 231-243.
Doran, J.L., Bingle, W.H. and Roy, K.L. (1988) Gene 65, 329-336.
Drabkin, H.J. and RajBhandary, U.L. (1985a) J. Biol. Chem. 260, 5588-5595. 
Drabkin, H.J. and RajBhandary, U.L. (1985b) J. Biol. Chem. 260, 5596-5602. 
Eigel, A. and Feldmann, H. (1982) EMBO J. 10, 1245-1250.
Engelke, D.R., Ng, S.Y., Shastry, B.S. and Roeder, R.G. (1980) Cell 19, 
717-728.
Fabrizio, P., Coppo, A., Fruscoloni, P., Benedetti, P., Di Segni, G. and 
Tocchini-Valentini, G.P. (1987) Proc. Nat. Acad. Sci. U .SA. 84, 
8763-8767.
Feinberg, A.R. and Vogelstein, B. (1983) Anal. Biochem. 132, 6-13.
Feinberg, A.R. and Vogelstein, B. (1984) Anal. Biochem. 137, 266-267.
Folk, W.R. and Hofstetter, H. (1983) Cell 33, 585-593.
Folk, W.R. (1988) Genes and Development 2, 373-375.
Fostel, J., Narayanswani, S., Hankalo, B., Clarkson, S.G. and Pardlk, M.L.
(1984) Chromosoma 90, 254-260.
Fuhrman, S.A., Engelke, D.R. and Geiduschek, E.P. (1984) J. Biol. Chem. 259, 
1934-1943.
Gabrielsen, O.S. and Oyen, T.B. (1987) Nucleic Acids Res. 15, 5699-5713. 
Gabrielsen, O.S., Homes, E., Korsnes, L., Ruet, A. and Oyen, T.B. (1989a) 
Nucleic Acids Res. 17, 6253-6267.
Gabrielsen, O.S., Marzouki, N., Ruet, A., Sentenac, A. and Fromageot, P.
(1989b) J. Biol. Chem. 264, 7505-7511.
Gall, J.G. and Pardue, M.L. (1969) Proc. Nat. Acad. Sci. U.SA. 63, 378-382. 
Galli, G., Hofstetter, H. and Bimstiel, M.L. (1981) Nature 294, 626-631. 
Gamulin, V., Mao, J., Appel, B., Smith, M.S., Yamao, F. and Soil, D. (1983)
1 5 5
Nucleic Acids Res. 11, 8537-8546.
Garber, R.L. and Gage, L.P. (1979) Cell 18, 817-828.
Geiduschek, E.P. and Tocchini-Valentini, G.P. (1988) Annu. Rev. Biochem. 57, 
873-914.
Gibson, T.J. (1984) Ph.D. Thesis, Cambridge University, England.
Glew, L., Lo, R., Reece, T., Nichols, M., Soli, D. and Bell, J. (1986) Gene 44, 
307-314.
Goddard, J.P., Squire, M., Bienz, M. and Smith, J.D. (1983) Nucleic Acids Res. 
11, 2551-2561.
Gonos, E.S. (1989) Ph.D. Thesis, Glasgow University, Scotland.
Gonos, E.S. and Goddard, J.P. (1990a) FEBS Lett. 276, 138-142.
Gonos, E.S. and Goddard, J.P. (1990b) Nucleic Acids Res. 18, 6705.
Gonos, E.S. and Goddard, J.P. (1990c) Biochem. J. 272, 797-803.
Gottesfeld, J. and Bloomer, L.S. (1982) Cell 28, 781-791.
Gouilloud, E. and Clarkson, S.G. (1986) J. Biol. Chem. 261, 486-494.
Green, C.J., Sohel, I. and Void, B.S. (1990) / .  Biol. Chem. 265, 12139-12142. 
Guilfoyle, R. and Weinmann, R. (1981) Proc. Nat. Acad. Sci. U .SA.1% , 
3378-3382.
Gupta, C., Roe, B.A. and Randerath, K. (1979) Nucleic Acids Res. 7, 959-970. 
Hall, B.J., Clarkson, S.G. and Tocchini-Valentini, G. (1982) Cell 29, 3-5.
Han, J.H. and Harding, J.D. (1982) Nucleic Acids Res. 10, 4891-4890.
Han, J.H., Rooney, R.J. and Harding, J.D. (1984) Gene 28, 249-255.
Hatfield, D., Lee, B.J., Hampton, L. and Diamond, A.M. (1991) Nucleic Acids 
Res. 19,939-943.
Hatlen, L. and Attardi, G. (1971) J. Mol. Biol. 56, 535-553.
Hauber, J., Stucka, R., Krieg, R. and Feldmann, H. (1988) Nucleic Acids Res. 
16, 10623-10634.
Hegg, L.A. and Thurlow, D.L. (1990) Nucleic Acids Res. 18, 2993-3000. 
Hershey, N.D. and Davidson, N. (1980) Nucleic Acids Res. 8, 4899-4910. 
Himeno, H., Tsunemi, H., Ueda, T., Watanabe, K. and Shimizu, M. (1990) 
Nucleic Acids Res. 18, 6815-6819.
Hipskind, R.A. and Clarkson, S.G. (1983) Cell 34, 881-890.
Hoagland, M.B., Stephenson, M.L., Scott, J.F., Hecht, L.I. and Zamecnik, P.C.
1 5 6
(1958) J. Biol. Chem. 231, 241-257.
Hoe, K.L., Hong, H.J., Yoo, S.H. and Yoo, O.J. (1987) Nucleic Acids Res. 15, 
10045.
Hofstetter, H., Kressmann, A. and Bimstiel, M.L. (1981) Cell 24, 573-585. 
Hohn, B. (1979) Methods Enzymol. 68, 299-309.
Holley, R.W., Apgar, J., Evesett, G.A., Madison, J.T., Marquisee, M., Marill, 
S.H., Penswick, J.R. and Zamir, A. (1965) Science 147, 1462-1465. 
Holmes, D.S. and Quigley, M. (1981) Anal. Biochem. 114, 193-197.
Hong, H.J., Yoo, S.H. and Yoo, O.J. (1987) Nucleic Acids Res. 15, 4987. 
Horvath, D. and Spiegelman, G.B. (1988) Nucleic Acids Res. 16, 2585-2599. 
Hosbach, H.A., Silberklang, M. and Me Carthy, B.J. (1980) Cell 21, 169-178. 
Hou, Y.M. and Schimmel, P. (1988) Nature 333, 140-145.
Hovemann, B., Sharp, S., Yamada, H. and Soil, D. (1980) Cell 19, 889-895.
Hu, J.C., Lund, E. and Dahlberg, J.E. (1983) Nucleic Acids Res. 11, 4809-4821. 
Huibregtse, J.M., Evans, C.F. and Engelke, D.R. (1987) Mol. Cell. Biol. 7, 
3212-3220.
Innes, M.A. and Gelfand, D.H. (1990) in PCR Protocols. A Guide to Methods and 
Applications, pp. 3-12, Innes, M.A., Gelfand, D.H., Sninsky, J.J. and 
White, T.J. (eds), Academic Press, California.
Jacob, S.T. (1973) Prog. Nucleic Acids Res. Mol. Biol. 13, 93-126.
Johnson, D.L. and Wilson, S.L. (1989) Mol. Cell. Biol. 9, 2018-2024.
Johnson, J.D. and Raymond, G.J. (1984) J. Biol. Chem. 259, 5990-5994. 
Johnson, J.D., Raymond, G.J. and De Parasis, J. (1984) Mol. Gen. Genet. 197, 
55-61.
Johnson, P.F. and Abelson, J. (1983) Nature 302, 681-687.
Kariya, Y., Kato, K., Hayashizaki, Y., Hineno, S., Tarui, S. and Matsubara, K.
(1987) Gene 53, 1-10.
Kassavetis, G.A., Riggs, D.L., Negri, R., Nguyen, L.H. and Geiduschek, E.P.
(1989) Mol. Cell. Biol. 9, 2551-2566.
Kassavetis, G.A., Braun, B.R., Nguyen, L.H. and Geiduschek, E.P. (1990) Cell 
60, 235-245.
Kim, S.H., Sussman, J.C., Suddath, F.L., Quigley, G.J., McPherson, A., Wang,
A.H.J., Seeman, N.C. and Rich, A. (1974) Proc. Nat. Acad. Sci. U.SA.
157
71, 4970-4974.
Kim, S.H. (1979) in Transfer RNA : Structure. Properties and Recognition. 
pp.83-100, Schimmel, P.R., Soil, D. and Abelson J.N. (eds.) Cold Spring 
Harbour Laboratory, CHS New York.
Klekamp, M.S. and Weil, P.A. (1986a) J. Biol. Chem. 261, 2819-2827. 
Klekamp, M.S. and Weil, P.A. (1986b) Arch. Biochem. Biophys. 246, 783-800. 
Klekamp, M.S. and Weil, P.A. (1987) J. Biol. Chem. 262, 7878-7883.
Klemenz, R., Stillman, D.J. and Geiduschek, E.P. (1982) Proc. Nat. Acad. Sci.
U.SA. 79, 6191-6195.
Knapp, G., Beckmann, J.S., Johnson, P.F., Fuhrmann, S.A. and Abelson, J.
(1978) Cell 14, 221-236.
Koski, R.A., Clarkson, S.G., Kuijan, J., Hall, B.D. and Smith, M. (1980) Cell 
22, 415-425.
Koski, R.A. and Clarkson, S.G. (1982) J. Biol. Chem. 257, 4514-4521.
Koski, R.A., Allison, D.S., Worthington, M. and Hall, B.D. (1982) Nucleic Acids 
Res. 10, 8127-8143.
Kressmann, A., Hofstetter, H., Di Capua, E., Grosschedl, R. and Bimstiel, M.L.
(1979) Nucleic Acids Res. 7, 1749-1763.
Krupp, J.L., Shu, H.H. and Martin, N.C. (1988) Nucleic Acids Res. 16, 770. 
Larson, D., Bradford-Wilcox, J., Young, L.S. and Sprague, K.U. (1983) Proc.
Nat. Acad. Sci. U.SA. 80, 3416-3420.
Laski, F.A., Fire, A.Z., RajBhandary, U.L. and Sharp, P.A. (1983) J. Biol.
Chem. 258, 11974-11980.
Lassar, A.B., Martin, P.L. and Roeder, R.G. (1983) Science 222, 740-748. 
Lasser-Weis, M., Bawnick, N., Rosen, A., Sarid, S. and Daniel, V. (1981) 
Nucleic Acids Res. 9, 5965-5978.
Lawn, R.M., Fritch, E.F., Parker, R.C., Blake, G. and Maniatis, T. (1978) Cell 
15, 1157-1174.
Lin, V.K. and Agris, P.F. (1980) Nucleic Acids Res. 8, 3467-3480.
Lofquist, A. and Sharp, S. (1986) J. Biol. Chem. 261, 14600-14606.
Lofquist, A., Garcia, A. and Sharp, S.J. (1988) Mol. Cell. Biol. 8, 4441-4449. 
Long, E.O. and Dawid, I.B. (1980) Annu. Rev. Biochem. 49, 727-764.
Looney, J.E. and Harding, J.D. (1983) Nucleic Acids Res. 11, 8761-8775.
1 5 8
Ma, D.P., Lund, E., Dahlberg, J.E. and Roe, B.A. (1984) Gene 28, 257-262.
Makowski, D.R., Haas, R.A., Dolan, K.P. and Grunberger, D. (1983) Nucleic 
Acids Res. 11, 8609-8624.
Maniatis, T., Hardison, R.C., Lacy, E., Lauer, J., O'Connell, C., Quon, D., Sim, 
G.K. and Efstratiadis, A. (1978) Cell 15, 687-701.
Mao, J., Schmidt, O. and Soil, D. (1980) Cell 21, 509-516.
Marchfelder, A., Schuster, W. and Brennicke, A. (1990) Nucleic Acids Res. 18, 
1401-1406.
Marschalek, R. and Dingermann, T. (1988) Nucleic Acids Res. 16, 6737-6752.
Martin, R. (1987) BRL Focus 9, 7-8.
Marzluff, W.F., White, E.L., Benjamin, R. and Huang, R.C.C. (1975) 
Biochemistry 14, 3715-3724.
Marzouki, N., Camier, S., Ruet, A., Moenne, A. and Sentenac, A. (1986) Nature 
323, 176-178.
Mattocia, E., Baldi, M.I., Pande, G., Ogden, R. and Tocchini-Valentini, G.P.
(1983) Cell 32, 67-76.
McBride, O.W., Rajagopalan, M. and Hatfield, D. (1987) J. Biol. Chem. 262, 
11163-11166.
McBride, O.W., Pirtle, I.L. and Pirtle, R.M. (1989) Genomics 5, 561-573.
McCabe, P.C. (1990) in PCR Protocols. A Guide to Methods and Applications, pp. 
76-83, Innes, M.A., Gelfand, D.H., Sninsky, J J . and White, T.J. (eds), 
Academic Press, California.
McLaren, A. and Goddard, J.P. (1986) Nucleic Acids Res. 14, 5938.
McPherson, J.M. and Roy, K.L. (1986) Gene 42, 101-106.
Melton, D.A. and Cortese, R. (1979) Cell 18, 1165-1172.
Melton, D.A., De Robertis, E.M. and Cortese, R. (1980) Nature 284, 143-148.
Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) Nucleic Acids Res. 16, 1215.
Morrison, N., Goddard, J.P., Boyd, E., Boum, D. and Conner, J.M. (1991) 
Hum. Genet, (in press).
Mony, M.J. and Harding, J.D. (1986) Mol. Cell. Biol. 6, 105-115.
Morton, D.G. and Sprague, K.U. (1984) Proc. Nat. Acad. Sci. U .SA. 81, 
5519-5522.
Muller, F. and Clarkson, S.G. (1980) Cell 19, 345-353.
1 5 9
Muller, F., Clarkson, S.G. and Galas, D.J. (1987) Nucleic Acids Res. 15, 7191. 
Murphy, M.H. and Baralle, F.E. (1983) Nucleic Acids Res. 11, 7695-7700. 
Naylor, S.L., Sakagushi, A.Y., Shows, T.B., Grzeschik, K.H., Holmes, M. and 
Zasloff, M. (1983) Proc. Nat. Acad. Sci. U S A . 80, 5027-5031.
Newman, A.J., Ogden, R.C. and Abelson, J. (1983) Cell 35, 117-125.
Nordheim, A. and Rich, A. (1983) Nature 303, 674-679.
Normanly, J., Ogden, R.C., Horvath, S.J. and Abelson, J. (1986) Nature 321, 
213-219.
Normanly, J. and Abelson, J. (1989) Annu. Rev. Biochem. 58, 1029-1049. 
Norrander, J., Kempe, T. and Messing, J. (1983) Gene 26, 101-106.
O’Connor, J.P. and Peebles, C.L. (1991) Mol. Cell. Biol. 11, 425-439.
O’Farrel, P.Z., Cordell, B., Valenzuela, P., Rutter, W.J. and Goodman, H.M.
(1978) Nature 274, 438-445.
O'Neil, V.A., Eden, F.C., Pratt, K. and Hatfield, D.L. (1985) J. Biol. Chem. 
260, 2501-2508.
Ochman, H., Medhora, M.M., Garza, D. and Hard, D.L. (1990) in PCR Protocols. 
A Guide to Methods and Applications, pp. 219-227, Innes, M.A., Gelfand,
D.H., Sninsky, J.J. and White, T.J. (eds), Academic Press, California. 
Ogden, R.C., Lee, M.C. and Knapp, G. (1984) Nucleic Acids Res. 12, 
9367-9382.
Olsen, S., Pirtle, I.L., Pirtle, R.M. and McBride, O.W. (1987) Am. J. Hum.
Genet. 41, (supplement) A180.
Palmer, J.M. and Folk, W.R. (1990) T.I.B.S. 15, 300-304.
Peterson, R.C. (1987) Biochem. Biophys. Acta. 908, 81-89.
Pieler, T., Appel, B., Oei, S.L., Mentzel, H. and Erdmann, V.A. (1985a) EMBO J. 
4, 1847-1853.
Pieler, T., Oei, S.L., Hamm, J., Engelke, U. and Erdmann, V.A. (1985b) EMBO 
J. 4, 3751-3756.
Pieler, T., Hamm, J. and Roeder, R.G., (1987) Cell 48, 91-100.
Pirtle, I.L., Shortridge, R.D. and Pirtle, R.M. (1986) Gene 43, 155-167. 
Raymond, G.J. and Johnson, J.D. (1983) Nucleic Acids Res. 11, 5969-5988. 
Raymond, G.J. and Johnson, J.D. (1987) Nucleic Acids Res. 15, 9881-9894. 
Raymond, K.C., Raymond, G.J. and Johnson, J.D. (1985) EMBO J. 4,
1 6 0
2649-2656.
Reilly, J.G., Ogden, R. and Rossi, J.J. (1982) Nature 300, 287-289.
Rich, A. and RajBhandary, U.L. (1976) Annu.Rev. Biochem. 45, 805-860.
Robertus, J.D., Ladner, J.E., Finch, J.T., Rhodes, D., Brown, R.S., Clark,
B.F.C. and Klug A. (1974) Nature 250, 546-551.
Rogers, J.H. (1985) Int. Rev. Cytol. 93, 187-279.
Rooney, R J. and Harding, J.D. (1986) Nucleic Acids Res. 14, 4849-4864.
Rooney, R.J. and Harding, J.D. (1988) Nucleic Acids Res. 16, 2509-2521.
Rosen, A., Sarid, S. and Daniel, V. (1984) Nucleic Acids Res. 12, 4893-4906.
Rosen, A. and Daniel, V. (1988) Gene 69, 275-285.
Roy, K.L., Cooke, H. and Buckland, R. (1982) Nucleic Acids Res. 10, 
7313-7322.
Ruet, A., Camier, S., Smagowiez, W., Sentenac, A. and Fromageot, P. (1984) 
EMBO J. 3, 343-350.
Russo, T., Duilio, A., Ammendola, R., Costanzo, F. and Cimino, F. (1987a) 
Nucleic Acids Res. 15, 8562.
Russo, T., Oliva, A., Duilio, A., Ammendola, R., Costanzo, F., Zannini, M. and 
Cimino, F. (1987b) Bioch. Bioph. Res. Commun. 149, 1118-1124.
Sajjadi, F.G. and Spiegelman, G.B. (1987) Gene 60,13-19.
Sajjadi, F.G., Miller, R.C. and Spiegelman, G.B. (1987) Mol. Gen. Genet.. 206, 
279-284.
Sakonju, S., Bogenhagen, D.F. and Brown, D.D. (1980) Cell 19, 13-25.
Sakonju, S., Brown, D.D., Engelke, D.R., Ng, S.Y., Shastry, B.S. and Roeder, 
R.G. (1981) Cell 23, 665-669.
Saluz, H. and Jost, J.P. (1989) Proc. Nat. Acad. Sci. U S A . 86, 2602-2606.
Sambrook, J. Fritsch, E.F. and Maniatis, T. (19891 Molecular cloning, a laboratory 
manual. Cold Spring Harbor Laboratory, C.S.H. New York.
Sampson, J.R., Di Renzo, A., Behlen, L. and Uhlenbeck, O.C. (1989) Science 
243, 1363-1366.
Sandmeyer, S.B. and Olson, M.V. (1982) Proc. Nat. Acad. Sci. U.S.A. 79, 
7674-7678.
Sandmeyer, S.B., Bilanchone, V.W., Clark, D.J., Marcos, P., Carle, G.F. and 
Brodeur, G.M. (1988) Nucleic Acids Res. 16, 1499-1515.
1 6 1
Sanger, F., Coulson, A.R., Barrell, B.G., Smith, A.J.H. and Roe, B.A. (1980) 
JM ol. B io l. 143, 161-178.
Santoro, C., Costanzo, F. and Ciliberto, G. (1984) EMBO J. 3, 1553-1559. 
Santos, T. and Zasloff, M. (1981) Cell 23, 699-709.
Schaack, J., Sharp, S., Dingermann, T. and Soli, D. (1983) J. Biol. Chem. 258, 
2447-2453.
Schaack, J., Sharp, S., Dingermann, T., Burke, D.J., Cooley, L. and Soil, D.
(1984) J. Biol. Chem. 259, 1461-1467.
Schaack, J. and Soil, D. (1985) Nucleic Acids Res. 13, 2803-2814.
Schlissel, M.S. and Brown, D.D. (1984) Cell 37, 903-913.
Schmidt, O., Mao, J., Ogden, R., Beckmann, J., Sakano, H., Abelson, J. and 
Soli, D. (1980) Nature 287,750-752.
Schmidtke, J. and Cooper, D.N. (1990) Nucleic Acids Res. 18, (sequences 
supplement) 2413-2547.
Schmutzler, C. and Gross, H J. (1990) Nucleic Acids Res. 18, 5001-5008. 
Schneider, H.R., Waldschmidt, R., Jahn, D. and Seifart, K.H. (1989) Nucleic 
Acids Res. 17, 5003-5017.
Schneider, H.R., Waldschmidt, R. and Seifart, K.H. (1990) Nucleic Acids Res.
18, 4743-4750.
Schulman, L.H. and Pelka, H. (1988) Science 242, 765-768.
Schulman, L.H. and Pelka, H. (1990) Nucleic Acids Res. 18, 285-289. 
Schweizer, E., MacKennie, C. and Halvorsen, H.O. (1969) J. Mol. Biol. 40, 
261-277.
Segall, J., Matsui, T. and Roeder, R.G. (1980) 7. Biol. Chem. 255, 11986-11991. 
Sekiya, T., Kuchino, Y. and Nishimura, S. (1981) Nucleic Acids Res. 9, 
2239-2250.
Setzer, D.R. and Brown, D.D. (1985) J. Biol. Chem. 260, 2483-2492.
Sharp, S., De Franco, D., Silberklang, M., Hosbach, H.A., Schmidt, T., Kubli,
E., Gergen, J.P., Wensink, P.C. and Soil, D. (1981a) Nucleic Acids Res. 9, 
5867-5882.
Sharp, S., De Franco, D., Dingermann, T., Farell, P. and Soil, D. (1981b) Proc.
Nat. Acad. Sci. U.SA. 78, 6657-6661.
Sharp, S., Dingermann, T. and Soli, D. (1982) Nucleic Acids Res. 10, 5393-5406.
162
Sharp, S., Dingermann, T., Schaack, J., De Franko, D. and Soli, D. (1983a) 
JBiol. Chem. 258, 2440-2446.
Sharp, S., Dingermann, T., Schack, J., Sharp, J.A., Burke, D.J., De Robertis,
E.M. and Soil, D. (1983b) Nucleic Acids Res. 11, 8677-8690.
Sharp, S., Schaack, J., Cooley, L., Burke, D.J. and Soil, D. (1985) Crit. Rev.
Biochem. 19, 107-144.
Shaw, K.J. and Olson, K.V. (1984) Mol. Cell. Biol. 4, 657-665.
Shibuya, K., Noguchi, S., Nishimura, S. and Sekiya, T. (1982) Nucleic Acids 
Res. 10, 4441-4448.
Shibuya, K., Nogushi, S., Yamaki, M., Nishimura, S. and Sekiya, T. (1985) 
J  Biochem. 97, 1719-1725.
Shortridge, R.D., Pirtle, I.L. and Pirde, R.M. (1985) Gene 33, 269-277. 
Shortridge, R.D., Johnson, G.D., Craig, L.C., Pirtle, I.M. and Pirtle, R.M. (1989) 
Gene 79, 309-324.
Smardo, F.L. and Calvet, J.P. (1987) Gene 57, 213-220.
Sollner-Webb, B. (1988) Cell 52, 153-154.
Southern, E.M. (1975) J. Mol. Biol. 98, 503-517.
Sprague, K.U., Larson, D., and Morton, D. (1980) Cell 22, 171-178.
Sprinzl, M., Hartmann, T., Weber, J., Blank, J. and Zeidler, R. (1989) Nucleic 
Acids Res. 17, (sequences supplement) rl-rl72.
Staden, R. (1986) Nucleic Acids Res. 14, 217-231.
Standring, D.N., Venegas, A. and Rutter, W.J. (1981) Proc. Nat. Acad. Sci.
U.S.A. 78, 5963-5967.
Steffenson, D.M. and Wimber, D.E. (1971) Genetics 69, 163-178.
Stillman, D J. and Geiduschek, E.P. (1984) EMBO J. 3, 847-853.
Stillman, D.J., Sivertsen, A.L., Zetner, P.G. and Geiduschek, E.P. (1984) J. Biol.
Chem. 259, 7955-7962.
Stillman, D.J., Better, M. and Geiduschek, E.P. (1985) J. Mol. Biol. 185, 
451-455.
Stuka, R. and Feldmann, H. (1988) Nucleic Acids Res. 16, 3583.
Suddath, F.L., Quiglely, J., McPherson, A., Sneden, D., Kim, J., Kim, S.H. and 
Rich, A. (1974) Nature 248, 20-24.
Suter, B. and Kubli, E. (1988) Mol. Cel. Biol. 8, 3322-3331.
1 6 3
Swerdlow, H. and Guthrie, C. (1984) J. Biol. Chem. 259, 5197-5207.
Szekely, E., Belford, H.G. and Greer, C.L. (1988) J. Biol. Chem. 263, 
13839-13847.
Szweykowska-Kulinska, Z. and Beier, H. (1991) Nucleic Acids Res. 19, 
707-712.
Thomann, H., Schmutzler, C., Hudepohl, U., Blow, M. and Gross, H.J. (1989) J.
Mol. Biol. 209, 505-523.
Thurlow, D.L., Shilowski, D. and Marsh, T.L. (1991) Nucleic Acids Res. 19, 
885-891.
Traboni, C., Cortese, R. and Salvatore, F. (1980) Nucleic Acids Res. 8, 
5223-5232.
Traboni, C., Ciliberto, G. and Cortese, R. (1984) Cell 36, 179-187.
Twigg, A.J. and Sherratt, D. (1980) Nature 283, 216-218. 
van Dyke, M.W. and Roeder, R.G. (1987) Nucleic Acids Res. 15, 5031-5039. 
van Tol, H., Stange, N., Gross, H.J. and Beier, H. (1987) EMBO J. 6, 35-42. 
van Tol, H. and Beier, H. (1988) Nucleic Acids Res. 16, 1951-1966.
Vnencak-Jones, C.L., Wahab, S.Z., Zehener, Z.E. and Holmes, W.M. (1987) 
Mol. Cell. Biol. 7, 4134-4138.
Wahab, S.Z., Holmes, W.M. and Zehner, Z.E. (1989) Gene 77, 361-370. 
Watson, J.D., Hopkins, N.H., Roberts, J.W., Steitz, J.A. and Weiner, A.M.
(1987) Molecular Biology of the Gene. The Benjamin Publishing Company. 
Weber, L. and Berger, E. (1976) Biochemistry 15, 5511-5519.
Weil, P.A., Segall, J., Harris, B., Ng, S.Y. and Roeder, R.G. (1979) J. Biol.
Chem. 254, 6163-6173.
Weiner, A.M., Deninger, P.L. and Efstratiadis, A. (1986) Annu. Rev. Biochem. 
55, 631-661.
White, T.J., Amheim, N. and Erlich, H.A. (1989) TJ.G. 5, 185-189.
Willis, J., Hottinger, H., Pearson, D., Chisholm, V., Leupold, U. and Soil, D.
(1984) EMBO J. 3, 1573-1580.
Wilson, E.T., Larson, D., Young, L.S. and Sprague, K.U. (1985) J. Mol. Biol. 
183, 153-163.
Wormington, W.M., Bogenhagen, D.F., Jordan, E. and Brown, D.D. (1981) Cell 
24, 809-817.
164
Wu, G.J., Railley, J.F. and Cannon, R.E. (1987) J. Mol. Biol. 194, 423-442. 
Yanish-Perron, C., Viera, J. and Messing, J. (1985) Gene 33, 103-119.
Yen, P.H. and Davidson, N. (1980) Cell 22, 137-148.
Yoo, S.H. (1984) Korean J. Genet. 6, 101-108.
Yoshinaga, S.K., Boulanger, P.A. and Berk, A.J. (1987) Proc. Nat. Acad. Sci.
U.S.A. 84, 3585-3589.
Yoshinaga, S.K., L'Etoile, N.D. and Berk, A.J. (1989) J. Biol. Chem. 264, 
10726-10731.
Young, L.S., Takahashi, N. and Sprague, K. U. (1986) Proc. Nat. Acad. Sci.
U.S.A. 83, 374-378.
Zasloff, M. and Santos, T. (1980) Proc. Nat. Acad. Sci. U.SA. 77, 5668-5672. 
Zasloff, M., Santos, T., Romeo, P. and Rosenberg, M. (1982) J. Biol. Chem. 
257, 7857-7863.
1 6 5
Publications
Bourn, D. and Goddard, J.P. (1990) Nucleic Acids Res. 18, 7442.
Morrison, N„ Goddard, J.P., Boyd, E., Bourn, D. and Connor, J.M. (1991) 
Hum. Genet, (in press).
